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Abstract
Kinetic analysis of dynamic PET data requires an accurate estimation of the concen-
tration of the available tracer in blood plasma, also known as the arterial input func-
tion (AIF). The gold standard method to determine the AIF involves serial blood
sampling and is avoided in practice due to its invasiveness. An image derived input
function (IDIF) can be a blood-free alternative but its accuracy is limited due to
partial volume (PV) effects caused by the restricted spatial resolution of PET scan-
ners. Furthermore, IDIFs are not accurate when metabolite products are present
in the blood. Magnetic resonance imaging (MRI) can provide complementary in-
formation to PET with high spatial resolution and excellent soft tissue contrast.
Furthermore, dynamic MRI techniques can be reliably used to measure the AIF, the
concentration of contrast agent in plasma, due to their high temporal resolution.
The underlying aim of this research is to improve IDIF estimation in PET, util-
ising spatial and temporal information from MRI. An IDIF measurement method
was developed which involves segmentation of carotid arteries from MR angiog-
raphy images and uses a practical PVC method to correct for PV effects. It was
demonstrated that the IDIFs can be used to compute the cerebral metabolic rate of
glucose in the brain with no significant difference compared to arterial sampling.
Abstract 4
The simultaneous estimation method (SIME) is an alternative technique used
to estimate the AIF by fitting time activity curves derived from multiple regions.
Due to its computational complexity, SIME is usually complemented with blood
samples. In this work, we observed that the early part of an image derived blood
curve or an MRI derived AIF could provide prior knowledge regarding the AIF. This
was incorporated into SIME to make more accurate kinetic parameter estimations
and to perform blood-free analysis of tracers with metabolites.
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Chapter 1
Introduction
Since the discovery of X-ray imaging by Roentgen [Roentgen, 1895] in 1895, di-
agnostic imaging has been used to look non-invasively inside the human body.
In 1953, the first clinical positron imaging device was developed by Brownell et
al. [Brownell and Sweet, 1953]. That scanner produced a low resolution image
only, but was sensitive in determining if a tumour existed in the brain. In order to
further increase sensitivity the first multiple detector positron imaging device was
developed in 1962 [Brownell et al., 1969]. That scanner, specifically developed for
brain imaging, was used for clinical purposes for nearly a decade and found signif-
icant clinical use in cancer imaging and in research to image molecular processes.
Dual-modality imaging systems, such as Positron Emission Tomography
(PET) /Computed Tomography (CT), were introduced in 2000s and today, over
5000 PET/CT systems are installed worldwide as PET/CT has become the modality-
of-choice for clinical oncology scans [Beyer et al., 2000]. The coregistered anatom-
ical information provided from CT scans benefited PET scanners which lack an
equivalent spatial resolution. However, PET/CT has several limitations which could
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be overcome by replacing the CT part with an Magnetic Resonance Imaging (MRI)
scanner. In clinical systems, PET and CT detectors are not combined together and
hence the PET and CT components have to be placed axially. Therefore, PET/CT
scanners can only be used for sequential imaging rather than simultaneous. This
may lead to errors in image alignment and registration and may result in residual
patient motion as the images are obtained at different times. In addition, sequential
imaging can limit the accuracy of combined dynamic PET and CT studies as the
physiology of the patient may change between the sequential scans. Finally, both
PET and CT imaging cause exposure to radiation which limits the use of PET/CT
scanners in research studies.
The development of hybrid PET/MRI scanners started in the late 90s and saw
some interest as MRI brought some advantages compared to CT in anatomical imag-
ing. MRI offers high resolution images and is able to provide a strong visualisation
of soft tissues. On the other hand, PET has a very high sensitivity and is very
useful in the imaging of metabolic processes in living bodies, but lacks the spatial
resolution offered by MRI. Hence, it can be said that PET and MRI are highly com-
plementary and combination of these two modalities was a natural research topic.
During this decade, fully integrated clinical PET/MRI scanners have been man-
ufactured by Siemens Healthcare and GE Healthcare where a 3 Tesla whole-body
MR system hosts a fully integrated PET detector in its isocenter. MRI provided
anatomical information with excellent soft tissue contrast and spatial resolution to
complement excellent sensitivity of PET. Advent of this simultaneous PET/MR
modality opened the doors for a wide research area, and researchers, radiologists
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and nuclear medicine physicians started to evaluate the clinical potential of this new
scanner and to validate new imaging applications. The technology and specifics of
these integrated PET/MRI systems are further described in this thesis.
1.1 Motivation
In both PET and MRI, dynamic data can be acquired immediately after an admin-
istration of a PET tracer or Gadolinium based MR contrast agent. As most PET
tracers can get into the cells and get bound or metabolised there, PET imaging
provides information about intracellular processes whereas MR can only provide
insight about processes happening in the extracellular space as Gd chelates cannot
penetrate into cells.
Both dynamic PET and MRI data can be analysed using compartmental ki-
netic analysis methods which require an accurate knowledge of the tracer/contrast
agent concentration in the blood over time, also known as the arterial input func-
tion (AIF). In both PET and MR imaging, the gold standard method to measure
the AIF involves collection of arterial samples during the scanning period, which
makes it an invasive and laborious process. Furthermore, MR compatible arterial
sampling instruments are required for arterial sampling in a PET/MR scanner which
can add to the costs. These limitations stop many research centres from collecting
arterial samples and there is therefore a need for more practical and non-invasive
alternatives.
The AIF can be measured using image-based methods from reconstructed PET
and MRI images, but these techniques have separate limitations and data correction
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steps that involve several assumptions. PET data can provide truly quantitative
information regarding the concentration of the PET tracer in the arterial plasma at a
specific time, whereas MRI scanners can only approximately relate the signal to the
contrast agent concentration. On the other hand, MRI can have a very high temporal
resolution which can be used to track the rapid changes in the early phase of the
dynamic scan whereas PET scanners are limited to lower temporal sampling as
they require sufficiently high counts to have meaningful data. Furthermore, due to
the lower spatial resolution of PET scanners, PET images can suffer from spill-over
effects from surrounding tissues, hence an AIF measurement from small arteries
will be contaminated from signal from background regions.
Acquiring dynamic PET and MRI data simultaneously can offer a better spatial
and/or temporal correlation of datasets from both modalities. Information from
these two modalities can be used to complement each other and enable combined
analysis of dynamic PET and MRI datasets. Simultaneously acquired PET and
MRI images can be aligned more easily as the patient motion and positioning is not
expected to change much between image acquisitions. Coregistered MR images
with higher spatial resolution can be used to obtain a more accurate segmentation
of the anatomical structures and use them to perform PVC and regional analysis of
PET images. This can also be applied to estimate an Image-derived input function
(IDIF) from PET images more accurately by utilising spatial information from MR
images. Simultaneous PET/MR imaging can be used to estimate PET-AIF and MRI-
AIF from the same scan and one can hypothesise that mutual information is present
between these two AIFs. If a reliable AIF conversion between PET-AIFs and MRI-
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AIFs could be performed, the complementary information from both modalities
would not only enable us to devise more accurate non-invasive methods to measure
the AIF, but would also provide an opportunity for a joint kinetic modelling of data
from both modalities.
(a)
PET/MRI Data
Derivation of PET-AIF 
parameters from MRI-
AIF
Utilising MRI-AIF in joint 
estimation of PET-AIF with 
kinetic parameters
Noninvasive analysis of 
PET tracers with 
radiometabolite products
Using Anatomical MRI 
images in quantification 
PET arterial TACs
(b)
(c) (d)
Figure 1.1: Brief outline of the project aims
The goal of this research project is to develop non-invasive PET input function
measurement techniques and to improve these by utilising MRI data. Our ultimate
aim is to apply developed methods to non-invasively analyse PET tracers with radio-
labelled metabolites, without the need to collect any arterial samples. The steps we
have been taking to reach this aim are illustrated in figure 1.1 and can be listed as:
(a) Improving the quantification of image derived PET arterial time activity curves
(TACs) by using anatomical MR images in the delineation of arterial voxels and
partial volume correction.
(b) Testing if a parameter conversion between a PET-AIF and an MRI-AIF can be
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performed
(c) Constraining the PET Simultaneous Estimation Method (SIME) which jointly
estimates the input function and kinetic parameters by incorporating prior in-
formation from PET or MRI blood curves.
(d) Using the constrained SIME method with prior AIF information to perform
blood-free kinetic analysis of PET data when radiometabolites are present in
the blood plasma.
1.2 Organisation of the Thesis
The aim of the first chapter is to give an introduction to PET/MRI imaging, state
our motivation and direction of research. In the second chapter, the physical theory
of PET and MRI imaging is briefly presented. The basics of PET and MRI scanners
are described and various data acquisition and data correction techniques are out-
lined. The design of hybrid PET/MRI scanners is also briefly described. Methods
used in the coregistration of PET and MRI images are presented and finally, PET at-
tenuation correction techniques with MR derived attenuation maps are summarised.
In Chapter 3, an introduction to dynamic imaging in PET and Dynamic MRI
is given, including the kinetic analysis and compartmental modelling of these dy-
namic data. Introduction to both Dynamic Contrast Enhanced MRI (DCE-MRI)
and Dynamic Susceptibility Contrast MRI (DSC-MRI) is also given in this chapter.
The need for accurate measurement of the arterial input functions in both dynamic
PET and MRI analysis is explained and a comparison of different methods used for
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measuring AIF is included.
Chapter 4 includes the methodology developed to derive an arterial input func-
tion from PET images by using anatomical information from MR angiography im-
ages. MR angiography images with almost five times smaller voxel size than PET
images are used to segment the carotid arteries. A novel PVC is also presented in
this chapter which only requires the segmentation of carotid arteries and does not
need parcellation of background regions. The PVC method is used to correct PVC
of dynamic PET frames for image derived input function extraction. The method is
tested on 18F-FDG datasets and validated against the gold standard arterial plasma
samples.
Simultaneous estimation of the arterial input function and kinetic modelling of
multiple brain regions is also possible without any need for separately measuring
the input function from images or blood samples. However, this method is computa-
tionally complex due to the high number of parameters to be estimated and may not
always work with the desired accuracy. In Chapter 5, the effects of incorporating
prior information to reduce the number of input function parameters on estimated
kinetic parameters is presented. The proposed method is evaluated with simulated
18F-FDG time activity curves.
In Chapter 6, the comparison of PET derived arterial input functions and MRI
derived arterial input functions are made. The necessary corrections such as ac-
counting for different injection durations are presented in detail. Input function
from 18F-fluorocholine and DSC-MRI studies are compared visually after neces-
sary corrections. These AIFs were fitted using analytical input function models and
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a comparison of fitted parameters is also presented.
In Chapter 7, the constrained SIME method with prior AIF information is used
to analyse clinical 18F-FDG and 11C-SB207145 PET datasets. The results obtained
with the proposed method are validated against results obtained using the gold stan-
dard arterial blood samples. Statistical tests are also performed to evaluate the per-
formance of the proposed method.
Finally, the conclusions of the research are further discussed in chapter 8 and
findings from each chapter are summarised. Suggestions for possible future re-
search directions are also discussed in this final chapter.
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Chapter 2
Background Theory to PET and MR
Imaging
2.1 Theory of Positron Emission Tomography
In positron emission tomography (PET), small amounts of positron-emitting ra-
dionuclides are tagged to molecules of interest, known as radiotracers and are ad-
ministered to the subject. PET scanners detect the photons emitted as the result
of radioactive decay and convert this measurement into a meaningful image which
shows the distribution of the radionuclide.
During the radioactive decay of the PET tracer, a positron and a neutrino are
ejected from the nucleus. The positron travels a finite distance, called positron
range, and gradually loses its kinetic energy until it comes to near rest and then
combines with an electron, causing an annihilation. This annihilation emits two 511
keV photons in opposite directions, 180◦ to each other, as illustrated in figure 2.1.
PET imaging relies on the detection of these annihilation events which is further
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explained in section 2.2.
Table 2.1: A selection of common PET radiotracers with their characteristics
Tracer Radio Nuclide Half-life (min) Biological Process
18F-FDG 18F 109.8 Glucose metabolism
18F-FMISO 18F 109.8 Hypoxia
11C-methionine 11C 20.4 Cellular amino acid uptake
15O-water 15O 2.03 Perfusion
82Rb-Chloride 82Rb 1.27 Perfusion
+Decay
-
Positron
Electron
511 keV photon
511 keV photon
Annihilation
Positron-emitting
radionuclide
Figure 2.1: The process of positron emission, decay and subsequent annihilation emitting
two photons in opposite directions.
Different chemical compounds, which are often used by the body like glucose
and water, can be tagged with positron emitting radionuclides to generate radioac-
tive tracers. Radionuclides with short half lives such as 18F, 11C, 13N and 15O
are usually used in PET imaging. New tracers are continuously being developed
in order to reveal different aspects of the process of interest. Some of the most
commonly used radiotracers are listed in table 2.1 [International Atomic Energy
Agency, 2008] [Sharma and McConathy, 2013].
Among all these PET radiotracers listed in table 2.1, 18F-fluorodeoxyglucose
(18F-FDG) is the most commonly used. 18F-FDG is a radiolabelled glucose ana-
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logue and it is used in PET imaging to determine sites where glucose metabolism
is high. 18F-FDG is taken up by glucose using cells such as brain, kidney or can-
cer cells and gets phosphorylated, preventing the glucose from being released again
from the cell. One application of 18F-FDG PET imaging is to detect tumours in
oncology imaging [Conti et al., 1996] [Fletcher et al., 2008]. Since the cancer cells
grow and divide faster than normal cells, they require more energy and metabolise
more glucose, resulting in increased glucose uptake. As a result of that, these tis-
sues have higher 18F-FDG uptake in the resulting PET images. Another common
tracer, 15O-water is a freely diffusible tracer and does not depend on the metabolic-
trapping mechanism which makes it useful for applications to measure blood flow
and perfusion [Lubberink et al., 2010] [Salerno and Beller, 2009].[18F]fluorocholine
(FCH) is a commonly used tracer for imaging brain tumours citeLam2011 [Roselli
et al., 2010] but also for prostate studies [Bauman et al., 2012]. It targets cellular
membrane phospholipids, primarily in cancer cells. It penetrates into cells through
choline transporters and accumulates in tumours due to malignancy-induced over-
expression of choline kinase.
2.2 PET Image Formation
The principle of PET imaging is the detection of the photons emitted from the
positron annihilation. A typical PET scanner is formed by multiple rings arranged in
a cylindrical shape. Once the scintillation detectors detect a pair of photons arriving
in coincidence, where a conincidence detector decides if the detection of this pair
of scintillation photons occurred within a specific timing window (6-10 ns) [Cherry
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and Dahlbom, 2006], they emit lower energy visible light photons which are de-
tected and amplified by the photomultiplier tubes or photo diodes. When the two
photons are detected within in a coincidence window, it shows that the positron an-
nihilation occurred somewhere on the line of response (LOR) connecting the two
opposing detectors (Figure 2.2). The rate of detections, count rates, will be propor-
tional to the activity of the source.
Figure 2.2: PET coincidence detection of a pair of 511keV photons emitted from an anni-
hilation. A line of response (LOR) is identified between the two detectors
During the PET acquisition, coincidence events related to each LOR between
pairs of detectors are stored in bins where LORs passing through the same point
within the object form a sinusoid curve in the raw data histogram, called a sinogram.
The set of these projections produces the sinogram for a single plane and these
sinograms are reconstructed to generate a 3D image of the subject.
As an alternative, list-mode acquisition can be performed which also records
the arrival times of the events in a list. The list-mode data are sorted into sinograms
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with additional timing information. The disadvantage of acquiring in list-mode is
that it occupies larger memory space. On the other hand, list-mode data can be used
to avoid binning of LORs into detector pixels or voxels, which can lead to informa-
tion loss. Direct reconstruction from list-mode data can avoid this step, fully util-
ising the temporal and spatial list-mode information. List-mode acquisitions have
applications in high resolution image reconstruction [Reader et al., 2002], dynamic
imaging [Nichols et al., 2002] and motion correction [Carson et al., 2003].
Once the sinograms are obtained, the source distribution can be reconstructed
using various methods. The aim of an image reconstruction method is to provide
an image which describes the distribution of the radiotracer within the object from
the detected coincidence events. One way of reconstructing PET data is using the
Filtered Back Projection (FBP) method, which is a version of the inverse Radon
transform [Kak and Slaney, 1988]. In this method, a filter function is applied to the
projections in Fourier space and the activity is back-projected in the image space.
The backprojection causes a blurring effect of the object and this is corrected by
applying ramp filtering as well as a smoothing function. FBP method has the ad-
vantage of being very fast and FBP derived images are widely used in quantitative
analysis as the resolution and variance in FBP derived images are predictable due
to the linear nature of the algorithm.
PET data can also be reconstructed using iterative reconstruction techniques,
which are iterative processes where the intermediate image converges toward the
’true’ image. Iterative reconstruction aims to model the data collection process and
includes statistical variance as well as other factors such as scattered and random
2.2. PET Image Formation 38
coincidence events. Maximum Likelihood Expectation Maximisation (MLEM)
[Shepp and Vardi, 1982] is an iterative algorithm which updates the image at each
iteration by using the ratio of estimated projections with the acquired projections
until convergence is reached. MLEM is usually regarded as a slow method due to
the large number of iterations required to get an optimal solution. Ordered Sub-
sets Expectation Maximisation (OSEM) algorithm [Hudson and Larkin, 1994] was
proposed as a more efficient alternative to MLEM. In OSEM, the projections are
grouped into subsets and the image is updated once for each subset.
Fully functional time-of-flight (TOF) PET systems were introduced in early
1980s to increase the signal to noise ratio [Lewellen, 1998]. In a TOF PET system,
the difference in arrival times between the 2 coincident photons is measured for each
annihilation event. This information is used to determine the most likely location of
the source along the LOR. The TOF information usually contains uncertainties but
even imperfect TOF information helps to improve the image reconstruction [Surti
et al., 2007].
2.2.1 Data Corrections
In practice, the PET data acquisition is not perfect and there are a few factors in
the measurement data that need to be taken into account. These effects need to
be corrected in order to acquire clinically useful images that can provide accurate
quantitative information from PET studies. One of these source of error is Compton
scattering, where a photon collides with another electron and changes direction.
This may cause the LOR not to pass through the annihilation location and will cause
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an erroneous LOR to be recorded (figure 2.3a). Correction for scatter is usually
done using a single scatter simulation approach, which is based on Monte Carlo
simulation of the path of scattered events [Watson et al., 1996].
Another source of error in PET data acquisition is the random coincidences
(figure 2.3b), where two photons which are not originated from the same source are
detected in the same timing window, causing an erroneous measurement of an LOR.
These are usually corrected using a delayed coincidence timing window in which
only random events can occur. Once measured, the mean of random counts are sub-
tracted from each sinogram bin to obtain the ’randoms subtracted’ data. Dead time,
or pile-up effect, is the arrival of a new photon at a detector before the processing
of the preceding photon is completed and can be another source of error in the ob-
tained PET data. Correction for the radioactive decay of the radionuclide from the
injection time is also need to be considered for accurate quantification of the PET
data. Decay correction is performed by calculating the exponential decay of the
tracer activity over the course of a scan and correcting the data acquired at a later
time back to the original activity recorded at the beginning of the scan. Half-lives
of some radionuclides used commonly in PET imaging are given in table 2.1.
Another major factor which needs to be considered is the attenuation effects,
which causes a reduction in the number of coincidences detected along the LOR due
to the dense tissue causing one or both photons to scatter or not to penetrate through
to reach the detectors. Traditionally, attenuation correction is done using a transmis-
sion source, where the ratio of detected events originating from a rotating rod source
is computed before and after the patient is placed in the scanner, allowing the total
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(a) Scatter coincidence (b) Random coincidence
Figure 2.3: Detection of scattered and random coincidence events, causing an erroneous
line of response.
attenuation along each LOR to be directly measured. However, as this approach
requires an extra scan some alternative methods are introduced. For instance, an
attenuation map can be computed from CT images in a combined PET/CT scanner
which can be used to differentiate the attenuation media within the patient body on
a voxel-by-voxel basis [Kinahan et al., 1998]. This is done by calculating attenu-
ation coefficients of x-ray in tissue and converting that to suitable values for PET
energy (511 keV) to produce the attenuation map. On the other hand, attenuation
correction is still a major problem in PET/MRI scanners and various new methods
have been recently introduced. Details about attenuation correction in PET/MR is
discussed in section 2.4.
2.2.2 Partial Volume Correction
Due to the limited spatial resolution of PET scanners and sampling of an activity
distribution into a finite voxel grid, PET images suffer from partial volume (PV) ef-
fects which can result in spill-over effects between neighbouring tissues. Even the
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images from high resolution research PET scanners (HRRT) for human brain with
a spatial resolution, 2.3-3.2 mm (FWHM) in the transaxial direction and 2.5-3.4
mm FWHM in the axial direction [Van Velden et al., 2008] suffer from PV effects
and need to be corrected. A typical modern PET scanner has a spatial resolution
of around 4.5 mm in the transaxial plane [Delso et al., 2011] [Levin et al., 2016].
This resolution and recontruction of images cause a greater blurring effect on the
images. Spatial resolution of a PET scanner can be measured by acquiring images
with a 22Na point source, which is the NEMA standard located at different loca-
tions within the field of view. FWHMs on the line profiles through the voxel on
reconstructed PET images are measured and regarded as the spatial resolution of
the scanner [Delso et al., 2011].
Larger PV effects are seen when imaging smaller structures such as carotid
arteries with a diameter of 4.5-6.5 mm [Krejza et al., 2006a] or grey matter of cere-
bral cortex with a thickness of 2-4 mm [Pakkenberg and Gundersen, 1997] and these
structures look blurred on the PET images. The blurring effect which is the main
cause of the PV effects can be described as the convolution of the activity within
the object with the Point Spread Function (PSF) of the imaging system. PSF de-
scribes the response of the scanner to a point source and represents the degree of
blurring applied to the reconstructed images [Soret et al., 2007] [Erlandsson et al.,
2012a]. Due to the PV effects, reconstructed voxels will often contain contributions
from neighbouring tissue types and will have spill-in effects from nearby high ac-
tivity objects and spill-out effects to background regions with lower activities. This
phenomenon is illustrated in figure 2.4.
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Figure 2.4: Line profiles of the true object and the measured object is shown in (a). Inten-
sities within the object are lost due to spill-out effects to surrounding tissues.
An axial slice of the true object (b) and the measured object with PV effects (c)
are also illustrated
It is essential to correct for spill-in and spill-out effects before making any
quantitative measurements on the reconstructed PET images. There have been mul-
tiple methods proposed to correct for PV effects and these can be applied both in
sinogram or image space, during or after the reconstruction process. These meth-
ods can then be classified as region based or voxel based methods. Erlandsson et al.
has presented a good review of the existing partial volume correction (PVC) meth-
ods [Erlandsson et al., 2012a]. Most of these methods use segmentation of various
brain structures from anatomical MR or CT images of the subject. Knowledge of
the anatomy can then be utilised in the PVC of the PET data. PV effects can be time
dependent due to tracer kinetics and cardiac, respiratory or patient motions. There-
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fore, each PET frame should be separately corrected, when analysing dynamic PET
images.
Meltzer et al. [Meltzer et al., 1990] proposed their method which corrects
for the spill-over effects between brain tissues including grey matter (GM) and
white matter (WM) and non-brain regions including cerebral spinal fluid (CSF) re-
gions. Assuming no uptake in non-brain tissues, the observed image was described
as contributions from two compartments which are convolved with PSF. Mu¨ller-
Ga¨rtner [Mu¨ller-Ga¨rtner et al., 1992] has extended this method to also correct for
spill-out and spill-in effects between GM and WM regions. In this method, the brain
MR image is segmented into GM, WM and CSF regions and the GM is corrected
for PV effects. The method works by scaling the background regions to an estimate
of their mean value, convolving it with the PSF and subtracting it from the observed
PET image, correcting for the GM voxels. The Muller Gartner method provides a
voxel-wise correction for the GM tissue
Rousset et al. proposed the Geometric Transfer Matrix (GTM) method [Rous-
set et al., 1998a] which performs region-based correction utilising anatomical MR
data. In this method, the MR image is parcellated into a set of discrete ROIs where
each region is assumed to contain a uniform activity which can accurately repre-
sented using its mean value. Each region is individually convolved with the PSF
and contribution of each region to its neighbours is calculated by summing the
voxel intensities which overlap true region a and blurred region b and dividing it
to total number of voxels in region a. These contributions are used to construct a
matrix known as the Geometric Transfer Matrix. Thus, GTM yields corrected re-
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gional mean values of segmented regions. If the segmentation and coregistration
errors are neglected, it can be said that using higher number of regions in GTM
correction can improve the accuracy of the PVC. Yang et al. [Yang et al., 1996]
presented their method where the brain is parcellated into multiple regions and each
region is represented using their true relative mean value to a reference region. This
image is convolved with the PSF to obtain the correction factors as the ratio of two
images, before and after the convolution. The main limitation of Yang’s method is
its requirement for strong prior information about true relative activity distribution
between the brain regions.
Erlandsson et al. reported a hybrid PVC method, named Multi-target cor-
rection (MTC) [Erlandsson et al., 2006]. Unlike GTM, MTC can provide a PV
corrected image and can correct for multiple regions. This method uses GTM
method to get PV-corrected mean values for various regions and then performs a
voxel-based PV correction for these regions. Erlandsson et al. presented an al-
ternative method called iterative Yang method, where the PVC was applied and
regional mean values are estimated in an iterative fashion. New regional values
were computed in each iteration and the correction was repeated [Erlandsson et al.,
2006]. This method corrects for PV effects in voxel basis and does not rely on
any prior information about the activity distribution between the regions. PVC
can alternatively be performed using wavelet-based correction techniques [Bous-
sion et al., 2006] [Shidahara et al., 2009]. These techniques involve transformation
from image domain to wavelet domain to perform multiresolution analysis of the
images [Turkheimer et al., 1999], which allows incorporation of anatomical infor-
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mation into PET images.
2.3 Theory of Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) was developed based on nuclear magnetic res-
onance (NMR), which is the phenomenon that in the presence of a magnetic field,
nuclei of atomic particles absorb and re-emit electromagnetic radiation. Protons
possess an intrinsic property referred to as spin which can be visualised as a form
of precessional movement about an axis. As shown in figure 2.4, these spins are
normally randomly aligned and in overall produce no net magnetic moment. When
an external magnetic field, B0, is presented, these spins align parallel or antiparallel
to the field, forming two spin states known as spin-up and spin-down. This is also
known as Zeeman splitting. As the spin-up state has lower energy, slightly more
spins will align parallel to the external magnetic field than antiparallel, creating a
net magnetic moment M0. This magnetisation is in order of µT and is measurable
by MR scanners.
Since the magnetisation also possesses an angular momentum, rotation around
the axis of B0 will be observed. The rate of this rotation, or precession, depends on
the strength of the torque force caused by the magnetisation, which can be written
as equation 2.1, also known as the Larmor equation
ω = γB0 (2.1)
where ω is the angular precessional frequency of the proton, also known as
2.3. Theory of Magnetic Resonance Imaging 46
Larmor frequency, γ is the gyromagnetic ratio, 42.58 MHz/T for protons, and B0 is
the strength of the external magnetic field. Using a larger field strength will increase
the speed of precession.
B0 field
M
a b
Figure 2.5: Alignment of spins in a magnetic field. (a) with no magnetic field, spins are
randomly oriented with no net magnetic moment. (b) In an external field, B0,
spins will align parallel or anti-parallel to the field, with a net magnetic mo-
ment, M0, parallel to the field.
The spins can be excited out of their alignment with a second magnetic field,
denoted as B1 orientated in a direction perpendicular to the B0 field. The B1 is also
known as an RF pulse and it can be turned on and off. When its frequency matches
the Larmor frequency, ω , ’resonance’ occurs which causes M0 to precess around
B1. In a rotating frame, the RF pulse causes the magnetisation to move away from
the longitudinal direction by an angle α , also knows as the flip angle [McRobbie
et al., 2006]. Applying a longer RF pulse will cause a bigger deflection of the net
magnetic field, and hence will increase the angle α .
Once the RF pulse is turned off, the protons return to their equilibrium state in
2.3. Theory of Magnetic Resonance Imaging 47
a process known as relaxation. This causes the signal to decay exponentially and
dephase as spins experience different magnetic field inhomogeneities and spin-spin
interactions. The precession of the net magnetisation causes an oscillating field
component in the transverse plane which induces a voltage in receiver coils appro-
priately placed relative to the field. This induced current gives rise to the observable
MRI signal. The B1 field can be generated by a coil similar to the one used for
detection which means that depending area of the body to be imaged, a single coil,
called volume coil, can be used for both excitation and detection purposes. How-
ever, it is common practice to use the transmitter coils in the body of the scanner
for excitation and use local surface coils for receiving the MR signal. This is par-
ticularly the case in the hybrid PET/MR scanners where we need to minimise PET
absorption by coils.
T1 Relaxation
Time
T2 decay
Mxy Mz
0.37 M0
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Figure 2.6: Illustration of T1 recovery and T2 relaxation curves which occur simultane-
ously. Reproduced from [McRobbie et al., 2006]
The relaxation which occurs once the RF pulse is turned off can be described
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using two separate time constants: T1 relaxation represents the rate which the mag-
netisation returns to alignment with the longitudinal axis following the application
of an RF pulse, and T2 relaxation, also known as spin-spin relaxation, represents
the rate which coherence is lost between spins in the transverse plane. T2 relaxation
is an exponential decay process and T2 is the time it takes for the magnetisation to
drop to 37% of its original size. On the other hand, T1 relaxation has an exponen-
tially increasing shape, but is slower than T2 relaxation. T1 represents the time it
takes for the magnetisation to reach to 63% of its final equilibrium value. T1 relax-
ation depends on the field strength and can get slower as the field strength increases
where T2 is less dependent to the field strength. These are illustrated in figure 2.6.
In addition to T2 decay, T∗2 relaxation occurs as a consequence of inhomo-
geneities in the main magnetic field, which can be caused by intrinsic defects in
the magnet or susceptibility-induced field distortions produced by the tissue. Stable
offsets in the main magnetic field across the imaging space cause different locations
to slowly accrue phase relative to each other. It can also be expressed as equation
2.3 where T2inhom represents the magnetic field inhomogeneities.
1
T ∗2
=
1
T2
+
1
T2inhom
(2.2)
Values of T1 and T2 depend on the property of tissues and the magnetic field
strength. T2 is always shorter than T1 and different tissues and pathologies have
different T1 and T2 values. In the brain, grey and white matter have distinct T1
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and T2 values which makes it easier to separate them and CSF in the image space.
Usually, most pathologies have longer T1 and T2 times, and appear darker on a T1-
weighted image and brighter on a T2-weighted image [McRobbie et al., 2006]. T1
usually varies between 300 to 2000 msec and T2 usually varies between 30 and 150
msec [Schild, 1990].
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Figure 2.7: Illustration of a spin echo pulse sequence. A 90◦ RF pulse is followed by a
180◦ pulse to reverse the spins. TE is the time between the first pulse and the
echo. TR is the time between repeated pulse sequences.
Signal echoes can be obtained using two different methods, gradient echo (GE)
and spin echo (SE). In GE sequence, an RF excitation pulse, which is usually less
than 90◦ is applied and is immediately followed by a negative magnetic gradient
lobe. This initial lobe causes the spinning protons to dephase in transverse direction.
Then a reversed positive gradient is applied which causes the spins to rephase and
compensate for the dephasing caused by the negative gradient lobe. After a certain
time, all the spins will come back into phase, generating a gradient echo.
In the SE method, as illustrated in figure 2.7 the spins are excited using a 90◦
pulse and left to their natural dephase caused by the external and internal magnetic
field inhomogeneities. While the spins are dephasing, a 180◦ pulse is applied to
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flip all the spins. However, these spins continue to dephase in the same direction
as before since their precessional frequencies are not changed. All of the spins
will come to rephase at a time equal to the delay between the 90◦ and 180◦ , also
known as the echo time (TE), and will form a spin echo. Application of the 180◦
phase reversal will mean that the echo height will be governed by the T2 relaxation
constant.
2.4 Image Formation in MRI
In addition to B0 and B1, MRI scanners have 3 separate gradient coils, which create
magnetic fields called gradients in x,y and z directions. This was introduced by Paul
Lauterbur in 1973 [Lauterbur, 1973] and later expanded by Sir Peter Mansfield to
develop echo planar imaging [Mansfield, 1977], variations of which are still utilised
clinically. These fields create linear variations in the magnetic field in these three
directions, and can be used to create spatial variation in the resonance frequency.
This phenomenon can be mathematically expressed as:
B(r) = B0+G.r (2.3)
where r is the 3 dimensional spatial location and G is the vector of gradient
field strengths. G can be in any of the x,y, and z directions. Compared to the main
magnetic field, gradient fields are quite small in strength (i.e 40 mT/m compared to
3 T main field) [Bushong and Clarke, 2013]. For example, the gradient coils can be
used to apply a gradient in the z direction, which allow for choosing the slice to be
excited. In this case, the thickness of the slice will be determined by the gradient
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strength G and the bandwidth (∆ω) of the applied RF pulse. The central frequency
of the RF pulse will dictate the slice position hence multiple slices can be selected
by choosing different frequency RF pulses.
As can be seen equation 2.3, the frequency ω depends on position in the pres-
ence of a gradient. The gradients can be controlled to alter the precessional fre-
quency and phase depending on the position. The received MR signal is in Fourier
space and is stored in a ’raw-data’ container named k-space. K-space contains the
frequency encoded and phase encoded data of the MR signal recorded from each
anatomical point of the object during MR acquisition.
Figure 2.8: Three of the most common k-space trajectories: (a) 2DFT, (b) multi shot echo-
planar imaging (EPI) and (c) spiral. The portion of k-space collected during a
single repetition period is shown by a black, solid line, and subsequent readouts
are shown as grey, dashed line. Taken from [Miller, 2004]
K-space can be measured following a single RF pulse or a number of RF ex-
citations. An MR pulse sequence is used to capture one line of kspace and can
be repeated with a repetition time (TR) with various phase encode gradient values
to capture the desired space. Multiple encoding trajectories can be used to fill the
k-space, where the most common ones include 2DFT trajectory, echo-planar (EPI)
trajectory [Mansfield, 1977] and spiral imaging [Meyer et al., 1992]. These encod-
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ing techniques are illustrated in figure 2.8. While 2DFT encoding is a multi-shot
imaging techniques where k-space is filled in multiple readouts, EPI can be used
to fill k-space at once and hence is a single-shot imaging technique, which makes
it useful in imaging functional studies or objects with significant motion. Spiral
encoding can be used both as single shot or multi-shot. Once the k-space is filled,
inverse discrete Fourier transform of k-space is computed to reconstruct the image
in a least squares sense.
2.4.1 Structural MR pulse sequences -MPRAGE
In MRI, several anatomical pulse sequences can be used to obtain MR images with
high spatial resolution in a short acquisition times. One main branch of these are the
Gradient echo (GE) sequences. First proposed by Muger and Brookeman [Mugler
and Brookeman, 1990], The three-dimension magnetisation-prepared rapid gradi-
ent echo (MPRAGE) sequence [Gillan et al., 1992] is one of the common sequence
to obtain a good-resolution T1 weighted images of the whole brain. This sequence
can be used to provide excellent tissue contrasts with full brain coverage in short
scan times. It is the equivalent of the Gradient Recalled Acquisition at Steady State
(GRASS) sequence present in GE Healthcare MRI systems or Turbo field echo
sequence in Philips MRI scanners [Nitz, 1999] [Chavhan et al., 2008]. These se-
quences specifically have short TR to make image acquisition less time consum-
ing. Unlike the spin echo sequence, no 180◦ pulse is applied as it increases the
acquisition times. Instead, a magnetic field gradient is superimposed on the exist-
ing magnetic field for a short time to induce large magnetic field inhomogeneities
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which causes the spins to dephase faster [Schild, 1990]. The magnetic gradients
are applied in opposite directions repetitively to induce a rephasing effect similar to
the effect caused by the 180◦ RF pulse in spin echo sequences. After rephasing of
spins, a gradient echo signal is received.
In MPRAGE pulse sequence, the sequence starts with a 180◦ inversion pulse
to enhance the contrast between the grey matter to white matter. After the inver-
sion time (TI), which is the waiting time after the inversion pulse (between 200-
1000msec), RF spoiling with a small flip angle and gradient encoding steps are
executed [Gillan et al., 1992]. In these fast imaging sequences, it is essential to use
RF pulses which cause a low flip angle(α). With the help of these small flip angles,
the longitudinal magnetisation is always kept at a certain value which is tilted with
the next RF pulse. This enables the receivers to get a reasonable signal even if the
next pulse comes after a very short TR [Schild, 1990]. MPRAGE images are com-
monly acquired in our centre as they are a practical way of obtaining MR images of
the brain with a high spatial resolution (around 1 x 1 x 1 mm voxel size) in a short
acquisition time (around 5 minutes).
2.4.2 Vascular MR pulse sequences
Time-of-flight MR Angiography (TOF-MRA) is a MR imaging sequence which is
mainly used to produce images of the blood vessels without any need for external
contrast agents. It utilises the inherent flow sensitivity of the MR signal to visu-
alise blood flow within the vessels [Saloner, 1995]. Moving spins within the blood
causes a great influence on the MR signal and can cause artefacts in MR images (i.e.
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bright arteries with high T1) as the Fourier transform of kspace assumes that signal
from each voxel does not change between measurements. TOF-MRA sequences
turns this phenomenon to their advantages by increasing the signal coming from the
blood. They utilise a gradient echo sequence with a short TR and TE. The short
TR and TE saturates the signal coming from the stationary spins, or tissues while
the unsaturated spins flowing into the imaging slice generate the majority of the
MR signal. The maximum MR signal is received when the blood can completely
transport itself across the imaging volume within a single TR [McRobbie et al.,
2006].
Figure 2.9: Maximum intensity projection (MIP) of the carotid arteries acquired using a
3D TOF-MRA sequence
The TOF-MRA sequence is applied perpendicularly to the direction of the
blood flow in order to maximise the blood signal. MRA may not work well if a
thick slice is used in the acquisition as slow flowing blood may be detected as stag-
nant. Image reconstruction can be done in 3D to get 3D TOF-MRA images. These
images can be used to generate maximum intensity projections (MIPs), which show
the maximum pixel value in three dimensions. These images can be used to vi-
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sualise even very small blood vessels with high contrast. A MIP projection of an
example 3D TOF-MRA image is shown in figure 2.9.
2.4.3 Dynamic MR pulse sequences
Dynamic MR acquisitions can be performed using MR sequences with high tempo-
ral resolution to perform quantitative measurements over MRI data. Dynamic MR
sequences are usually used with injection of Gadolinium (Gd) based contrast agents
which cause a reduction in T1 and T2 relaxation times. They are usually found in
the form of chelates as Gd itself is a toxic in its elemental form. They are admin-
istered to the subject through their veins using a concentration of 0.1 mmol/kg for
an adequate signal enhancement [Geraldes and Laurent, 2009]. Due to the reduc-
tion in relaxation constants, Gd-based contrast agents causes a brighter region in T1
weighted images but a darker region in T2 weighted images. MR contrast agents can
be used with dynamic sequences, which can allow one to perform quantitative mea-
surements, such as blood flow and perfusion measurements on dynamic data. Since
the bolus travels with a high speed after the injection, having a high temporal resolu-
tion is essential to capture the most information with these sequences. Two different
generic approaches can be used to acquire dynamic MR data with contrast agents.
Dynamic Contrast Enhanced MRI (DCE-MRI) is a technique based on T1 weighted
image acquisitions whereas dynamic susceptibility contrast enhanced MRI (DSC-
MRI) uses T2 or T2∗ weighted images. Common sequences used for these two main
dynamic MRI techniques are briefly summarised in the next subsections. Choosing
a suitable MR sequence depends on the desired dynamic measurement type, image
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quality, the desired field of view, spatial and temporal resolution. Further infor-
mation regarding the interpretation of DCE-MRI and DSC-MRI and their kinetic
modelling is included in chapter 3.
2.4.3.1 DCE-MRI
Gradient echo based sequences are mostly used in DCE-MRI acquisitions. The
standard fast GE sequences such as FLASH, turbo FLASH, spoiled gradient-
recalled echo (SPRG), volumetric interpolated breath-hold (VIBE), etc., can be used
in a repetitive setting to acquire dynamic images [Essig et al., 2013]. In 3D acqui-
sitions, the high amount of spatial coverage might cause reductions in the temporal
resolution, and require a modern scanner with a good gradient system.
Before starting the dynamic acquisition, pre-contrast agent images with vari-
able flip angles are obtained in order to be used for T1 mapping. The information
from T1 mapping is later used to convert the MR signal to actual Gd concentrations.
This is further described in Chapter 3. During the acquisition of pre-contrast im-
ages, the TR and TE are kept as constants and only the flip angle is changed. The
number of used flip angles can vary from 2 to 7 [Cheng et al., 2006] [Commit-
tee, 2012]. As an alternative to the variable flip angle technique, optimised Look
Locker pulse sequences can be used to obtain data for T1 mapping [Freeman et al.,
1998] [Henderson et al., 1999].
DCE-MRI acquisitions usually lasts around 5 to 7 minutes after the injection
since the Gd-chelates have fast washout characteristics. For the DCE-MRI pulse
sequences, short TE (ideally TE<1.5ms) and short TR (ideally TR<3ms) are used.
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High temporal resolution, 3 seconds or less, is recommended if the blood signal is
to be captured for arterial input function (AIF) measurements. A flip angle ranging
between 25◦ and 35◦ are used in order to minimise saturation effects [Committee,
2012]. The number of slices can be increased with a cost of losing temporal res-
olution while increasing the coverage with a good spatial resolution. On the other
hand, the slices thickness can be increased with less slices to improve the temporal
resolution with the same FOV with poorer spatial resolution. Therefore, it is im-
portant to maintain the balance between the required spatial resolution, FOV and
temporal resolution.
2.4.3.2 DSC-MRI
Dynamic susceptibility contrast enhanced MRI (DSC-MRI) is mainly used in brain
perfusion studies for blood flow and blood volume measurements [Rempp et al.,
1994] [Kennan and Ja¨ger, 2003]. Similar to DCE-MRI measurements, it requires
rapid pulse sequences to be able to make serial measurements of the signal loss dur-
ing the passage of the bolus through the tissue. It utilises the effect of Gd contrast
agent on the T2 or T2∗ of the brain tissue as the contrast agent travels through the
brain. Spin-echo pulse sequences can be used to obtain T2 weighted measurements
where gradient echo pulse sequences are used to obtain T2∗ weighted measure-
ments [Kennan and Ja¨ger, 2003]. Typically, injection of a double dose Gd contrast
agent (0.2 mmol/kg) is required when SE pulse sequences are used whereas a sin-
gle dose (0.1 mmol/kg) is sufficient with GE-based pulse sequences [Jahng et al.,
2014] [Essig et al., 2013].
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Paramagnetic Gd contrast agents induce a change in the average bulk suscepti-
bility of tissues which can be detected by MRI scanners. After the rapid bolus injec-
tion (3-5 mL/sec), the contrast agent gets compartmentalised within the vessels due
to the presence of the blood-brain barrier, disturbing the local magnetic field. This
affects the magnetic field in the surrounding tissues which start to dephase, causing
a loss in the T2 and T2∗ signals.
In order to characterise the first pass of the bolus in fast flowing blood, temporal
resolution of at least 1.5 second is recommended. Due to the high temporal resolu-
tion required, DSC-MRI images usually have smaller FOV compared to anatomical
MRI or DCE-MRI scans. In our centre, T2∗ weighted GE-EPI pulse sequences are
commonly used for DSC-MRI acquisitions. As shown in figure 2.8 GE-EPI allows
the filling of multiple k-space lines using a single shot GE pulse and is very sen-
sitive to the susceptibility effects as the signal drop is relatively larger compared
to SE-based sequences. In a 3T MRI system, TE is chosen to be in range of 25
to 40 ms and TR between 1500-2000 ms, where flip angle is varied between 60◦
and 90◦ [Haaga, John R. Lanzieri and C., 2004] [Jahng et al., 2014]. DSC-MRI
acquisitions usually last around 2-3 minutes only.
2.5 The Physical Basis of PET/MRI
Combination of PET and MRI scanners has been a major research topic for decades
due to the excellent tissue contrast of the MR images and to eliminate the extra
radiation caused by CT scans in PET/CT scanners. It can be argued that MR can
outperform CT when anatomic information from soft-tissues and organs is required.
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In addition, functional MR imaging techniques can be simultaneously acquired with
a hybrid PET/MR scanner, which can provide complementary information to PET
data and enhance the overall quantitative imaging performance.
One of the major technical challenges which was stopping the advent of com-
bined PET/MR scanners was the electro-magnetic interaction due to the high MR
magnetic fields. Photomultiplier tubes of the PET detectors are very sensitive to
magnetic fields and need to be properly shielded to prevent the interferences from
the MR system. The traditional PET detectors and their associated electronics con-
tain conducting and radiofrequency emitting components, which can interfere with
the MRI system. In addition, the presence of the magnetic field prohibits using fer-
romagnetic components in the PET/MR scanner. The constrained space within the
MR bore where the PET system can be placed had also needed to be considered.
Different vendors applied different design choices to overcome these problems and
to combine PET and MRI scanners, as briefly discussed in this section.
Philips and General Electric initially chose to develop sequential PET/MR
scanners, where PET and MR images are obtained sequentially, rather than simul-
taneously, similar to existing PET/CT scanners. One such system is the Philips
Ingenuity TF PET/MRI scanner, a hybrid scanner with Philips time-of-flight GEM-
INI TF PET and Achieva 3T MRI system. In this system, the PET and MRI gantries
are co-planar and can be placed in the same scanning room, sharing the same bed.
After one scan is completed, the patients slides into the other scanner. GE’s initial
solution was also a sequential system where the PET and MR scanners were placed
in different scanning rooms. After one scan, the patient is moved to the other room
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to have the next scan, and a post-processing program is used to align PET and MRI
images.
Siemens designed the first simultaneous whole-body PET/MRI system called
Biograph mMR, which made simultaneous scanning possible. Their design was
similar to concept proposed by Shao et al. in 1997 [Shao et al., 1997] used for
BrainPET insert. The Biograph mMR fully integrates the PET and MR modalities
into a single imaging system and allows simultaneous acquisition of PET and MRI
images without compromising on image quality. As shown in figure 2.11, a ring of
PET detectors is placed inside the bore of the MRI scanner, between the gradient
coils and the RF coil.
In order to overcome electromagnetic interference and enable integration of
PET and MRI, Siemens replaced the photomultiplier tubes used in the scintillation
crystal blocks of established PET and PET/CT systems with a combined Lutetium
Oxyorthosilicate (LSO) crystals and Avalanche Photo Diodes (APD) for optimised
readout, components that are not susceptible to magnetic fields (Figure 2.10). A
combination of LSO crystals and APD was able to detect positron annihilation
events even inside strong magnetic fields.
Another advantage of using photo diodes is their small size compared to photo-
multiplier tubes. As MRI already has a small bore size, there is only a limited space
to place the PET detectors. 56 of these detector blocks are placed circumferentially
to form one detector ring. The full PET detector unit contains 8 of these rings and
spans a longitudinal field-of-view of 25.8 cm.
A few years after the introduction of the Siemens Biography mMR scanner, GE
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Figure 2.10: PET detector assembly for mMR with 64 Lutetium Oxyorthosilicate crystals.
Courtesy of Siemens Healthcare.
Figure 2.11: Siemens Biograph mMR scanner and its schematic representation showing the
placement of the PET detectors inside the MR system. Courtesy of Siemens
Healthcare.
Healthcare introduced their combined PET/MR system, called SIGNA PET/MR.
Their system also had a PET ring integrated into a 3T MR system resulting in a
patient bore opening of 60 cm, with a 25 cm axial FOV. GE used lutetium based
scintillators with silicon photomultipliers (SiPM) for their PET detectors. Using
these detectors, GE utilised time of flight PET technology in the SIGNA PET/MR
scanner, making it the only TOF PET/MR system available [Levin et al., 2016]. This
design offers fast coincidence timing resolution (less than 400ps) making it suitable
for TOF PET. It is currently the only commercially available simultaneous TOF-
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PET/MR system and initial results show no loss in image quality in reconstructed
PET and MR images compared to images from PET/CT and standalone MR systems
[Iagaru et al., 2015] [Levin et al., 2014].
2.6 Coregistration of PET/MR data
Even when a simultaneous PET/MRI scanner is used in image acquisition, PET and
MRI data needs to be geometrically coaligned before any PET/MR image analysis
is performed. This process is called image registration and is performed to bring
intra-modality or inter-modality images, which can be acquired at different times
or different scanners, aligned in the same image space. In PET/MR imaging, this
allows the reader to obtain functional and anatomical information at the same time.
There are two approaches to perform image registration, extrinsic registration
methods which rely on external markers which are placed on the subject and are
detectable by the scanner, or intrinsic registration methods which are purely based
on the image data. Extrinsic methods are usually avoided due to their invasiveness
and complications. On the other hand, it is very hard to validate registration per-
formance in intrinsic registration as the ground truth usually does not exist. In this
work, intrinsic image registration was performed only.
During the registration of two images, the best transformation to spatially align
one image to another needs to be computed. The types of transformations which are
commonly used in medical imaging can be classified as: rigid, affine and non rigid
transformations. Rigid transformations involves translation and rotation of the tar-
get image to match the reference image. Rigid registration has 6 parameters in total:
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3 parameters to represent the translation on each axis and 3 parameters to represent
rotation around each axis. In affine transformation, there are 12 parameters in to-
tal as it additionally applies scaling and shearing on the target image. Rigid and
affine registration methods apply a global transformation to the target image. On
the other hand, local warping can also be applied in non-rigid registration, which
makes it a more complex method than the others. Non-rigid transformations can be
parametrically defined using statistical shape models [Cootes et al., 2004], B-spline
shapes [Rueckert et al., 2006] [Modat et al., 2010], and discrete cosine transforma-
tions [Ashburner and Friston, 1999].
During the image registration, a cost function is defined and used within an
optimisation scheme to find the best similarity between the target and reference
images. Various cost functions can be used for different image registration appli-
cations. The sum of squared differences (SSD) or cross-correlation are often used
when the source and reference images are acquired using the same modality. These
cost functions assume that both images have correlated image intensities, which is
usually a valid assumption in intra-modality images. For inter-modality images,
cost functions based on statistical dependencies are often chosen, such as Mutual
Information (MI), Normalised Mutual Information (NMI), and Normalised Cross
Correlation (NCC) [Maintz and Viergever, 1998] [Oliveira and Tavares, 2014].
In this work, FMRIB’s Linear Image Registration Tool (FLIRT) (University of
Oxford, UK) [Jenkinson and Smith, 2001a] [Jenkinson et al., 2002] was used for
registration of PET and MRI data. This software can be used to perform translation
only, rigid and affine transformations using the cost functions listed in the previous
2.7. Attenuation Correction in PET/MR scanners 64
paragraph. This package can be downloadeded as part of the FSL (FMRIB Software
Library) software package [Woolrich et al., 2009] [Jenkinson et al., 2012].
2.7 Attenuation Correction in PET/MR scanners
Due to the lack of transmission data in PET/MR scanners, methods to derive the
attenuation map from MRI data need to be developed to perform attenuation cor-
rection on PET data. However, as the MR data mainly reflect the proton density
of tissues, photon attenuation information cannot be directly derived from MR im-
ages [Izquierdo-Garcia et al., 2014]. In addition, the RF coils present between
the subject and the detector also cause additional attenuation, which may require
a separate correction [Wagenknecht et al., 2013]. Therefore, performing an accu-
rate attenuation correction in PET/MR scanners is a challenge and a number of
methods have been proposed. These methods can be classified into two categories:
segmentation-based methods and atlas-based methods.
The segmentation-based techniques parcellate the MR image into different tis-
sue classes and assign an attenuation coefficient to approximate the attenuation
characteristics of each tissue class. These methods assume that the attenuation
coefficients of soft tissue at 511keV are constant and therefore a predetermined
attenuation coefficient can be used [Wagenknecht et al., 2013]. In PET/MRI imag-
ing, the DIXON sequence [Coombs et al., 1997] can be used to produce gradient
echo fat only and water only MR images by adjusting the echo time (TE). These
images then can be used to divide the body image into separate tissue classes such
as air, lung, soft tissue and fat. Then, attenuation factors are assigned for each
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class [Martinez-Mo¨ller et al., 2009]. Ultrashort echo time (UTE) or zero echo time
(ZTE) sequences can also be applied to get additional bone information to use in the
segmentation [Izquierdo-Garcia et al., 2014] [Arabi et al., 2015]. These sequences
are used in brain studies to obtain three-class attenuation maps including air, soft
tissue and bones [Catana et al., 2010] [Keereman et al., 2010]. An axial slice of an
example UTE image is shown in figure 2.12a. Berker et al. proposed an attenua-
tion correction method which uses combination of UTE and Dixon sequences for
bone and fat detection with a four class PET attenuation map [Berker et al., 2012].
Results showed that this method can be used to obtain visually similar attenuation
maps compared to those derived from CT images, with a high voxelwise agree-
ment. However these studies concluded that the accuracy of these methods heavily
depends on the segmentation of the bones, which can be negatively affected due to
susceptibility effects especially at bone/air and soft-tissue air interfaces [Mehranian
et al., 2016]. Different tissue types may produce similar signal intensities which
can be another threat to the performance of the segmentation-based attenuation cor-
rection methods. In addition, these methods do not provide any correction for the
additional attenuation effect caused by the MR components.
Atlas based methods use a number of atlases or templates where the subject’s
MR images can be registered to and converted to pseudo-CT images using a CT
atlas [Hofmann et al., 2008] [Burgos et al., 2014] [Sekine et al., 2016] [Wollenwe-
ber et al., 2012] [Izquierdo-Garcia et al., 2014]. Brain templates are generated by
taking the mean of the the attenuation maps to reflect population based attenuation
coefficients. These methods are susceptible to registration errors and inter-subject
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(a) UTE
(b) UTE µmap (c) pCT µmap
Figure 2.12: Axial slice of a brain image acquired using a UTE sequence (a) is shown with
attenuation maps derived using the UTE image (b) and derived from a pseudo
CT image based on an atlas-based method [Burgos et al., 2014]
anatomical variability. A large image database can be used to account for inter-
subject variability and multiple atlas registrations can be used to minimise registra-
tion errors [Hofmann et al., 2008] [Burgos et al., 2015] [Sekine et al., 2016]. Then
each voxel in the MR image is substituted by a CT value using image similarity
measurements. Results from multi-atlas methods were shown to be more accurate
than single atlas methods and yielded more similar results to gold standard CT based
attenuation maps. Attenuation maps derived using an atlas based method [Burgos
et al., 2015] and a UTE image are shown in figure 2.12b and 2.12c. These images
show that some unsubtle differences can be seen in µ maps derived using UTE
based or atlas based techniques.
Chapter 3
Quantitative Analysis of PET and
MRI data
3.1 PET
3.1.1 Quantification in PET
In typical static PET scans, the radioactive PET tracer is usually administered to the
subject outside the scanning room and there is a waiting period of 20 minutes to 1
hour, until the tracer uptake reaches equilibrium in the tissue of interest. After this
waiting period, the patient is placed inside the PET scanner and data acquisition is
performed for around 20 minutes. Static imaging techniques are usually used to
obtain one late-scan PET image where the metabolic assessment can be approxi-
mated and relative tracer uptake of the target tissue can be obtained. An exciting
property of PET scanners is that the acquired data can be truly quantitative. After
necessary calibrations, the signal recorded by a PET scanner gives absolute tracer
concentration measured in Becquerels per millilitre (Bq/mL). The relative tracer
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uptake is often characterised using the standardised uptake value (SUV), a metric
commonly used to quantitatively interpret PET images in a clinical setting. To cal-
culate SUV, the radiotracer uptake is corrected for the amount of injected activity
and the distribution volume within the patient. Typically patient body weight is
used to represent the distribution volume. SUV can be calculated using the equa-
tion 3.1. This equation can be modified to replace the body weight with lean body
mass (LBM) [Tahari et al., 2014] or body surface area [Kim et al., 1994]. Even
though SUVs can only approximate the metabolic processes within the body, they
are a simple way of obtaining quantitative information from PET imaging without
getting into the complications of dynamic PET imaging techniques such as arterial
blood sampling.
SUV =
CPET
Dose/Weight
(3.1)
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Fig. 3.1 A representation of main differences in static and dynamic PET imaging.
3.1.2 Principles of PET tracer kinetics
Spatial information regarding the location of tracer uptake can be obtained from static PET
images. Acquiring dynamic PET data also offers temporal information such as the rate of
influx of a tracer to the tissue of interest.
Based on the Fick principle, Kety and Schmidt described a blood flow model [Kety and
Schmidt, 1945], which states that the rate of change of the tracer concentration in tissue
is proportional to the blood flow(F) and the difference between the concentrations entering
and exiting the tissue of interest, as shown in equation 3.1:
dCT
dt
(t) = F(Ca(t) Cv(t)) (3.1)
where CT , Ca and Cv are the tracer concentrations in tissue, arterial and venous blood
respectively. For rapidly diffusable PET tracers (e.g 15O-water, the tissue concentration
equilibrates with the venous outflow and these concentrations are related by the volume of
distribution VD, by VD =CT/Cv. Hence, the equation 3.1 can be rewritten as:
dCT
dt
(t) = F(Ca  (CT/VD)) (3.2)
Figure 3.1: A representation of main differences in static and dynamic PET imaging.
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The PET signal can also be measured from the time of tracer administration
until the end of the scan, with very short intervals of time, allowing us to track
the behaviour of the tracer over the time course of the scan. This is defined as
dynamic imaging and an illustration of the differences between static and dynamic
PET is shown in figure3.1. Dynamic imaging can provide some benefits over static
imaging as the process of tracer uptake, retention and washout can be assessed in
more detail. Furthermore, using dynamic imaging can reduce the bias which might
be present in static images due to the chosen time of data acquisition. In order to
analyse the dynamic behaviour of the PET tracer upon injection, kinetic analysis
methods are used.
3.1.2 Principles of PET tracer kinetics
Dynamic PET data can be analysed using kinetic models to obtain quantitative in-
formation about dynamic processes in the tissue of interest. This can be done by
defining the time varying systems by using compartments in which the tracer is as-
sumed to be distributed homogeneously. The PET tracer can exchange between
these compartments and these exchanges are defined using ordinary differential
equations (ODEs). These ODEs are then solved to obtain values for the rate con-
stants which represent the transport of tracer from one compartment to another. To
simplify compartmental modelling, linear regression methods or graphical analysis
techniques can be used to quantify acquired PET time series. Introduction to these
techniques are given in this section.
Based on the Fick principle, Kety and Schmidt described a blood flow model
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[Kety and Schmidt, 1945], which states that the rate of change of the tracer concen-
tration in tissue is proportional to the blood flow (F) and the difference between the
concentrations entering and exiting the tissue of interest, as shown in equation 3.2:
dCT
dt
(t) = F(Ca(t)−Cv(t)) (3.2)
where CT , Ca and Cv are the tracer concentrations in tissue, arterial and venous
blood respectively. For rapidly diffusible PET tracers (e.g 15O-water), the tissue
concentration equilibrates with the venous outflow and these concentrations are re-
lated by the volume of distribution VT , by VT =CT/Cv. Hence, the equation 3.2 can
be rewritten as:
dCT
dt
(t) = F(Ca− (CT/VT )) (3.3)
The volume of distribution can be described as the volume of tissue that should
contain the same concentration as in blood relative to total tissue volume. This
equation can be solved for CT using Laplace transform as:
CT (t) = FCa(t)⊗ e(−
F
VT
t) (3.4)
However the Kety-Schmidt model is only valid for tracers which are fully ex-
tracted from blood to tissue. For other traces, only a fraction of tracer is extracted
into the tissue through capillaries and the rest transfers directly into the veins. For
such tracers, the extraction fraction, which is the amount of trapped tracer in the
first pass to the amount delivered, has to be considered. Renkin and Crone [Renkin,
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1959] [Crone, 1965] calculated the extraction fraction E using the following equa-
tion:
E = 1− e(−PS/F) (3.5)
where PS is the permeability surface area product (mL/min/mL), which is the
multiplication of total available capillary surface area and the permeability of the
PET tracer. These relationships can be used to construct compartmental systems.
Alternatively, kinetic analysis of dynamic PET data can be performed using
spectral analysis [Cunningham and Jones, 1993] which was introduced by Cunning-
ham and Jones in 1993. Spectral analysis is a more generalised technique and does
not require any priori assumptions regarding the number of compartments required
to analyse that specific tracer. In this technique, the tissue TAC is modelled using
sum of single exponentials, which represent the impulse response of the tissue, con-
volved with the AIF. The tissue TAC is fitted using this model and a non-negative
linear least squares estimation to produce estimates of macroparameters such as VT .
Spectral analysis can also be used to estimate the number of compartments required
to perform compartmental model analysis of a specific tracer.
3.1.3 Compartmental Model Analysis
Compartmental models can be used to describe the behaviour of the tracer measured
using dynamic PET studies, where each compartment reflects a different anatomi-
cal, physiological or biochemical stage. Each compartment is characterised by the
concentration of the tracer within it as a function of time. When compartmental
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models are used to define a system, it is assumed that tracer is uniformly distributed
in each compartment and no concentration difference is present inside each com-
partments. Sets of ordinary differential equations can be written to represent the
tracer concentration entering and exiting each compartment. These equations are
then solved to obtain the quantitative values of interest.
Figure 3.2 illustrates the process of representing a region of interest in a brain
using compartmental models. The black circles on 3.2b represents the radioactive
tracer molecules as they are seen in the blood and some of them in the extravascular
extracellular space. Assuming that there are receptors in the brain specific to the
tracer used, some of the tracer is bound to these receptors. This information can be
used to construct a compartmental model by identifying the primary states of the
tracer and the transfers between these states. Ordinary differential equations can be
written to describe the rate of change in tracer concentration in each compartment.
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Fig. 3.3 Schematic diagram of tissue compartmental models. (a) One-compartmental model
with two rate constants, (b) two-compartmental model with four rate constants, (c) three-
compartmental model with six rate constants
and available for binding. The other compartment CB tells us about the concentration of the
tracer which is specifically bound to the molecule of interest, or phosphorylated for the case
of FDG . The two-compartmental model can be described by two ODEs, shown in equa-
tions 3.7 and 3.8. It should be stated that this model is a reversible model as the metabolised
tracer can go to free state. For FDG, k4 can be approximated to 0, meaning that the trapped
FDG does not go back to free state. Such tracers are analysed using irreversible models.
dCF(t)
dt
= K1CP(t)+ k4CB(t)  (k2+ k3)CF(t) (3.7)
dCB(t)
dt
= K3CF(t)  k4CB(t) (3.8)
In some cases, using a two-compartmental model can be inadequate to describe the
behaviour of the tracer and a third tissue compartment is introduced. This model is called
three-compartmental model and is shown in figure 3.3c. The third compartment is called
non-specifically bound compartment, CNS. The main difference between the bound and
nonspecific bound states is that non-specific binding is not saturable and not displaceable.
a b c
Figure 3.2: Schematic of the compartmental modelling process as applied to PET images.
(a) A region of interest is identified on the PET image, (b) the contents of
the region and the possible states of the tracer in the region is conceptualised,
(c) the ligand states are represented using compartments and mass balances
on each compartment is written by ordinary differential equations. Adapted
from [E.D. Morris, 2004]
The simplest model used in PET is the one-compartmental model, which is
most commonly used to describe blood flow measurement by 15O-water but can
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also be used to describe kinetics of some radioglands. As can be seen in figure 3.3a,
this model shows the bidirectional flux of tracer between blood and tissue. The
net tracer flux into tissue is expressed using the equation 3.6, where CT (t) is the
time-varying tracer concentration in tissue, CP(t) is the concentration of the tracer
in the plasma and K1, k2 are the two first-order kinetic rate constants, representing
the transfer from arterial blood plasma to tissue and tissue to blood respectively. It
can be seen that equation 3.3 and 3.6 are similar, where K1 = FE and k2 = K1/VT .
The assumption made is that the tracer is homogeneously distributed within each
compartment (blood and tissue in this case).
dCT (t)
dt
= K1CP(t)− k2CT (t) (3.6)
Equation 3.6 can be solved for CT (t) using Laplace transform, giving:
CT (t) = K1e−k2t⊗Cp(t) = K1
∫ t
0
CP(τ)e−k2(τ−t)dτ (3.7)
The 1 tissue compartmental model can be expanded to a 2 tissue compartmen-
tal model, as shown in figure 3.3b, where the PET tracer has three states: tracer in
plasma, free tracer in tissue and tracer bound to the tissue of interest. 18F-FDG is
commonly analysed using 2 tissue compartmental model, where the 18F-FDG gets
trapped and phosphorylated in the second compartment. Concentration of the tracer
in plasma is regarded as the input to the system. CF represents the extravascular
pool of the tracer within the tissue, where the tissue is free and available for bind-
ing. The other compartment CB tells us about the concentration of the tracer which
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(a) 1-TC Model (b) 2-TC Model
(c) 3-TC Model
Figure 3.3: Schematic diagram of tissue compartmental models. (a) One-compartmental
model with two rate constants, (b) two-compartmental model with four rate
constants, (c) three-compartmental model with six rate constants
is specifically bound to the molecule of interest, or phosphorylated for the case
of FDG. The two-compartmental model can be described by two ODEs, shown in
equations 3.8 and 3.9. It should be stated that this model is a reversible model as the
metabolised tracer can go back to free state. For 18F-FDG , k4 can be approximated
to 0, meaning that the trapped FDG gets trapped in the second tissue compartment.
Such tracers are analysed using irreversible models.
dCF(t)
dt
= K1CP(t)+ k4CB(t)− (k2+ k3)CF(t) (3.8)
dCB(t)
dt
= K3CF(t)− k4CB(t) (3.9)
In some cases, using a two-compartmental model can be inadequate to de-
scribe the behaviour of the tracer and a third tissue compartment is introduced. This
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model is called three tissue compartmental model and is shown in figure 3.3c. The
extra compartment is often called non-specifically bound compartment, CNS. The
main difference between the bound and nonspecific bound states is that non-specific
binding is not saturable and not displaceable. The three-compartmental model can
be described by the following equations:
dCF(t)
dt
= K1CP(t)− (k2+ k3+ k5)CF(t)+ k4Cb(t)+ k6CNS(t) (3.10)
dCB(t)
dt
= k3CF(t)− k4CB(t) (3.11)
dCNS(t)
dt
= k5CF(t)− k6CNS(t) (3.12)
For these compartmental models, the measured data with PET, CPET , can be
described as the sum of concentrations for each compartment, assuming that there
is no tissue blood volume or tissue vascular fraction. By knowing CPET and CP,
the arterial input function (AIF), rate constants K1 to k4 can be calculated by least
squares curve fitting. However in practice, the VOI drawn in the tissue also includes
a fraction of blood present in capillaries and tiny vascular structures. In brain stud-
ies, the fraction of blood volume (Vb) is sometimes assumed to be a constant value
(i.e. 0.05 for grey matter) [Leenders et al., 1990] but is often estimated together with
kinetic parameters. This relationship can be written for two tissue compartmental
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model as:
CT = (1−Vb)(CF +CB)+VbCWB (3.13)
As can be seen in 3.13, the blood volume contributes to the tracer concentra-
tion in whole blood, CWB. The whole blood concentration can include the tracer in
plasma, red blood cells and other radioactive components such as metabolite prod-
ucts.
Once the microparameters (K1 to k4) are estimated, these can be combined to
compute macroparameters which can have a better reproducibility than micropa-
rameters. In 18F-FDG studies, common macroparameters of interests are net influx
rate constant (Ki) and cerebral metabolic rate of glucose consumption (cMRGlc)
which is directly related to Ki. Total volume of distribution (VT ) and binding poten-
tial (BP) are also common macroparameters computed after kinetic modelling. Net
influx rate and total volume of distribution can be computed as followings:
Ki =
K1k3
k2+ k3
(3.14)
VT =
K1
k2
(3.15)
for 1-TC model
VT =
K1
k2
(1+
k3
k4
) (3.16)
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for 2-TC model.
In some cases, these macroparameters can also be computed using graphical
analysis techniques which are further described in the following section.
3.1.4 Graphical Analysis Techniques
PET kinetic modelling can be simplified by using graphical models which are based
on compartmental models. Graphical methods benefit from not requiring any non-
linear computational fitting. For irreversible tracers, the Patlak model [Patlak et al.,
1983] [Rutland, 1985] can be used whereas the Logan analysis [Logan et al., 1990]
is one of the approaches that can be used to analyse tracers with reversible binding
kinetics.
3.1.4.1 Patlak Method and Logan Analysis
The Patlak approach [Patlak et al., 1983] involves linearisation of the two-
compartment model for irreversible tracers (i.e 18F-FDG), where k4 can be assumed
to be zero. It describes the behaviour of the system when the free tracer in tissue
has reached its steady state. This usually happens in late time points after the bolus
passage of the tracer. The Patlak approach can be formulated as equation 3.17.
CT (t)
CP(t)
= K
∫ t
0 CP(τ)dτ
CP(t)
+V (3.17)
If the total distribution space of the tracer in the tissue is plotted against the
normalised integrated tracer concentration in the plasma, a linear increase is ex-
pected to be seen. This relationship is shown in figure 3.4 where the net distribution
space is CT (t)/CP(t) and θ is integrated tracer concentration in arterial plasma:
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Figure 3.4: Patlak plot with the best linear fit to data points with filled rectangular points
The slope of the linear fit is directly proportional to influx constant (Ki) and
rate of glucose consumption cMRGlc for FDG, which can be estimated by using
equation 3.18, where LC is the lumped constant which represents the difference
between FDG and glucose in transportation and phosphorylation and is assumed
to be constant. CPG represents the cold glucose concentration in plasma which is
usually measured from a blood sample.
cMRGlc =
KiCPG
LC
(3.18)
The original formulation of Logan analysis [Logan et al., 1990] is similar to
Patlak technique but Logan analysis is applied to PET radiotracers with reversible
binding characteristics. The Logan plot can only be used to calculate the distribution
volume if a suitable, receptor-free reference region is present or if the metabolite
corrected plasma concentration is known. The measured PET activity in tissue can
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Figure 3.5: Logan plot with the best linear fit to data points with filled rectangular points
be plotted using:
∫ t
0 CT (τ)dτ
CT (t)
= K
∫ t
0 CP(τ)dτ
CT (t)
+V (3.19)
When both sides of this equation are plotted, as shown in figure 3.5 the plot
approaches a straight line after a suitable time. K, the gradient of this line gives us
the distribution volume of the tracer (VT ) in the tissue.
3.2 MRI
3.2.1 Dynamic MRI
Perfusion is physiologically defined as the steady-state delivery of blood to the
tissue of interest and is one of the important physiological parameters measured
in dynamic studies. There are several techniques developed using MRI to derive
perfusion-related parameters, mainly used with gadolinium-based contrast agents.
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These techniques use dynamic MRI, a similar concept to dynamic PET. Perfusion
MRI is widely used in research studies, especially in brain imaging to assess acute
stroke or intracranial tumours [Essig et al., 2013].
As also briefly introduced in Chapter 2, Gd-based contrast agents shorten T1,
T2 and T2∗ relaxation times, changing the contrast in the reconstructed MR im-
ages. This can be used to quantify the concentration of the contrast agent in
the tissue of interest. Gd-based contrast agents are found in chelates, and due to
their large molecular size, they cannot penetrate into the intracellular space of tis-
sues and have a rapid excretion from the body. Gd-DTPA (Magnevist, Schering
AG, Berlin, Germany) and Gd-DOTA (Dotarem, Guerbet, Paris, France) [Thomsen
et al., 2002], [Bousquet et al., 1988] are two of the commonly used MR contrast
agents in our institute.
Various methods have been developed to noninvasively measure the perfusion
parameters with MRI. It must be noted that most of the work has been directed to
the brain region, to measure the cerebral perfusion with MRI. The main methods
used in this context can be listed as: Dynamic Contrast Enhanced MRI (DCE-
MRI), Dynamic Susceptibility Contrast Enhanced MRI (DSC-MRI), and Arterial
Spin Labelling (ASL). The first two methods require the injection of a contrast
agent. DCE-MRI utilises the relaxivity effect of this contrast agent on the signal
echo and DSC-MRI utilises the susceptibility effect of Gd on the signal echo. On
the other hand, ASL uses magnetically labeled blood as a tracer to give desired
perfusion parameters. There is no section included for ASL in this thesis but more
information about it can be found in the literature [Kim and Kim, 2007] [Kwong
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et al., 1995] [Detre et al., 2012]. DSC-MRI and DCE-MRI are further explained in
the following sections.
3.2.2 DCE-MRI Quantification Techniques
Dynamic Contrast-Enhanced (DCE) imaging has been increasingly used in char-
acterising tumour biology and treatment response. It requires acquisition of T1-
weighted MRI images in series with short time intervals before and after the injec-
tion of the contrast agent. Using the data obtained from DCE-MRI, compartmental
models, similar to the techniques used to analyse dynamic PET images as explained
in section 3.1.3, can be used to get information about the dynamic behaviour of the
contrast agent within the tissue of interest.
When the paramagnetic contrast agent enters the body, it changes the relax-
ation times of water protons and hence increases the contrast observed in the T1-
weighted images. The increase in relaxation rate, 1/T1, can be related to the molar
concentration of the contrast agent in each voxel using equation 3.20.
1
T1
=
1
T10
+ r1CGd (3.20)
where T10 is the spin-lattice relaxation time before the arrival of contrast agent
and r1 is the spin-lattice relaxivity constant. CGd represents the molar concentra-
tion of the Gd in tissue of interest. However, this equation is valid only with the
assumption the Gd available in the tissues relaxes all of the water independent of
time. Therefore in-vivo, a nonlinear relationship between the signal intensity and
the Gd concentration, which can be specific to the pulse sequence, is often used.
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After finding the Gd contrast agent concentration from the MRI signal en-
hancement, pharmacokinetic modelling can be performed. Similar to analysis of
dynamic PET data, compartmental models can be used to analyse DCE-MRI data.
The main difference between dynamic PET and DCE-MRI compartmental analysis
is that in DCE-MRI, there is no need for a second tissue compartment to represent
intracellular processes as the Gd chelates can not pass the cell membrane and stay
in the extracellular space.
CP CEES
Ktrans
kep
Gd Bolus Injection
Renal Excretion
Figure 3.6: Tofts model which with one tissue compartments, used to perform kinetic anal-
ysis on DCE-MRI data. Ktrans represent the transfer from blood plasma to
extracellular space and kep represent the transfer back to the blood plasma
The simplest compartmental model used in DCE-MRI analysis is the one-
compartmental model, or Tofts model, which includes a compartment represent-
ing extravascular extracellular space (EES) [Tofts and Kermode, 1991] [Tofts et al.,
1999]. Equation 3.21 can be extracted from this model, which is identical to the
PET one tissue compartmental model. Similar to PET, CP(t) represents the concen-
tration of the contrast agent found in the blood plasma, so called the arterial input
function. Again, this can be measured in subjects by using arterial blood samples,
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an image derived method or population average. This is further explained in section
3.3.
CEES(t) =CP⊗Ktranse(−kept) (3.21)
CT (t) =VbCWB+CP⊗Ktranse(−kept) (3.22)
where CP is the AIF, Ktrans is the rate constant for the transfer between the
blood plasma and extravascular extracellular space (EES) and kep is the rate constant
describing the transfer from extracellular space to intravascular space.
The Tofts model was originally constructed for agents which are diffusible,
and remain extracellular, rather than very large molecules that remain intravascu-
lar [Tofts et al., 1999]. However in some tissues, particularly in tumours, the as-
sumption of negligible intravascular agent is invalid. To overcome this limitation,
the extended Tofts model can be used which also allows for the intravascular con-
tribution, as shown in equation 3.17. Here, Vb is the volume fraction of the plasma
space. The total Gd concentration in a voxel or ROI is the sum of the EES contri-
bution, which is usually the dominating part, and the intravascular contribution.
3.2.3 Theory of DSC-MRI Acquisition and Quantification
Dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI)
with bolus injection of Gd-based contrast agent is one of the most commonly used
MRI methods to obtain brain perfusion images. It has a fast acquisition time, around
2 minutes, and provides a higher contrast-to-noise ratio compared to other perfusion
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imaging methods, such as ASL or perfusion CT.
The contrast in DSC-MRI images is based on the signal changes generated
during the passage of the contrast material through the vasculature. The Gd based
contrast agent behaves differently within the brain compared to the rest of the body.
Due to the presence of blood-brain barrier, the contrast agent is trapped in the in-
travascular area, in contrast to other body regions where it rapidly equilibrates be-
tween intravascular and extravascular extracellular compartments. This causes a
significant decrease in T2 and T ∗2 relaxation signals which can be converted into
time-dependent concentration of the contrast agent for each voxel [Rosen et al.,
1990]. The concentration of the contrast agent in a ROI can be expressed using the
equation 3.23.
CT (t) = CBF(CP(t)⊗R(t)) = CBF
∫ t
0
CP(τ)R(t− τ)dτ (3.23)
Where the CP is the arterial input function, CBF is cerebral blood flow, R(t)
is the impulse function of the system (or the residue function) and ⊗ describes
a convolution operation. R(t) can be described as the fraction of contrast agent
concentration at time t after an ideal instantaneous input bolus [Calamante, 2002]
[Calamante, 2013]. This equation can be deconvolved to measure the CBF of the
patient.
DSC-MRI can also be used to measure cerebral blood volume (CBV) and the
mean transit time (MTT) parameters. CBV represents the fraction of tissue volume
occupied by blood, usually in units ml g−1 and MTT is the time it takes in seconds
3.3. Arterial Input Function 85
for the contrast agent to travel from vascular space and arrive to the tissue of interest.
The relationship between CBF, CBV and MTT parameters is written as:
MTT =
CBV
CBF
(3.24)
Due to the compartmentalisation of the contrast agent in the vascular space,
it can be assumed that the CBV is proportional to the normalised amount of total
contrast agent, as written in 3.25:
CBV = ϕ−1
∫
CT (t)dt∫
CP(t)dt
(3.25)
where ϕ is a scaling factor which is used as a normalisation factor to account
for the fact that higher amounts of injected contrast agent will cause higher concen-
trations reaching the tissue, regardless of the value of CBV.
3.3 Arterial Input Function
An accurate knowledge of the arterial input function (AIF) is required for correct
quantification of dynamic PET and dynamic MRI datasets. AIF describes the con-
centration of tracer in PET, or contrast agent, within the blood plasma which is
available to get bound or metabolised. Usually, the whole AIF, from the time of in-
jection to the end of the scan, is required if the complete time course of the dynamic
PET or MR datasets is desired to be analysed. An example of arterial input func-
tion is shown in figure 3.7. When a bolus injection is used, the AIF curve increases
rapidly to its peak value with the arrival of the tracer/contrast agent to the arteries
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and after about half a minute, the rate of change decreases and plateaus as most of
the tracer is transferred from the plasma.
Figure 3.7: A representation of arterial input function obtained from carotid arteries in a
brain 18F-FDG study
There are various methods to obtain the AIF and each of these has its own
advantages and disadvantages. There is no agreed guideline to be used in the mea-
surement of AIF and this field is open to research as its correct estimation is vital for
accurate kinetic analysis. A brief description of AIF measurement methods is given
in the next section and their comparison is made stating strengths and weaknesses
of each method.
Arterial blood sampling can be regarded as the gold standard of the methods
used for the measurement of arterial input function. Following the injection of the
radiotracer, serial blood samples are drawn over time and blood sample tubes are
centrifugated to seperate plasma. Then, a measured volume of blood from each
sample is analysed in a radiation detector, giving the concentration of tracer present
in the blood plasma at that time point. Typically, around 20 to 30 blood samples
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are required for routine modeling of a dynamic PET scan [Muzi et al., 2012]. Even
though this method gives most accurate measurement of the input function, it is
a very invasive process which involves risks to the subject and practitioner alike
and is complicated as it requires handling radioactive blood. In addition, it is time
consuming and can be more costly as it requires extra staff and equipment. For this
reason it is difficult to justify arterial blood sampling for routine clinical imaging.
One of the other limitations of arterial sampling is the possible delay and dispersion
problems. Arterial samples are usually withdrawn from a radial artery which can
be distant to the tissue of interest. In such cases, the AIF measured from arterial
samples would suffer from delay and dispersion effects which need to be accounted
for before an accurate kinetic analysis can be performed. Even though arterial blood
sampling can be used to measure the concentration of PET tracer and MR contrast
agent, it is more often a method of choice in PET studies.
One alternative method to blood sampling is to use of standardised, population-
based arterial input functions. In this method, an average of AIF curves from a
group of subjects is calculated and is used as the AIF in future kinetic analyses of
that tracer. This can also be combined with one or two measured arterial blood
samples, which are used to scale the population based AIF [Takikawa et al., 1993].
The main advantage of this method is its simplicity as no individual AIF measure-
ment is required. However, it brings the risk of introducing large errors into the
kinetic analysis as the AIF curve shapes can vary between subjects and scans. In
addition, finding a reliable population derived AIF can be possible in dynamic MRI
and common PET tracer studies (i.e. 18F-FDG study) but is more difficult when less
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common or more recent PET tracers are studied.
Another approach to derive AIF involves placing a volume of interest (VOI)
on a suitable artery present in the dynamic PET or MRI image, and deriving the
time activity curve of the tracer concentration in plasma over the time course of
the scan. The AIF obtained using this method is called an image derived input
function (IDIF). The VOI can be placed on the artery manually or automatic image
segmentation methods can be used to delineate arteries. The advantage of IDIF
extraction is that it is completely non-invasive and requires only post-processing
of the image data. However, arteries can be very small in diameter, compared to
the resolution of the reconstructed images in PET, and used images can contain
significant amount of noise and blurring. In this case, detection of arterial voxels
can be problematic using both manual and automatic segmentation methods. The
images also suffer from PV effects, introducing errors to the measured total activity,
and a PV correction needs to be performed to correct for spill-in and spill-out from
neighbouring voxels around the artery before an IDIF measurement is done.
As an alternative to traditional methods to obtain arterial input function, Feng
et. al [Feng et al., 1997] proposed their technique which can simultaneously ex-
tract AIF and physiological parameters from dynamic PET images. In this method,
the AIF is modelled using a mathematical expression. Time activity curves are ob-
tained from multiple regions and kinetic parameters to fit these curves are estimated
together with AIF parameters. Details about this method can be found in Chapter 5.
One big problem affecting measurement of an AIF in several PET studies can
be the presence of metabolite products in the blood plasma. As illustrated in figure
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Figure 3.8: A representation of metabolite formation process which happens during the
metabolism of the PET tracer in intracellular space.
3.8, during the metabolism of the PET tracer in the body organs, metabolite side
products can be formed, which can consequently transfer back to the blood. These
metabolite products can still carry the radionuclide label and hence contribute to the
radioactive concentration in the blood. These metabolite products usually do not
transfer to the brain tissues as they cannot pass the blood-brain barrier. However,
they can sometimes reach other tissues and organs and a modified compartmental
model to account for metabolites needs to be used in such cases [Tomasi et al.,
2012] [Watabe et al., 2006].
The measured blood concentration therefore needs to be corrected for the con-
centration of metabolites before it can be used as an AIF. This is performed by col-
lecting several arterial blood samples during the PET acquisitions and measuring
the concentration of labelled metabolites. The measured blood samples are firstly
converted into plasma samples by separating the plasma from red blood cells. The
tracer is then further separated from metabolites using High Performance Liquid
Chromatography (HPLC). Radioactivities of each fraction are measured using a
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well counter. The parent fraction can be then computed by taking the ratio of the
parent tracer concentration to total plasma concentration. A parent fraction is 1 at
time zero and then follows an exponential decay as the metabolites start to build
in the blood. Samples in parent fraction are usually fitted using parametric mod-
els [Tonietto et al., 2016]. The fitted parent fraction is multiplied with the plasma
blood curve to obtain the true AIF.
Chapter 4
Improved quantification of clinical
dynamic FDG images using image
derived input functions with
MR-defined carotid arteries
4.1 Introduction
Image derived input function is a non-invasive alternative to arterial blood sampling
and measure the AIF from reconstructed PET images. The simplest way to mea-
sure the tracer concentration in blood plasma is to place a volume of interest on a
suitable artery and measure the tracer concentration within that VOI in each frame.
However, this method has severe limitations when it is applied to brain images. Due
to the limited spatial resolution of the PET images, reconstructed images of small
objects usually suffers from partial volume effects. This causes errors in the quan-
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tification of PET images including image derived input function (IDIF) calculation.
For instance, carotid arteries have a small diameter of about 4-6 mm [Krejza et al.,
2006b] which makes it challenging for typical PET scanners with an intrinsic reso-
lution of 4 to 5 mm to delineate its actual geometry. Anatomical MRI images with
higher spatial resolution can be used in such cases to correct for spill-in and spill-out
effects, and hence improve the PET quantification and IDIF estimation. This brings
the challenges of PET/MRI image registration, anatomical segmentation of carotid
arteries from MRI images, and partial volume correction of each PET frame. In
this chapter, the methods we have developed to address these challenges within the
PET IDIF measurement context are described. Furthermore, the validation of the
PVC and IDIF method with simulated and clinical 18F-FDG data against the gold
standard arterial blood samples is presented.
4.2 Literature Survey
The most straightforward way of deriving an IDIF is locating a large diameter blood
pool, such as the heart [Choi et al., 1991] or the aorta [van der Weerdt et al., 2001],
placing the VOI in their inner structure to minimise or neglect the PV effects. These
techniques were successfully validated in multiple studies. However, since a vascu-
lar structure with a large diameter is not present in the field of view in brain PET
studies, the IDIF measurements are usually performed on carotid arteries. Carotid
arteries have an average diameter which is slightly smaller than the spatial resolu-
tion of the PET camera, which makes it necessary to apply a correction for spill-in
and spill-out effects. In this section, we particularly focus on techniques which
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utilise MRI information to more accurately derive IDIF from PET data.
There have been various studies aiming to validate IDIF extraction techniques
over the last 20 years. In 1998, Chen et al. [Chen et al., 1998] developed and
validated a method to non-invasively measure cMRGlc using 18F-FDG PET data.
The spill-in effects were corrected by including a spill-in correction based on a
ROI drawn outside the carotid arteries. Recovery coefficients and spillover coef-
ficients were estimated by using linear or nonlinear least square methods to fit the
carotid and background curves. Fregonara et. al also presented a study in 2009
where eight different IDIF extraction methods used in dynamic FDG studies were
compared [Zanotti-Fregonara et al., 2009a]. The methods were compared on two
numerical human brain phantoms as well as on four healthy volunteers with FDG
scans. Six of the methods they compared were algorithms that rely on anatomic
information such as ROIs over the carotid arteries where two of them work without
any prior anatomic assumption, automatically extracting TACs using kinetic infor-
mation. Area under curve, cMRglc values calculated with Patlak analysis [Patlak
et al., 1983] and individual rate constants were calculated. The results of this com-
parison study showed that extracting the IDIFs without any blood samples to scale
the tail of the curves is difficult and late venous blood samples should be obtained
if possible. None of the methods presented in this paper managed to completely
correct the partial volume effects and usually underestimated the curve tail. The au-
thors concluded that a reliable blood-sample-free IDIF extraction method was not
available for FDG PET brain studies at the time of writing.
Since anatomical brain images with a much higher spatial resolution can be
4.2. Literature Survey 94
obtained using MRI scanners, there have been a growing interest to use MR images
in the PVC of the PET images before deriving the IDIF. Furthermore, detection of
blood vessels using manually drawn ROIs can be inaccurate due to human errors
which tends to be non-reproducible. Therefore, using automatic artery segmenta-
tion on MRI images for PET-AIF determination can be beneficial. In 1997, Litton
used internal carotid arteries defined on MR images to derive the corresponding ra-
dioactivity curves on the PET images [Litton, 1997]. It was concluded that their
study was limited by the poor resolution of the PET scanner used at that study. Tre-
bossen et al. [Trebossen et al., 1998] also tried to derive a PET IDIF by placing an
ROI on the internal carotid arteries on HR PET images, but corrected for the PV
effects using geometry extracted from an anatomical MRI image with a voxel size
of 1 mm and GTM method [Rousset et al., 1998a]. In their work, they assumed a
PSF of PET scanner to be 6.8 mm FWHM. The results were compared to arterial
samples and variations were seen in the estimated cMRGlc values (in a range of 2%
to 27%).
In 2012, da Silva et al. [da Silva et al., 2013] used a high resolution MR-
compatible BrainPET insert within a 3T Siemens MR scanner to acquire simultane-
ous PET and MRI images. In this study, three healthy volunteers were scanned. The
MPRAGE MRI images were resliced to the PET space and isocontours were defined
on carotid arteries. These coordinates were transferred to coregistered dynamic PET
images. It was concluded from their study that an accurate co-registration of the
carotid arteries can be obtained for PET and MRI images acquired by an integrated
scanner. Hence, carotid arteries defined on higher resolution MRI images can be
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transferred onto PET images for a more accurate AIF determination. Fung et al.
have also published their work where they used MR-defined carotid centrelines for
an image-derived input function in PET [Fung and Carson, 2013]. They performed
[15O] water PET on nine healthy patients with blood samples for conventional input
function measurement. The same patients also had T1-weighted MPRAGE images
on a separate 3T MR scanner. Left and right carotid arteries were segmented from
this MRI image using the active contour model of Chan and Vese [Chan and Vese,
2001]. After that, the centrelines were extracted from the segmented carotids. To
do that, the vessel centrelines were modelled as cubic B-spline curves. The curved
shape of arteries was characterised entirely in 3D space by using control points in
the 3D coordinate system of the image and centreline models were fitted to the
segmented arteries. Locations of the control points which minimise the sum of
the squared Euclidian distance between carotid voxels and and their corresponding
nearest points along the B-spline curve were estimated in an iterative manner. After
the segmentation of carotid arteries and extraction of their centrelines, non-brain tis-
sue was extracted from MR images and stripped MR brain images were registered
to PET images using a rigid transformation. As a final registration step, local reg-
istration was performed to re-register centrelines using rigid transformation. This
step was done to eliminate small registration errors which could be present after the
global registration step. The input function was extracted using the mean value of
carotid centreline intensities on dynamic PET frames and areas under curves were
compared to the arterial input function obtained from blood samples. They have
assessed their method by comparing the area under curve (AUC) of the IDIF and
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the CBF to the gold standard curve, obtained from arterial blood samples. Their re-
sults showed that the method was able to yield a consistent IDIF for a subject across
multiple injections, if a scaling factor can be derived from the ratio of IDIF and ar-
terial blood samples. However, they concluded that carotid ROIs with larger diam-
eters will be required in a simultaneous PET-MR system, as its resolution would be
lower than the HRRT, causing some more spill-in effects. Lyoo et al. [Lyoo et al.,
2014] developed a fully automatic method to derive IDIFs in [11C](R)-rolipram
PET studies, utilising T1 weighted structural MR images. Time average of the PET
frames were measured and the average was spatially normalised to the Montreal
Neurological Institute (MNI) MR template space. Then the average of spatially
normalised PET images for 10 subjects was computed to create a template for this
specific ligand. The time activity curves for grey matter and white matter were de-
rived from regions segmented from coregistered MR images. Carotid arteries were
manually segmented from the average of early PET images to generate a template
for the blood signal. The template TACs for GM, WM and carotid arteries were
used within a supervised clustering method to describe similarity of each voxel to
these template TACs. The delineated carotid artery voxels were used to generate
the image derived whole blood curve. PVC was performed using a method similar
to that presented by Chen et al. [Chen et al., 1998]. A good similarity in VT values
computed by arterial samples and IDIFs was observed.
Time of flight MRI angiography (MRA) images with a high spatial resolution
and a good arterial blood signal contrast can be used to improve the accuracy of
carotid artery segmentation. Su et al. [Su et al., 2013b] used MRA images together
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with [15O]H2O data acquired on a high resolution PET scanner to derive IDIFs.
Carotid arteries, signal contributing tissue i.e brain tissue, muscle and non-signal
contributing tissue i.e bone, cerebrospinal fluid, and airways were segmented from
the MRA images using a modified adaptive segmentation algorithm [Wilson and
Noble, 1999]. The PET data were modelled as a linear mixture of true arterial signal
and PV effects from surrounding tissues. The amount of partial volume effect was
derived from an empirically derived PSF, which was found by matching the IDIF
to arterial samples for one subject. The AIF was simultaneously measured with
the CBF and highly reproducible CBF estimations with a good agreement to arte-
rial samples were obtained. Jochimsen et al. [Jochimsen et al., 2016] also utilised
MRA images to segment arteries from neck images in [15O]H2O sheep studies to
derive the IDIF. In order to segment the arteries, a vessel enhancing filter to en-
hance the blood signal was applied. Then, an image thresholding and a clustering
technique was applied to segment the major arteries. In the PV correction, a PSF,
which was derived from a cylindrical syringe phantom experiment, was used. The
GTM method was used to correct for PV effects and the normalised mean activity in
each PET frame was used to derive the IDIF. They found that CBF values estimated
by the IDIFs were 22% higher than the ones estimated with arterial samples. This
was due to the differences in sampling locations as a result of delay and dispersion
effects. Su et al. has also used TOF-MRA images to derive the IDIF in amyloid
scans with PiB tracer [Su et al., 2015]. Similar to their previous work, the recov-
ery coefficients were determined based on an experimentally measured PSF and
segmented artery and background regions. Metabolite correction was performed
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using population based data. The distribution volume VT was computed using Lo-
gan graphical analysis and a good agreement with a comparable variability against
arterial samples was observed.
Audrey et al. has presented effects of using atlas based and ZTE-based MR
based attenuation techniques in the shape of the derived IDIFs [Fan et al., 2016].
They have focused on the neck region where atlas based attenuation techniques are
more problematic. A difference was observed in the estimated IDIF peaks where
the atlas based MRAC method yielded a smaller peak. A difference in the CBF
measurements was also observed. Khaligni et al. has developed a method to get
PET angiography images using time of flight information on GE Healthcare’s Signa
PET/MR scanner [Khaligni et al., 2016a]. The optimal time to segment arteries
from PET images was found by binning the PET list mode file every second and
plotting the total number of true and scatter coincident events over time. The PV
effects were corrected using the artery volumes calculated from TOF-MRA images.
This method was applied to [15O]H2O PET studies and it was observed that using
MRA images with smaller voxel size and and a thinner slab resulted in more ac-
curate CSF estimates and are recommended for IDIF estimation [Khaligni et al.,
2016b].
4.3 Theory of the Single Target Correction method
As described in the literature review section of this chapter, there have been various
IDIF extraction techniques which can be applied to multiple PET tracer studies. In
order to account for PV effects, these existing methods require complete parcella-
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tion of the images into multiple regions, including the background regions. When
used to measure IDIF from carotid arteries, these PVC methods bring the need for
unnecessary complex segmentation of brain structures. In this section, a more prac-
tical PVC method, called Single-Target Correction (STC) is presented. This method
requires the segmentation of the structure of interest (i.e. carotid arteries) only and
is not dependent on any separately segmented background regions.
For a carotid artery IDIF extraction application, the STC only requires de-
lineation of the carotid arteries, and an accurate measurement of the point spread
function, representing the blurring applied to the reconstructed PET images. It is
not dependent on any separately segmented background regions and hence, unlike
other methods, it does not require complex segmentation of the background ar-
eas. The correction is an iterative procedure and is performed on a voxel-by-voxel
basis to correct for spill-in effects. Individual voxel values were used for the spill-
in correction. Uniform activity concentration is assumed for spill-out effects and
a region-based concentration is performed. The STC method is an extension of
the previously published Multi-Target Correction method [Erlandsson et al., 2006],
which itself is an extension of the Mu¨ller-Ga¨rtner method [Mu¨ller-Ga¨rtner et al.,
1992].
The first step in the PVC involves creation of the blurred mask image. In
each iteration step, the spill-over effects are corrected between the voxels which are
within the volume of interest and background voxels present outside the VOI. This
is done by subtracting a background term, which is re-calculated in each iteration.
After that, the algorithm corrects for spill-out by dividing by recovery coefficients,
4.3. Theory of the Single Target Correction method 100
which depend only on the size and shape of the VOI and on the PSF of the system.
This follows from the assumption of uniformity.
If a(·) is the true image, the image, b(·), which is blurred by the PSF, can be
described as follows:
b(x) =
∫
a(y)h(x,y)dy (4.1)
where h(·,·) is the PSF, which is assumed to be position-invariant although this
is not strictly necessary, and x and y are 3D spatial coordinates.
If a VOI is defined, called Ω, the STC method can be described as follows in
pseudo-code:
a˜0 = b(x) (4.2)
R(x) = IΩ(x)
∫
y∈Ω
h(x,y)dy+(1− IΩ(x))
∫
y6∈Ω
h(x,y)dy (4.3)
for k=0 to N-1, begin
gk(x) = IΩ(x)
∫
y6∈Ω
a˜k(y)h(x,y)dy+(1− IΩ(x))
∫
y∈Ω
a˜k(y)h(x,y)dy (4.4)
a˜k+1(x) =
1
R(x)
(b(x)−gk(x)) (4.5)
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end
where a˜ (·) represents the PV corrected image after k iterations. Ia is the indica-
tor function for Ω, R(·) involves the recovery factors to correct for spill-out effects,
gk(·) is the spill-over term that is estimated at iteration, and N represents the total
number of iterations used in the correction. Convergence is typically reached after
5-10 iterations. The result is an image, in which all voxels inside Ω have been cor-
rected for PVE, but the correction also extends beyond the boundaries, as far as the
width of the PSF.
The main difference between STC and the Mu¨ller-Ga¨rtner method [Mu¨ller-
Ga¨rtner et al., 1992] is that STC does not require prior estimation of the mean value
in the background region/regions for the spill-in correction. Instead, this correc-
tion term is estimated iteratively on a voxel-by-voxel basis. For this purpose, it is
necessary to estimate the spill-over in both directions across the region boundary.
4.4 Experiments with simulations
In order to test the performance of the STC in partial volume correction for IDIF
applications, a simulation study was designed to simulate PET images from seg-
mented carotid artery MR data. This simulated PET data were used to check the
performance of the STC method on different tracer concentrations. The data were
also used in the evaluation of an image-based PSF measurement method.
4.4.1 Generation of simulated data
Segmented carotid arteries from a TOF MR angiography image were used as the
ground truth in this simulation work. The segmented carotid arteries was a binary
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Figure 4.1: Overview of the method used to generate simulated PET data of carotid arter-
ies. Carotid arteries segmented from MRA images are blurred with the PSF
and then forward projected and reconstructed using OSEM method to obtain
simulated PET images. The PET image is inputted to the PVC method with the
segmented arteries to obtain corrected PET image.
image with a voxel size of 0.39 x 0.39 x 1 mm. First, an attenuation map was gen-
erated using this true image by assigning an attenuation coefficient value of 0.096
cm−1 to the artery region. To generate a digital 3D phantom, emission values were
assigned to a uniform background region and inside carotid arteries on the seg-
mented images. Six phantoms were generated with a carotid artery to background
ratios of 1/10, 1/5, 1/3, 1/1, 1.5/1 and 2/1. Therefore, it can be said that 3 of these
digital phantoms were used to mainly evaluate the performance of spill-out correc-
tion, and 2 were used to mainly evaluate the spill-in correction.
Overview of the steps taken to generate simulated data is illustrated in figure
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4.1. Each phantom was blurred using an isotropic Gaussian PSF with FWHM of
6.50 mm. Then the blurred phantoms were forward projected using Software for
Tomographic Reconstruction (STIR) [Thielemans et al., 2012] to simulate the 3D
PET acquisition data. The Siemens Biograph mMR scanner geometry was simu-
lated, taking account of attenuation and scatter. Poisson noise was added to the
projected data. PET images were reconstructed using OSEM with 3 iterations and
21 subsets for a 3D matrix with a voxel size of 2.08 x 2.08 x 2.013 mm.
4.4.2 Application of the STC method to the simulated data
PV correction was applied to each reconstructed phantom image and the perfor-
mance of the PV correction was compared against the true intensities. Firstly, the
reconstructed images were resampled to MR angiography space (0.39 x 0.39 x 1
mm) using tri-linear interpolation. The STC PVC was applied on coregistered PET
images with 15 iterations and the segmented carotid arteries as the mask image.
In order to evaluate the effect of different PSFs in the PVC, STC was applied to
each of the reconstructed phantoms with 15 iterations and the errors between the
recovered and true carotid activities were computed for different PSFs. The optimal
PSF FWHM value was found by minimizing the mean error, averaged across the
six phantoms.
An alternative method was also applied with an aim to measure the PSF di-
rectly from the reconstructed images. In this method, as illustrated in figure 4.2,
the centroids of the left and right carotid arteries in each axial slice were calculated.
Next, the carotid arteries were blurred with the 3D PSF and line profiles were drawn
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Figure 4.2: Illustration of method used to derive PSF from reconstructed PET images. The
difference between FWHM of line profiles drawn through the centroids on PET
and blurred MR images was minimized by varying the PSF
in x and y directions through artery centroid locations. The segmented images were
blurred using a 3D Gaussian PSF. Line profiles were drawn through centroids of
left and right carotid arteries in x and y directions on both PET and blurred seg-
mented MR images. These line profiles were fitted with a Gaussian function and
mean FWHMs of Gaussian fits were calculated for PET and blurred MRI data. This
was repeated in an optimisation routine to find the optimal PSF, which gave the
lowest difference between the mean FWHM of fitted Gaussian functions on PET
and blurred segmented MR line profiles. In order to check the effect of errors in
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the carotid artery segmentation on the measured PSF values, the experiment was
repeated with under-segmented and over-segmented carotid arteries. This was done
by eroding and dilating the original carotid arteries by adding or removing one or
two voxels to its diameter.
4.5 18F-FDG Experiments
4.5.1 Materials
All of the datasets presented in this chapter were provided by Department of Clini-
cal Physiology, Nuclear Medicine and PET of University of Copenhagen.Dynamic
PET and anatomical MRI images were acquired on 21 healthy male subjects (mean
age: 28.3 years, range: 22 to 40 years). All of the subjects had given written in-
formed consent before the scans. The protocol for the experiments was approved
by the Danish National Committee on Health Research Ethics (h-4-2012-167) and
the studies were conducted in accordance to the Declaration of Helsinki.
Each subject received an intravenous bolus injection of 200 MBq of 18F-FDG
over 20 seconds followed by 10 mL of saline flush and underwent a dynamic PET
scan on a Siemens Biograph 64mCT scanner (Siemens Healthcare, Erlangen, Ger-
many). The PET scans lasted for 1 hour and 19 PET frames were reconstructed
using the following frame durations: 6 x 10 seconds, 2 x 30 seconds, 3 x 60 sec-
onds, 2 x 150 seconds, 2 x 300 seconds and 3 x 600 seconds. The PET images
were reconstructed using OSEM with four iterations and 24 subsets and a 4-mm
Gaussian filter was applied. The data were reconstructed into a 128 x 128 matrix
with a pixel size of 2.5 mm and 74 slices were acquired with a slice thickness of
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3mm. Attenuation correction was performed using information from the CT scan.
The PET data were corrected for randoms, scatter, attenuation and radioactive de-
cay. In order to stand as a gold standard in the comparison, arterial blood samples
for measurement of radioactivity concentration in arterial plasma were drawn from
the radial artery at 33 time points with various time intervals. For the early samples,
10 second intervals were used in order to get a good definition of the input function
peak. Sampling was performed using vials with internal vacuum over 3 s at the
beginning of each time interval. Immediately prior to each measurement, a similar
vial was used to rinse residual activity out of the catheter. Plasma radioactivity con-
centrations were measured in a well-type gamma counter (COBRA 5003; Packard
Instruments). Plasma glucose level and haematocrit were also measured for each
subject.
The MR scans were acquired on a 3T Philips Achieva MRI scanner (Philips
Medical Systems, Best, The Netherlands). A 32-channel phased array head coil
was used in all scans. MPRAGE scans were obtained with a 3D T1-weighted turbo
field echo sequence (150 slices, FOV=241x180x165 mm3, TE=2.78 ms, TR=6.9
ms, flip angle = 9 degree) and were reconstructed into a 150 x 224 x 224 matrix
with a voxel size of 1.1 x 1.1 x 1.1 mm. 3D time of flight MR Angiography images
were also acquired (TR=23 ms, TE=3.5 ms, flip angle= 18 degree) from 100 slices
covering the lower head and upper neck regions. These slices had a thickness of 1
mm and covered a region of 200 x 200 cm. They were reconstructed to a voxel size
of 0.39 x 0.39 x 1 mm. The summary of acquired PET and MR images is shown in
figure 4.3.
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Figure 4.3: Images used in this study: (a) PET frame showing the arteries, (b) MPRAGE
image of the brain, (c) TOF MR angiography image of neck region (d) PET
frame co-registered to the MR angiography image. Marked voxels show the
arterial voxels delineated from the MR angiography image
4.5.2 Data Analysis
Data from 2 of the 21 subjects were not included in the data analysis due to the
movement of the head during the dynamic PET scan. Carotid arteries were seg-
mented from MRA images using ITK-SNAP version 3.2 [Yushkevich et al., 2006],
which includes an automatic active contour segmentation toolbox. Images were
classified into two tissue classes using tissue classification and a region-growing
algorithm was applied in the region with the arteries. Because of the different field
of view of MRA images compared to the PET images, segmentation was limited
to 3 cm below the petrous section of left and right internal carotids arteries (figure
4.3d). Maximum intensity projection image of segmented arteries for one subject is
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Figure 4.4: Maximum intensity projection of segmented carotid arteries for one subject
shown in figure 4.4.
FSL linear image registration tool [Jenkinson and Smith, 2001b] was used in
the PET-MR image registration. Due to the different fields of view of the MRA and
PET images, a two-step image registration method was applied where MPRAGE
images were also utilised as they have the same field of view as the PET images.
Within modality registration, MPRAGE to MRA, was performed using transla-
tion (3 parameter) followed by a rigid registration (6 parameter) locally applied to
masked carotid arteries. For the intramodal MRI registration, the correlation ratio
was used as the cost function. For the cross-modal registration, the sum of earliest 6
PET frames (0-60 seconds) was computed to maximise the intensity in the arteries
and was registered to the MPRAGE image using a rigid registration (6 parameter).
Normalised mutual information was used to minimise the cost function. The com-
bined matrix of these three transformations was used to resample PET frames onto
MRA space. Each registration was visually confirmed by overlaying the segmented
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carotid arteries on the registered PET frames.
PV effects in dynamic PET frames were corrected using the STC, where the
binary mask of the segmented carotid arteries was used as the region of interest. A
three-dimensional position-invariant isotropic Gaussian function with 6.8 FWHM
was used to represent the PSF of the scanner. This PSF FWHM value was empiri-
cally derived from PET images by implementing the PSF measurement method by
fitting a Gaussian function to line profiles across the carotid artery centroid points,
as described in the simulation work section of this chapter (section 4.4.2). The
method was applied to the two PET frames with highest arterial intensities (20 to
40 s) and the mean FWHM value between frames was calculated. This was repeated
for all of the 19 subjects and the mean calculated FWHM is used in the PVC of all
subjects (6.800.36 mm, range of 6.05 mm to 7.38 mm). Individual FWHMs are
shown in figure 4.5. PVC was applied to each PET frame individually. The PVC
algorithm was found to converge in 10 iterations, after which the mean intensity
within the carotid arteries stopped changing significantly.
Cblood = HCT ·CRBC +(1−HCT ) ·Cplasma (4.6)
After correcting for PV effects, whole blood TAC was measured by computing
the mean intensity within the segmented carotid arteries. In order to obtain the
IDIF, whole blood concentration was converted to plasma concentration using a
rearranged version of equation 4.6, where HCT represents measured haematocrit
and CWB, CRBC and CP represent the radioactivity concentration in whole blood,
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Figure 4.5: PSF FWHMs calculated for each subject
red blood cells and plasma respectively. A population based CRBC/CP relationship
was used in this conversion [Phelps et al., 1979]. An example of derived plasma
concentration to whole blood concentration is shown in figure 4.6.
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Figure 4.6: Concentration ratio of FDG tracer in blood plasma to that of whole blood for
one subject, derived using rearranged version of equation 4.6. The linear curve
was sampled for each second
As the arterial blood samples were taken from the radial artery, while the IDIFs
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were obtained from carotid arteries, there was a time difference and dispersion be-
tween these two input functions. To make a fair comparison against arterial blood
samples, delay and dispersion were applied to the measured IDIFs. Delay was
added to the IDIF by shifting the curve to later times to match the tracer arrival
times of IDIF and arterial samples. Then it was convolved with a monoexponen-
tial function to simulate dispersion. This was done in an optimisation to estimate
the delay and time constant of dispersion that gave the best match between the
subjects IDIF and arterial AIF peak shapes. This was performed for each subject
independently and the averaged delay and dispersion values were used in the kinetic
analysis. Finally, to see the effect of scaling, the measured IDIF curve with blood
samples, the ratio between the mean of the last three arterial blood samples and the
mean of the last three IDIF activities were calculated and the uncorrected and PV
corrected IDIF curves were scaled using this ratio.
4.5.3 Performance Evaluation of Input Functions
In order to evaluate the performance of the derived IDIFs against the measured
arterial input function of each subject, TACs from grey and white matters were fitted
using both input functions. All PET kinetic analysis was done using PMOD (PMOD
Technologies, Zurich, Switzerland). For each subject, 2 TACs were extracted using
average grey matter and white matter activity and these were fitted using the 2-
tissue compartment model with 3 rate constants (K1, k2, and k3). The rate constant
representing the transfer of tracer from metabolised state back to the unmetabolised
state was assumed to be negligible (k4=0). Cerebral blood volume (Vb) was also
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estimated during the curve fitting. Using the estimated rate constants, cMRglc was
computed for each input function.
In this analysis, the lump constant (LC) was set to be 0.89 [Graham et al.,
2002] (Irreversible FDG model) and CPG was measured by taking a blood sample
from each subject before the PET scan. The input functions derived before partial
volume correction (IDIFUncorrected), after partial volume correction (IDIFPVC) and
from plasma samples (AIFsamples) were fitted with the Feng input function model
which consists of the sum of a gamma-variate function and two exponentials [Feng
et al., 1993]. The performance of the proposed method was also tested by compar-
ing the area under curve (AUC) of derived IDIFs to arterial samples. Paired students
t-test was used to evaluate the statistical difference between AUC and cMRglc val-
ues calculated using IDIFPVC and AIFsamples where a significance level of 0.05 was
adopted throughout.
4.6 Results
4.6.1 Simulation results
Figure 4.7 illustrates the ratio of recovered intensity after partial volume correction
to the true intensity within the carotid arteries for each iteration. The first value
(iteration 1) represents the intensities before the PVC is applied and it can be seen
that the PV effect increases when the difference between the carotid artery intensity
and background intensity is increased. This is caused by the reduced relative spill-
in effect from background tissues to the arteries as the intensity within the arteries
is increased. When the PSF with 6.50 mm FWHM was used, which is identical
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to the PSF used to blur the mask image in the phantom generation, the correction
converged to a solution after ten iterations. As can be seen in 4.7a, at least 87.4%
of the true intensity was recovered for all of the six phantoms.
PSF with 6.74 mm FWHM was found to give the smallest difference between
the recovered and the true intensities across the all datasets. 4.7b shows the re-
sults when this optimal PSF was used and it can be seen that a better recovery was
reached with this PSF where 92.9% of true intensity was recovered at minimum. A
similar PSF FWHM value, 6.72 mm, was obtained when it was measured by draw-
ing line profiles to carotid centroids of the reconstructed PET and MR images and
results with this PSF is illustrated in figure 4.7c. At minimum, 92.4% of the carotid
artery intensity could be recovered with this PSF.
Figure 4.8 shows the image-derived PSF values when the carotid arteries were
under-segmented or over-segmented by one or two voxels in x and y directions. It
can be seen that when the arteries were eroded by 2 voxels, a PSF FWHM of 6.91
mm was computed. On the other hand, when the arteries were dilated by 2 voxels in
x and y directions, PSF FWHM of 6.38 mm was computed. A polynomial relation-
ship was observed between the calculated PSF FWHM values as the carotid artery
diameter was changed. The effect of using these erroneous PSF values on recov-
ery performances of STC was illustrated in figure 4.9. As expected, smaller PSFs
resulted in undercorrection of the activity and using PSF FWHM of 6.38 mm recov-
ered only 88.9% of the true activity. On the other hand, using an overestimated PSF
FWHM caused overcorrection of the activity where the mean intensity after PVC
with PSF FWHM of 6.91 resulted was 105.8% of true activity. An approximately
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Figure 4.7: Recovered intensity to true intensity ratios for each iteration of partial volume
correction. Results are shown for 6 different background to carotid intensity
ratios. (a) shows the result when PSF FWHM is 6.5 mm, (b) PSF is 6.74 mm
and (c) 6.72mm
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Figure 4.8: PSF FWHM calculated with segmentation errors where carotid arteries are
eroded or dilated by adding or removing 1 or 2 voxels to its diameter. Neg-
ative changes represents the under-segmented arteries where positive changes
represent over-segmentation. Voxel size is 0.391 x 0.391 mm.
Figure 4.9: Effect of using different PSF FWHM values on the PVC performance. Recov-
ery of true intensity value is shown in percentages
4.6. Results 116
linear relationship was observed between the PSF FWHMs and recovered intensity
to true intensity percentage ratios.
4.6.2 18F-FDG results
The mean value for prescan blood glucose was 5.07 mmol/L (4.3-5.7 mmol/L) and
average haematocrit was 41% (36-45%). Figure 4.9 shows the IDIFPVC derived
from one subject plotted together with IDIFUncorrected and AIFSamples as well as
IDIFPVC and IDIFUncorrected scaled with blood samples. It can be seen that ap-
plication of the PV correction increases the intensities both at early and late parts
of the input function. The tail of the IDIFPVC (after 3 minutes) was well matched
with AIFSamples which shows that the PVC method worked successfully to recover
the accurate intensity values within the carotid arteries. The first frames of the
IDIFUncorrected and IDIFPVC after the delivery of the tracer showed a much higher
difference where the PVC increased the peak of the input function by 300% in av-
erage. After PVC, a close match between AIFSamples and IDIFPVC peak shapes was
observed (figure 3b). The AIFs plotted in figure 4.9 were corrected for delay and
dispersion effects. Across the 19 subjects, an average time shift of 9.49 seconds was
observed between the peaks of these two input functions. The average dispersion
time constant was computed as 4.70 seconds between the carotid artery and radial
artery time activity curves.
Comparison of the computed AUC values for each of the three input func-
tion curves was illustrated in figure 4.11. The mean and standard deviation of
AUC values in MBq.min/mL was 15.5 ± 2.0 for IDIFUncorrected, 19.7 ± 2.0 for
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Figure 4.10: (a) IDIFUncorrected, IDIFUncorrected scaled with blood samples, IDIFPVC,
IDIFPVC scaled with blood samples,and AIFSamples plotted together for one
subject. (b) Input function curves plotted for first 4 minutes only to show the
peaks. Dispersion was added to IDIFPVC and IDIFUncorrected curves. (c) Input
function curves plotted for last 30 minutes.
4.6. Results 118
IDIFUncorrected scaled with blood samples, 26.0 ± 2.9 for IDIFPVC , 22.7 ± 2.8
for IDIFPVC scaled with blood samples and 26.8 ± 2.6 for AIFSamples. In all of
the 19 subjects, IDIFUncorrected had significantly lower AUC values (paired t-test,
p <0.0001), which confirms the underestimation of the input function due to PV
effects. It was seen that applying the PVC brought the area under the IDIF curve to
a good agreement with the AIFSamples. Comparing the area under the IDIFPVC and
AIFSamples for each subject, there was no statistically significant difference between
AUC of these curves with a p value of 0.16. AUC of IDIFPVC scaled with late blood
samples was also found to be significantly different from AIFSamples (p <0.001).
AIFSamples IDIFPVC IDIFPVC Scaled IDIFUncorrectedIDIFUncorrected Scaled
1
1.5
2
2.5
3
3.5 ×10
4 AUC
Figure 4.11: Area under curves (AUCs) of AIFSamples, IDIFPVC , IDIFPVC scaled with blood
samples, IDIFUncorrected, and IDIFUncorrected scaled with blood samples Dots
represent individual AUCs and lines represent the mean AUC across the group
Table 1 and 2 lists the summary of the kinetic parameter and cMRGlc re-
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sults estimated for grey matter and white matter using IDIFUncorrected, IDIFPVC and
AIFSamples. When IDIFUncorrected was used, cMRGlc in grey matter was overes-
timated by 50.9% on average compared to the estimates with AIFSamples. Simi-
larly, cMRGlc in white matter was overestimated by 45.4% when IDIFUncorrected
was used. Using the IDIFPVC largely improved the estimates, bringing the aver-
age absolute error to 5.6% and 7.5% respectively. Performing a paired t-test on
the results obtained with IDIFPVC and AIFSamples showed no statistically significant
difference for both regions (p=0.12). Bland-Altman plots of individual cMRGlc
estimates for white and grey matter are shown in figure 4.12, illustrating that there
was no consistent bias in the produced white matter results. However, there is a
statistically significant positive trend in the grey matter cMRGlc results (Pearson
correlation, p <0.005). At present, this effect remains unexplained.
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Figure 4.12: Bland-Altman Plots of cMRglc estimates with arterial blood samples and PV
corrected IDIF for (a) grey matter and (b) white matter.
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Table 4.1: Mean value and standard deviation of kinetic parameters and cMRglc estimates for grey matter calculated using arterial samples, PV
corrected IDIF, PV corrected IDIF scaled with blood samples, uncorrected IDIF and uncorrected IDIF scaled with blood samples for 19
subjects. The symbol * indicates parameters with significant difference to arterial samples (paired t-test, p <0.05).
Grey Matter
Vb K1 k2 k3 K1/ k2 Ki cMRglc
Blood AIF 0.059 ± 0.019 0.123 ± 0.014 0.121 ± 0.045 0.079 ± 0.023 1.175 ± 0.581 0.049 ± 0.004 26.88 ± 2.36
PVC IDIF 0.050 ± 0.020 *0.149 ± 0.022 0.124 ± 0.044 *0.056 ± 0.025 1.323 ± 0.490 0.046 ± 0.008 25.38 ± 4.66
Scaled PVC IDIF 0.050 ± 0.020 *0.166 ± 0.038 0.118 ± 0.044 *0.053 ± 0.024 *1.592 ± 0.645 0.049 ± 0.005 26.95 ± 2.92
Uncor. IDIF *0.076 ± 0.015 *0.427 ± 0.098 *0.219 ± 0.063 *0.046 ± 0.007 *2.017 ± 0.429 *0.074 ± 0.009 *40.56 ± 4.82
Scaled Uncor IDIF *0.101 ± 0.022 *0.325 ± 0.070 *0.220 ± 0.070 *0.047 ± 0.008 *1.531 ± 0.293 *0.057 ± 0.007 *31.35 ± 3.91
Table 4.2: Mean value and standard deviation of kinetic parameters and cMRglc estimates for white matter calculated using arterial samples, PV
corrected IDIF, PV corrected IDIF scaled with blood samples, uncorrected IDIF and uncorrected IDIF scaled with blood samples for 19
subjects. The symbol * indicates parameters with significant difference to arterial samples (paired t-test, p <0.05).
White Matter
Vb K1 k2 k3 K1/ k2 Ki cMRglc
Blood AIF 0.029 ± 0.008 0.044 ± 0.009 0.092 ± 0.030 0.040 ± 0.013 0.512 ± 0.125 0.013 ± 0.002 7.22 ± 1.10
PVC IDIF 0.027 ± 0.010 *0.054 ± 0.012 0.101 ± 0.032 *0.030 ± 0.009 0.573 ± 0.136 0.012 ± 0.003 6.68 ± 1.35
Scaled PVC IDIF 0.027 ± 0.008 *0.061 ± 0.014 0.096 ± 0.024 *0.027 ± 0.009 *0.655 ± 0.157 0.013 ± 0.002 7.26 ± 1.07
Uncor. IDIF *0.038 ± 0.008 *0.151 ± 0.037 *0.181 ± 0.040 *0.027 ± 0.006 *0.850 ± 0.180 *0.019 ± 0.004 *10.50 ± 1.89
Uncor. IDIF scaled *0.048 ± 0.010 *0.114 ± 0.028 *0.179 ± 0.041 *0.027 ± 0.006 *0.652 ± 0.015 *0.015 ± 0.003 *8.05 ± 1.16
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For individual kinetic parameter estimates, using the IDIFUncorrected overesti-
mated the K1 parameter by 247.0% on average for grey matter and white matter.
This error was reduced to 21.0% and 22.7% after the PVC. There was no statisti-
cally significant difference on the k2 parameter values produced with IDIFPVC and
AIFSamples (p=0.98). On the other hand, using the IDIFUncorrected underestimated
k3 values but IDIFPVC reduced this difference by a factor of two, similar to the
improvement seen for k2 results. IDIFPVC was able to return Vb, k2 and cMRGlc
values with no significant differences.
Using three arterial blood samples to scale the IDIFPVC slightly improved the
mean of cMRGlc estimates, with an average absolute percent difference of 0.3%
and 1.5% and no statistically significant difference (p=0.93 and p=0.72) against
AIFSamples for grey and white matter respectively. Scaling increased the error on
the K1 parameter, with 35.0% and 38.6% error against the AIFSamples. Similar to
IDIFPVC results, scaled IDIFPVC was able to return Vb, k2 and cMRGlc with no
significant difference to AIFSamples. Scaling the IDIFUncorrected with blood caused
an improvement on the cMRGlc estimates. However, there was a significant dif-
ference between scaled IDIFUncorrected and AIFSamples cMRGlc estimates (p<0.01).
Furthermore, it yielded large errors on the individual kinetic parameter estimates.
4.7 Discussions
Simulated data results showed that STC can be accurately applied to regions with
different region-to-background activity ratios and can correct for spill-in and spill-
out effects reliably. It was observed that using a PSF with a larger FWHM than the
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PSF used in the simulation of datasets resulted in a more accurate PV correction.
This indicates that further blurring was caused by the forward-projection, recon-
struction and resampling of the data, mainly due to interpolation effects caused by
these processes. A PSF FWHM value closer to the optimal value could be accu-
rately measured from the reconstructed PET images and using this PSF resulted in
similar recovery performance for all of the datasets. This indicates that a reliable
PSF can be measured from reconstructed PET images if the true shape and size of
the region of interest is known.
Due to the small diameter of carotid arteries, IDIFs directly estimated from re-
constructed PET frames are severely affected by the partial volume effects. Results
from this study show that such IDIFs have significantly lower tracer concentration
even when the arterial VOIs are delineated from high-resolution MR anatomical
images. Errors caused by partial volume effects are especially observed in the early
frames, where the peak of the input function is highly underestimated. Perform-
ing a partial volume correction greatly improved the recovery of signal intensities
within the carotids and a good visual agreement was observed against input function
curves acquired from serial arterial sampling. Using the PV corrected IDIFs also
yielded a good agreement between the estimated cMRGlc values with the arterial
samples. Scaling the PV corrected IDIF with late blood samples resulted in smaller
AUC values compared to the arterial samples. This can be due to the variation of
the error in the PV correction at different time points as the early frames are more
affected from spill-out effects than later time points. Therefore a single scaling con-
stant measured at the latest part of the curve may not be sufficient to calibrate the
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whole input function.
In this work, we have used a novel image-based partial volume correction
method in the IDIF estimation. This method only requires an accurate segmen-
tation of the region of interest, which is the carotid artery in this application. This
eliminates the need for complete parcellation of the image into separate regions,
which is a necessary step for most image-based partial volume correction meth-
ods to operate [Rousset et al., 1998b] [Erlandsson et al., 2012b], or even definition
of representative background regions [Zanotti-Fregonara et al., 2009b]. Therefore,
here we have implemented a more practical PV correction method for the purpose
of IDIF measurements.
The performance of the presented method highly depends on the accuracy of
segmentation, image registration and point spread function estimation. As presented
here, time of flight MR angiography images can be easily used to segment carotid
arteries as they clearly distinguish signal coming from inflowing blood compared
to neighbouring voxels. Typical T1-weighted MPRAGE images have larger voxel
size which can affect the accuracy of the segmentation of internal carotid arteries
with small diameter. Furthermore, background regions neighbouring the carotid ar-
teries have higher intensity on MPRAGE images and can interfere with the region-
growing algorithm. We attempted to apply the same segmentation method on the
MPRAGE images but observed discontinuities in the segmented arteries and leak-
age to background tissues. MR Angiography is now routinely performed in many
clinical and research brain imaging studies and a high resolution 3D MR angiogra-
phy image of the carotid region can be easily acquired.
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This method can be also be applied to other body parts where a suitable arte-
rial structure is within the field of view. For instance, the proposed method has been
used to derive IDIF in Rubidium-82 colorectal PET studies where the femoral ar-
teries were segmented from higher resolution CT perfusion images [Dickson et al.,
2015]. Similarly, STC was applied to correct for the PV effects present on the PET
images and IDIF was computed using the proposed technique. The derived AIFs
were not compared against the gold standard AIF due to lack of arterial samples,
but a significant increase in the IDIF peaks was observed after the PVC was applied.
The authors of that work confirmed that application of the proposed method to de-
rive the AIF substantially corrected for spill-in and spill-out effects seen in different
PET frames and induced a significant change in the estimated K1 parameter values.
Mismatches in the PET/MR registration can lead to errors in the measured
IDIF curves as they may cause inclusion of signal from non-arterial voxels in the
measurement. In order to minimise the errors caused by misregistration, we de-
veloped a two-step registration method and alignment of carotid arteries was vi-
sually inspected for each dataset. However it is likely that small mismatch errors
were present in these data since the PET and MRI images were acquired on sep-
arate scanners and patients may have had different head positioning across scans,
making the registration step more problematic. Using a simultaneous PET/MRI
system is likely to improve the performance of IDIF extraction as it could reduce
co-registration errors.
IDIF methods including our proposed method are vulnerable to subject motion
during the dynamic PET and MR scans. Subject motion during the MR angiography
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acquisition can distort the shape of the arteries and lead to errors both in carotid
artery segmentation and registration. Interframe motion in the PET data can cause
the carotid arteries to change location between the frames, causing mismatch to
the coregistered mask image and hence inconsistence in the measured TACs. Such
effects can cause underestimation of the IDIF and lead to overestimation of the
cMRGlc parameter. Mourik et al. [Mourik et al., 2011] simulated motion effects and
compared IDIFs with motionless IDIFs. Results of this simulation work showed that
when patient motion is more than 6◦ rotation or 5 mm axial translation after the first
10 minutes of the scan, at least 10% overestimation or underestimation of the VT
was observed. Zanotti-Fregonara et al. [Zanotti-Fregonara et al., 2012] evaluated
the effects of simulated translational and rotational motion on IDIFs and observed a
difference in the AUC of the IDIFs compared to the motionless measurements of up
to 19% for rotations and 66% for translations. However, the errors were found to be
less than 10% in clinical scans without any motion correction. Authors concluded
that motion artefacts only minimally affect IDIF estimation in brain PET imaging.
However, in the presence of motion, blood samples could be used to scale the IDIF.
External markers can be placed onto the subject’s head to track the possible
head movements. However, such methods usually require an external device and
require a clear view of the markers placed on the head [Fulton et al., 2002]. With
the help of PET/MRI scanners, simultaneously acquired MR data can be used to
perform motion tracking and correct dynamic PET frames for motion effects. This
can be done by repeatedly acquiring anatomic volumes using fast MRI navigator
sequences, such as EPI, and coregistering these images to correct for any motion
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which can happen between acquisitions [Catana et al., 2012]. This information
can be then utilised to correct motion in the simultaneously acquired dynamic PET
data [Keller et al., 2015] [Catana et al., 2011]. Such techniques can enable us to
minimize the motion artefacts between the PET frames and the reference MRI im-
age used for the carotid artery segmentation. Application of a reliable motion cor-
rection method will hence enhance the accuracy of the proposed IDIF method in the
presence of significant subject motion.
One limitation of this study was the arterial blood sampling protocol used to
obtain the arterial input function. AIF was sampled for every 10 seconds for the
first two minutes, which might cause errors in the definition of the AIF peak. The
sampling thereby closely matches the initial framing. However, the measured AIFs
and IDIFs were fitted with an analytical input function model in the kinetic analysis
which could reduce the negative effects caused by the sampling protocol. During
the AIF fitting, we took into account the fact that each blood samples was taken
over a 3 second period, while the IDIF represented an average over each PET frame
duration. The accuracy of the IDIFs would depend on the accuracy of segmentation,
registration and PSF measurement methods, while the AIF could be affected by
issues related to the blood sampling. These can be possible explanations for the
significantly different K1 and k3 parameters.
A small time difference between the peaks of the IDIFPVC and AIFSamples was
observed which can be caused by different PET tracer arrival times to the carotid
arteries and the radial artery, tubing used in arterial sampling and variation in blood
velocity in different arteries. This time difference in AIF peaks may also introduce
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errors in the estimated kinetic parameter values. There are several methods present
in the literature to correct arterial samples for these time delay and dispersion effects
[Meyer, 1989] [Iida et al., 1988], but in this case we have chosen not to modify
the gold standard arterial blood sample curve. Therefore, in order to make a fair
comparison, time delay and dispersion were applied to the measured IDIFs instead.
It could be argued that due to its proximity to brain tissues, an IDIF measured from
carotid arteries, corrected for PV effects, might be a more accurate representation
of the input function in brain kinetic analysis than arterial samples obtained from a
radial artery.
There was a good agreement between IDIFPVC and AIFSamples in terms of the
macro-parameter Ki. However, the micro-parameters K1 and k3 were significantly
different. This may suggest that, when using IDIFPVC, the outcome values should
be restricted to Ki, in which case it would be possible to use a simple Patlak anal-
ysis [Patlak et al., 1983] [Graham et al., 2002], obviating the need for full kinetic
modelling. On the other hand it is not entirely clear which set of estimated micropa-
rameters are closer to the true values. The K1, k2, k3 and cMRGlc values obtained
with our method are well within the range of previously published values for grey
matter tissues in healthy subjects (K1: 0.068-0.161), k2: 0.071-0.301, k3: 0.03-0.10,
cMRGlc: 28.60 ± 4.73) [Yushkevich et al., 2006].
The ultimate goal of this work is to provide a non-invasive and practical way of
measuring the input function from PET images and eliminate the need for arterial
sampling in clinical practice. The method was validated in healthy subject 18F-
FDG studies but can be extended to analyse patients with various disorders. For
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instance, 18F-FDG PET tracer can be used in Dementia studies to calculate the
hypometabolism by comparing estimated cMRGlc values to healthy subject values.
On average, approximately 12% reduction in cMRGlc values is observed in subjects
with dementia [Chawluk et al., 1990] [Ishii et al., 1997] [Mosconi et al., 2009].
Based on the grey matter cMRGlc results presented in this chapter, a sample size of
17 will be required to detect the 12% difference between the control and dementia
subject’s cMRGLc values with a power of 0.80. On the other hand, 6 subjects will
be needed to be included in each of the patient and control groups when blood
sample derived AIFs are used.
4.8 Conclusions
In conclusion, the proposed IDIF estimation technique, which uses STC to correct
for contamination from neighbouring tissues, only requires the segmentation of the
carotid arteries with no separate need for parcellating the background region. The
carotid arteries were segmented using MR angiography images with excellent ves-
sel contrast. The proposed method does not require any arterial or venous blood
samples to be used in PV correction and curve scaling. Results were validated
against AIFs determined from serial arterial blood samples and no significant dif-
ference was seen in the area under input function curves and estimated cMRGlc
values. Only two of four microparameters could be retrieved with no significant
differences. However, the cerebral metabolic rate of glucose consumption (cMR-
Glc) parameter, which is usually the main parameter of interest in 18F-FDG, was
derived accurately with no significant difference to arterial samples. These results
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indicate that the proposed method can be used as a practical alternative to measure
the blood signal in the carotid arteries with no need for arterial or venous blood
sampling.
Chapter 5
Exploiting Prior Information in the
PET SIME Method
5.1 Introduction
The simultaneous estimation (SIME) method is a non-invasive image-based method
to perform kinetic analysis of dynamic PET data. In this method, the input function
is expressed as a mathematical function in which parameters are estimated together
with the kinetic parameters. SIME requires time activity curves from different re-
gions with various kinetic behaviours and each region is modelled using a tissue
compartmental model. Assuming that the input function is uniform across the re-
gions, the AIF is estimated simultaneously with the kinetic rate constant parameters
for each region. SIME usually requires a blood sample, or another scaling factor
to normalise the estimated input function and ensure model identifiability. SIME is
fully described in detail in the next section.
An accurate measurement of the input function is also essential in the analy-
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sis of dynamic-susceptibility contrast (DSC) MRI and dynamic contrast enhanced
(DCE) MRI data. In these techniques, the injected bolus of gadolinium-based con-
trast agent causes a signal drop on T2 and T ∗2 weighted images and a signal rise
on T1 weighted images. These signal changes can then be used to derive the con-
centration of the contrast agent in the plasma. Estimation of the input function can
have some advantages in MRI, due to its higher spatial and temporal resolution. For
most PET tracers with neglected uptake in the lungs, the early peak of the input
function mainly describes the delivery of the PET tracer to the tissue of interest and
is dominated by the cardiac output and blood flow. The same applies to the delivery
of the Gd contrast agent. Therefore, if the PET data and MRI data are obtained at
the same time, similarities are expected to be seen in the early parts of the PET-AIF
and MRI-AIF. Hence, the early part of an MRI-AIF can be used to obtain some
prior information about the bolus shape of the input function, which can be incor-
porated in the SIME method. In addition, in cases where IDIF methods can not be
used non-invasively to measure the AIF (i.e. due to presence of radiometabolites
in blood plasma), the whole blood TAC, which can be noninvasively derived from
PET images using the methodology presented in Chapter 4, can be used to obtain
prior information regarding the AIF.
This chapter presents details of our approach to utilise prior information within
the SIME method. A simulation study was performed to evaluate the effects of in-
jecting this prior information on the accuracy of estimated kinetic parameters. The
method was tested with simulated 18F-FDG and results were compared with or with-
out the prior information and different AIF scaling methods against the known true
5.2. Literature Survey 133
AIF. An inter-subject analysis was performed by simulating TACs using published
kinetic parameters from different studies. Results have shown that incorporating the
prior AIF information within the simultaneous estimation significantly improved the
bias on estimated Ki values. The overview of the constrained SIME implementation
is illustrated in figure 5.1.
5.2 Literature Survey
The SIME method was introduced by Feng et al. in 1997 [Feng et al., 1997], as
an alternative method to perform non-invasive quantitative analysis of dynamic
PET data. The method was tested using Monte Carlo simulation and it was con-
cluded that a reliable estimation of cMRGlc could be obtained in FDG studies in
the presence of at least three ROIs with different kinetics. Wong et al. [Wong et al.,
2001] used a modified version of SIME, called simultaneous estimation with post-
estimation (SIMEP), where the input function estimated by SIME was used to indi-
vidually fit each TAC as a second step to obtain the kinetic parameters. The authors
showed that the standard deviation of the parameter estimations was improved when
SIMEP was used and SIMEP provided similar results to those obtained by arterial
samples. Wong et al. also presented another modified version of SIME where they
replaced nonlinear least squares with a Monte Carlo method called simulated an-
nealing in the minimisation of the cost function [Wong et al., 2002]. The main
benefit of using simulated annealing was to avoid the local minima problems that
the nonlinear least squares method can face during optimisation. The method was
tested with simulated dynamic SPECT data with 99mTc-teboroxime which has faster
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kinetics compared to 18F-FDG. The authors showed that using simulated annealing
improved the accuracy of the estimated input function and physiological parame-
ters, and yielded more similar AIF and kinetic parameter estimates than nonlinear
least squares method. The simulated annealing method also was less sensitive to
noise than the nonlinear least squares method. It was concluded that simulated an-
nealing can be a better method to use with tracers that are critically dependent on
the shape of the input function.
In later work, Guo et. al [Guo et al., 2007] tried to obtain the early peak of
the input function during the first 40 seconds, from an image-based PET carotid
artery measurement and used this information together with three venous plasma
samples obtained towards the end of the study to improve the SIME method. A
voxel clustering method was used in their method to obtain TACs from three regions
with varying kinetic behaviour. The results showed that their proposed model was
able to recover the AIF with good performance. They observed Ki estimates with no
significant difference estimated with the proposed method and gold standard arterial
samples. In similar work, Sanabria-Bohorques et al. used three arterial samples to
calibrate an IDIF derived from [11C]-Flumazenil PET studies [Sanabria-Boho´rquez,
2003] and estimated the shape of the early AIF peak using SIME with various TACs
from various brain regions. A good agreement with AIFs derived from arterial
samples was observed. Both AIFs also yielded correlated VT estimates.
Ogden et al. [Ogden et al., 2010] used SIME to analyse various PET tracers
including 18F-FDG and three [11C] labelled tracers which typically require metabo-
lite analysis. Simulated annealing was used in the optimisation of the cost function.
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Their results showed that SIME with simulated annealing was a promising alterna-
tive to non-invasively perform kinetic analysis of dynamic PET data for 4 different
PET tracers. Similar results to arterial samples were obtained using the proposed
method. However, at least one plasma sample was required to ensure the identifia-
bility of the solution. Even though this is more practical than performing full arterial
sampling, it still requires the complications of obtaining plasma concentration and
correcting for metabolites. In 2005, Zanderigo et al. [Zanderigo et al., 2014] pre-
sented an extended version of this method where the need for an arterial sample
for AIF normalisation was substituted with a non-invasive measurement. Instead
of using a single blood sample, they used an anchor value which can noninvasively
computed using multiple linear regression on variables such as injected tracer dose,
body mass index and/or body surface area. They observed that using tracer dose
and body mass index gave the best performance. The proposed method was able to
estimate VT and binding potentials non-invasively with a comparable performance
to full kinetic analysis with arterial blood samples. Their proposed method was
successfully validated in CUMI studies [Shrestha et al., 2014] but was claimed to
be applicable for other tracers. SIME has also been successfully applied to analyse
DCE-MRI datasets [Irving et al., 2013]
5.3 Simultaneous Estimation Method (SIME)
The outline of the SIME method is illustrated in figure 5.1. In this example, three
TACs extracted from different brain regions were used and each region was mod-
elled using a two tissue compartment model with 4 rate constants. It is assumed
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that the AIF is same across all of the brain regions. The AIF is modelled using a
mathematical model, whose parameters define the curve shape.
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Figure 5.1: Schematic diagram of simultaneous estimation approach using two tissue com-
partment model. Time activity curves from different ROIs are incorporated
together with AIF parameters in the objective function to be optimised.
Cp(t) = (A1t−A2−A3)e−λ1t +A2e−λ2t +A3e−λ3t (5.1)
In the original SIME method, Feng et al. [Feng et al., 1997] used Feng’s in-
put function model [Feng et al., 1993] with 6 parameters as shown in equation
5.1, where λ1, λ2 and λ3 are the eigenvalues of the model and A1, A2 and A3 are
the coefficients of the model. This model is the sum of a gamma variate function
which describe the bolus of the AIF with two exponentials which represent the late
washout phase.
In the kinetic model, the impulse response of 2-TC model was convolved with
the AIF model to create the cost function to be optimized, as shown in equation
5.2. K1,k2, k3 and k4 represent the kinetic rate constants for each region and V b is
the cerebral blood volume for each region, which represents the amount of activ-
ity in the vascular space present in that region. The activity in the cerebral blood
5.3. Simultaneous Estimation Method (SIME) 137
volume adds to the signal measured from the tissue of interest and therefore needs
to be taken into account during kinetic analysis, which can be performed using the
relationship in equation 5.3. Contribution of this activity is linked to the amount of
tracer in the whole blood.
Ci =
N
∑
i=1
M
∑
i=1
[CP(t)⊗hi(k1,k2,k3,k4,Vb; t)] (5.2)
CT (t) = (1−Vb)Ci(t)+VbCwb(t) (5.3)
The 6 parameters of the AIF model and the 5 parameter of each ROI (K1,k2,
k3,k4,Vb) were fitted simultaneously. In SIME, at least one blood sample is often
used to normalise the estimated AIF. In the original method [Feng et al., 1997],
Feng et al. proposed withdrawing three arterial blood samples towards the end of
the study and fit an exponential function through them to get the parameter values
of A3 and λ3. AIF scaling using the blood samples was shown to improve the
robustness of the method.
One drawback of SIME is its computational complexity, as a large number of
parameters are estimated at once. As part of this work, we try to incorporate prior
information about the early part of an input function which can be derived from
another source (i.e. image derived blood signal or MRI-derived AIF) to reduce the
number of estimated parameters in the SIME.
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Table 5.1: True values of the kinetic parameters used to generate the three time activity
curves
Grey Matter White Matter Tumour
K1
(mL/cm3/min)
0.041 0.023 0.028
k2
(1/min) 0.120 0.073 0.087
k3
(1/min) 0.064 0.034 0.047
k4
(1/min) 0.0075 0.0098 0.0084
Ki
(mL.cm−3/min) 0.0143 0.0073 0.0098
Vb
(mL/100g) 5.80 2.50 4.40
5.4 Simulation work
In this section, work done to see the effect of including prior information about
the early part of input function derived from another source on the performance of
SIME is presented. An experiment is designed with simulated 18F-FDG data and
the results are compared to true values used in the simulation. The effect of fixing
the λ1 parameter in the AIF model to its true value is evaluated by studying the bias
on the estimated kinetic parameters.
5.4.1 Materials and Methods
The command line interface of Compartment Model Kinetic Analysis Tool
(COMKAT) [Muzic and Cornelius, 2001] was used to generate the simulated data,
set up the model, and perform the parameter optimisation. COMKAT is a free, open
source kinetic modelling software package, written using MATLAB and provides
ready-made kinetic modelling functions as well as a graphical user interface to
analyse dynamic PET images.
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In our model, Feng’s parametric input function (eq 5.1) was used with his
published average values (A1 = 851.1225, A2 = 21.8798, A3 = 20.8113 in µCi/mL
and λ1 = 4.1339, λ2 = 0.1191, λ3 = 0.0104 in 1/min). No time delay was assumed
in the arrival of the PET tracer. Kinetic rate constant and cerebral blood volume
values from a published brain study were used to generate time activity curves of
different brain regions [Hawkins and Huang, 1986] as listed in table 5.1. A two
tissue compartment model was used in modelling, hence the total measured PET
activity was computed using equation 5.2. The TACs of different regions were
sampled at 29 time points, consisting of 6x5 sec scans, 2x15 sec scans, 6x30 sec
scans, 3x2 min scans, 2x5 min and 10x10 min scans.
σ(t) =
√
η2xCT (t)
∆ tk
(5.4)
Gaussian noise was added to TACs using equation 5.4 where CT is the total
measured PET activity, ∆ tk is the frame duration and η is the scaling factor used to
set the noise level added to the data [Landaw and DiStefano, 1984]. In this work,
η was set to 0.5, 2 and 4. This noise model was multiplied with a pseudorandom
number generator, using MATLAB’s randn function, to randomise the generated
noise. 50 realisations were created for each of these three noise levels. Examples of
resulting TACs for three regions are plotted in figure 5.2 for different noise levels.
The SIME cost function includes common input function parameters between
all regions, together with kinetic parameters from different ROIs, which are esti-
mated simultaneously. The cost function can be written as equation 5.5. The fmin-
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Figure 5.2: Simulated time activity curves for grey matter, white matter and tumour re-
gions. TACs are generated with added Gaussian noise using the noise ampli-
tudes (a) 0.5 (b) 2 and (c) 4 and equation 5.4
con function of MATLAB Optimisation Toolbox was used to minimize this cost
function. The optimisation was done using Ordinary Least Squares (OLS). For all
cases, tolerances on parameter values (TolX) was set to 10−4, tolerances on the ob-
jective function value (TolFun) was set to 10−4 and maximum number of function
evaluations was set to be 104.
φ(p) =
n
∑
i=1
m
∑
j=1
w
[
Ei(t j)−Mi(t j)
]2 (5.5)
where n is the number of regions, m is the number of time points in each TAC,
w is the weighting, E is the measured concentration of the tracer in the region at
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time point t j and M is the model output with parameter vector p, which includes
5 parameters (K1,k2,k3,k4 and Vb) from each region of interest and 6 parameters
(A1,A2,A3,λ1,λ2,λ3) from the AIF model. Uniform weighting was applied in this
optimisation.
As mentioned previously, one or more arterial or venous blood samples can
be used to scale the input function and normalise the estimated AIF. In this work,
two different scaling methods were implemented and their performances were eval-
uated. The first AIF scaling method is in the original SIME work by Feng et. al,
where multiple blood samples towards the end of the study were used to aid the re-
covery of AIF [Feng et al., 1997]. As A3 and λ3 dominate the tail of the AIF model,
which represents the end of the scanning period, it can be assumed that these pa-
rameters can be obtained by fitting two or more blood samples measured near the
end of scanning. In this simulation work, parameters A3 and λ3 were kept fixed
to their true values in order to reproduce the effect of this scaling method on the
parameter estimates.
An alternative AIF scaling method was also implemented, where only one
blood sample is obtained at the end of the scan. Then, the ratio of estimated AIF’s
endpoint to the actual radioactive tracer concentration obtained by blood sample is
used as a factor to scale the whole input function. This was simulated by computing
the ratio of true input function endpoint to estimated input function endpoint and
multiplying the whole input function with this ratio.
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5.4.2 Analysis of parameter estimates
The simulation study was repeated 5 times using the simulated dataset at each of 3
noise levels. The five different experimental scenarios can be listed as following:
1. No prior information, single point AIF normalisation
2. With prior information, single point AIF normalisation
3. No prior information, multiple point AIF normalisation
4. With prior information, multiple point AIF normalisation
5. Input function parameters fixed to their true values
AIF parameters and rate constants, together with the blood background, were
estimated for each of 50 noise realisations. In the fifth case, all of the six AIF
parameters were fixed to their true values and only the kinetic parameters were
estimated. This was done in order to see the accuracy of estimated parameters
when the perfect AIF was used.
In order to simplify the analysis of results, influx rate, Ki values of the esti-
mated kinetic parameters were calculated and used in the analysis. A sensitivity
analysis on the fixed value of the AIF parameter was performed by deliberately
including an error on the fixed λ1 parameter. This is performed to simulate the situ-
ations where λ1 can not be extracted due to small variations in the AIF peak shapes.
We have added±10% error on the fixed λ1 parameter values and evaluated its effect
on the Ki estimates. All the starting parameters, lower and upper bounds, and op-
timisation settings were kept identical to the ones used in the previous experiment.
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Figure 5.3 illustrates how the AIF changes with different λ1 values.
CVP =
SD|P|
|P| ×100% (5.6)
Bias =
∣∣∣∣Ptrue−PPtrue
∣∣∣∣×100% (5.7)
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Figure 5.3: Simulated arterial input function with different λ1 values. λ1 was set to 4.134
to represent Feng’s AIF model. AIFs with ±10% error on λ1 are also shown to
model the effect of error in the AIF.
Finally, in order to further evaluate the performance of the method, the simula-
tion study was repeated with four other sets of rate constants obtained from various
published FDG brain tumour studies (group 2 from [Ishikawa et al., 1990] group 3
and 4 from [Kimura et al., 2009], and group 5 from [Spence et al., 2004]). Similar
to the first study, rate constants were obtained from grey matter, white matter and
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tumour tissue (Range of K1: 0.023-0.10 mL/cm3/min, k2: 0.087-0.162 1/min, k3:
0.032-0.107 1/min, k4: 0.001-0.15 1/min, BV: 0.3-0.7 mL/100g). TACs were gen-
erated using these rate constants and Feng’s input function and gaussian noise was
added to the generated TACs. Single-blood AIF sampling was performed only.
For each of these runs, absolute bias and coefficient of variation (CV) values
were calculated and used in the performance comparison. These were calculated by
using equations 5.6 and 5.7 respectively, where P represents the mean of parameter
over 50 noise realisations, SDP represents the standard deviation of P and P
true is
the true value of the parameter.
5.5 Results
Firstly, the effect of fixing one of the AIF parameters to its true value on the bias
and coefficient of variation of estimates was explored. The average bias on kinetic
parameters of each ROI is shown in figure 5.4 for each of the 5 methods and noise
levels used. It can be seen that when no AIF parameter was fixed and AIF scaling
with a single blood sample was used, the average bias on the Ki estimates, averaged
over three noise levels, was approximately 13.8%. This was reduced to 5.4% when
the λ1 parameter of AIF was fixed to its true value. When the AIF was scaled
using the method where the tail was fit to multiple blood samples, the average bias
was 13.5% and was reduced to 10.6% after λ1 was fixed to its true value. The
average bias on the estimated Ki was 5.2% when all six parameters of the input
function were set to their true values and only values of the kinetic parameters and
the vascular fraction for each ROI were estimated. The same trend was seen at all
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noise levels. Also the biases of the fits were close to the bias with true input function
when one input function parameter was obtained from prior information. However
the observed improvement was decreased as the noise level increased.
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Figure 5.4: Percentage absolute bias on 50 Ki estimates, averaged over three ROIs, when
noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars on top show the bias with the
scaling method with one blood sample obtained at the end of the study, green
bars show the bias with the scaling method where the tail is fit to the multiple
blood samples obtained towards the end of the study and red bars show the bias
which would be present when all six parameters of the AIF was set to their true
values.
The biases on Ki estimates and average biases of k2,k3,andk4 are shown in
figure 5.5. It can be seen from these figures that fixing the λ1 parameter generated
the biggest improvement on the K1 estimates. When the single blood sample AIF
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scaling method was used, the bias on K1 was reduced from 46.3% to 10.3%, av-
eraged over all noise levels. When the alternative AIF scaling method was used,
58.6% bias was seen on K1 estimates even after the λ1 parameter was fixed to its
true value. The bias of parameters k2,k3,k4 and Vb were comparable across the two
AIF scaling methods. Fixing the λ1 parameter caused much smaller improvements
on k2,k3,k4, compared to the K1 estimates. Vb estimates had 66.8% absolute bias
which was reduced to 64.8% when λ1 parameter was fixed to its true value for the
single point AIF normalisation method. However, the high bias on the BV did not
affect the accuracy of Ki estimates. This was confirmed by a separate experiment
by estimating the Ki with Vb fixed to its true value where only 0.28% increase in
overall bias was observed.
Figure 5.6 shows the summary of coefficient of variation of estimated Ki pa-
rameters, averaged over three ROIs and plotted for each noise level. These results
indicate that both AIF scaling methods yielded Ki estimates with no significantly
different CV values. Before the λ1 parameter was fixed, using the scaling method
with single blood sample resulted in Ki estimates with 6.3% CV, which was reduced
to 5.7% after fixing the λ1 parameter. In the case of AIF scaling method with mul-
tiple blood samples, this method produced Ki estimates with 6.7% CV and this was
improved to 5.4%. Finally, the run with the true input function estimated the influx
rate parameter with average CV of 4.0%.
These results shows that fixing the λ1 parameter of AIF did not result in a
significant improvement in CV values of Ki estimates. Both AIF scaling methods
produced similar CV values and none was able to match the accuracy of parameter
5.5. Results 147
(a) (b)
(c)
Figure 5.5: Absolute bias on 50 K1 and an average of the k2,k3,andk4 parameter estimates,
averaged over three ROIs. Results are shown for noise levels (a) 0.5, (b) 2, (c)
4. Only one blood sample AIF normalisation results are shown. Green bars
indicate the bias on K1 estimates and blue bars indicate the average bias on
k2− k4 estimates.
estimates with the true AIF. For the single blood sample AIF scaling method, im-
provement was only seen in the lowest noise level but almost identical CV values
were seen with the datasets with higher noise. When the AIF was scaled using mul-
tiple blood samples, the CV of estimates was halved when the noise was set to 0.5.
The improvement decreased as the noise level was increased.
Figure 5.7 shows the bias on Ki values when the λ1 is underestimated or overes-
timated by 10%. Results obtained with the single blood sample AIF scaling method
are shown only. Bias on parameter estimates obtained with no λ1 fixing and when
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Figure 5.6: Coefficient of variation values over 50 Ki estimates, averaged over three ROIs,
when noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars on top show the
CV with the scaling method with one blood sample obtained at the end of the
study, green bars show the CV with the scaling method where the tail is fit to
the multiple blood samples obtained towards the end of the study and red bars
show the CV which would be present when all six parameters of the AIF was
set to their true values.
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Figure 5.7: Absolute percentage bias on estimated Ki values for low noise data. Blue bars
show results without the MRI component, one PET-AIF parameter fixed as-
suming it can be obtained from MRI-AIF, ±10% error added on the fixed AIF
parameter. Red bar shows the bias on estimates when all the AIF parameters
were fixed to their true values.
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Figure 5.8: Results of the inter-individual variability analysis. Reduction in absolute bias
of Ki estimates after fixing λ1 to its true value are shown for five different
simulation studies. Results for noise level 2 and single point AIF normalisation
method are shown only. Black bars show the results with no MRI information
and grey bars denotes the results with λ1 fixed.
λ1 was fixed to its true value are also included in the plot for comparison pur-
poses. These results show that much lower bias values were obtained, compared
to the original SIME method with no prior information, even when ±10% error
was present in the fixed AIF parameter. The method estimated rate constants more
accurately when the λ1 was underestimated rather than overestimated.
Results of the inter-individual simulation study are shown in figure 5.8. Ab-
solute bias on Ki estimates obtained in 5 different simulation studies with TACs
generated with different sets of rate constants are included. Significant reduction in
absolute bias of estimates was obtained by fixing λ1 to its true value in all of the 5
different simulation studies. It can be seen that including the prior AIF information
reduced the bias in the range of 3.4% to 12%.
5.6. Discussion and Conclusions 151
5.6 Discussion and Conclusions
In this chapter, we proposed a novel approach for improving AIF estimation and
hence kinetic parameter estimation in dynamic FDG-PET studies with the SIME
method by utilising prior information for the early part of the input function. We
used simulated data to compare estimated parameters with and without the prior
AIF information. With the single-point AIF normalisation method, the bias in the
Ki values was reduced by 77%, 57% and 51% respectively for each noise level using
the proposed method, to a level similar to that obtained with fully know AIFs. For
single blood sample AIF normalisation method, utilising the prior information gave
slightly better results than true AIF results at the highest noise level. A similar
behaviour was also seen for the K1 estimates. A paired t-test comparison of the
absolute error in individual k2 estimates obtained with both methods showed that
the difference in both sets of estimates is not statistically significant, with p values
of 0.09, 0.37 and 0.23 for the three ROIs.
The improvement in Ki biases was insensitive to small errors in the fixed values
of λ1 (±10%). The bias-reduction was much lower when the more complex nor-
malisation procedure was used, which involves collecting multiple blood samples
in practice. The biggest improvement was seen in the K1 estimates. The variance in
Ki was reduced only in the low-noise case. The reduction was slightly larger with
the more complex normalisation.
One way of obtaining prior information regarding the early part of the AIF can
be utilising an MRI derived AIF. The AIF measured from a DCE-MRI or DSC-
MRI with a Gd based contrast agent will give accurate results regarding the peak of
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the input function due to its high temporal resolution. In a simultaneous PET/MRI
study, the blood flow and cardiac output, which dominate the early part of an AIF,
are expected to be similar between the PET and MRI studies. Hence, if it is assumed
that there is negligible PET tracer uptake by the lungs, it can be expected to see high
degree of similarities between the peak shapes of the PET-AIF and MRI-AIF. This
assumption was shown to be valid in preclinical studies [Poulin et al., 2013] [Evans,
2015]. We also evaluate this hypothesis in Chapter 6 with clinical PET and MRI
AIFs.
In addition to FDG studies, the SIME method is a promising approach to anal-
yse other tracers (i.e. [Wong et al., 2001] [Ogden et al., 2010]). As the parametric
AIF measured using this method will be free of metabolite products, it can poten-
tially be used to study tracers with metabolites present in the blood. This is further
explained and tested in Chapter 7.
In conclusion, we have shown that the accuracy of kinetic parameter estimation
by the SIME method can be improved by introducing prior information about the
AIF. Prior AIF information was used to fix some of the parameters of the parametric
AIF to their true values which reduced the bias on the estimated kinetic parameters.
The method requires a single blood-sample at the end of the scan for AIF normali-
sation and can be used to avoid the need for collecting multiple blood samples.
Chapter 6
Comparison of PET and MRI
derived input functions
6.1 Introduction
An accurate measurement of the AIF is also necessary in the kinetic analysis of dy-
namic Magnetic Resonance Imaging (MRI) with paramagnetic contrast agents like
Gadolinium (Gd) chelates. In MRI, the arterial input function can be measured by
withdrawing arterial samples but it is usually avoided in practice due to its invasive-
ness. Population based AIFs [Parker et al., 2006] [Orton et al., 2008] [Shukla-Dave
et al., 2009] are commonly used in dynamic MRI analyses but are limited in their
accuracies due to inter-subject variations. DCE-MRI and DSC-MRI techniques can
also be used to provide personal estimation of the AIF by measuring the effect of
Gd-based contrast agent on T1, T2 and T2∗ signals. Using DSC-MRI to measure the
AIF can have some advantages over PET. This biggest benefit of using MRI it its
higher temporal resolution which can be used to detect the rapid changes during the
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first passage of the contrast agent.
For most PET tracers with no or minimal uptake in the lungs, the early peak of
the input function mainly describes the delivery of the PET tracer or MRI contrast
agent to the tissue of interest and is dominated by the cardiac output and blood
flow [Calamante et al., 1999]. Therefore, if the PET data and MRI data are obtained
at the same time, similarities are expected to be seen in the early parts of the PET-
AIF and MRI-AIF. However, the peak shape of an input function also depends on
the injection duration which are usually different in PET and MRI. PET tracers
are usually injected with a slow injection rate due to low temporal sampling of PET
scanners. On the other hand, a fast injection rate is favoured in the administration of
MRI contrast agents to get the highest signal intensity possible [Aerts et al., 2008].
The difference in bolus shapes caused by different injection duration make an AIF
comparison and/or an AIF conversion more difficult. In this chapter, we propose
an input function model which addresses this problem and accounts for injection
duration in the AIF fitting. PET-AIFs and MRI-AIFs were fitted using this input
function and bolus shapes were visually compared after necessary corrections. It
is also checked if fitting the PET-AIF and MRI-AIFs with the same input function
produced similar model parameters and if a parameter conversion can be reliably
performed.
6.2 Literature Review
There have been multiple attempts to compare PET derived and MRI derived AIFs
and to investigate if an AIF conversion can be done from one modality to the other.
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The majority of these studies were performed in preclinical studies where it was
attempted to introduce a mixture of Gd-DTPA contrast agent and the PET tracer in
a single injection. A brief summary of these studies including some human studies
is presented in this section.
In 2005, Ibaraki et. al [Ibaraki et al., 2005] presented their work where AIFs
derived from DSC-MRI studies were compared to AIFs from 15O-water PET stud-
ies. In order to make a comparison possible, bolus injection duration of the PET
tracer and MR contrast agent were kept the same (around 3 seconds). PET and MR
data were acquired using separate scanners. PET-AIFs were determined using arte-
rial blood samples and were corrected for delay and dispersion effects. For seven
healthy volunteers, they observed similar shapes between PET-AIF and MRI-AIF
pairs. Average time to peak values were identical for PET-AIF and MRI-AIF, 15.1
± 2.0 sec and 14.9 ± 2.2 sec respectively. Similarly, both PET-AIF and MRI-AIF
had similar average peak widths, 6.5 ± 0.4 sec and 6.7 ± 1.1 respectively. As
the 15O-water is a freely diffusible tracer, similar tail shapes were also observed
between the AIF tails.
In 2013, Poulin et. al [Poulin et al., 2013] proposed a method to convert an
arterial input function derived from Gd-DTPA in MRI, into a 18F-FDG AIF in PET.
In their study they performed PET and MRI experiments on seven healthy rats us-
ing separate scanners. During the dynamic PET study, a solution of 18F-FDG and
Gd-DTPA was injected using an automatic injection pump. Blood samples were
collected at seventeen different time points to determine plasma concentrations of
18F-FDG and Gd-DTPA in each of the samples. A second MRI-AIF was also mea-
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sured from the DCE-MRI images, where a separate contrast agent injection was
performed with a similar protocol. Peaks of PET-AIF and MRI-AIF curves were
normalised to one and then fitted with convolution of a rectangular function, repre-
senting the injection, with a bi-exponential representing the elimination. For 7 rats,
PET-AIFs and MRI-AIFs were fitted using this model and population based ratios
(Gd-DTPA/FDF) for each parameter was computed. These population based ratios
were used to convert PET-AIF to MRI-AIF or vice versa in normalised concentra-
tion. A single blood sample at the maximum concentration of 18F-FDG/Gd-DTPA
is used to scale the curves in mM or kBq/µL. However, it was also shown that a
normalisation factor calculated from the relationship of injected dose to the maxi-
mum concentration of 18F-FDG or Gd-DTPA can be alternatively used instead of
the blood sample. For all of the rats, similar peak shapes were observed between
the PET-AIF and MRI-AIF pairs but tails showed major differences due to different
uptake and clearance rates. After the normalisation, fitting, conversion and scaling
steps, the MRI-AIFs, both derived from the blood samples and DCE-MRI, could
be used in PET and MRI kinetic analysis. These AIFs produced consistent esti-
mates of the cMRGlc, tumour metabolic rate of glucose, as well as Ktrans, ve and
Vb parameters.
In similar work by Evans et al. [Evans, 2015], a combined bolus injection of
Gadovist MR contrast agent and 18F-FDG was performed to 12 wild type Wistar
rats in a MRI scanner. The PET-AIF and MRI-AIF were measured by withdrawing
serial arterial blood samples. Similar to the work done by Poulin et. al [Poulin
et al., 2013], MRI-AIFs were measured from DSC-MRI images as well as the ar-
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terial samples. However, in this study, the blood sampling was performed in the
MR scanner so no separate contrast agent injection was performed. An automatic
AIF determination algorithm was applied to derive the AIF from DSC-MRI im-
ages [Evans et al., 2012]. Following the DSC-MRI data acquisition, DCE-MRI
images were also obtained which were used to normalise the tail of the DSC-MRI
AIF to absolute contrast agent concentrations. The method proposed by Poulin et
al [Poulin et al., 2013] was used to perform AIF conversion on this data. Blood
sample scaling was performed on three different points, at the peak, midpoint and
the endpoint of the AIF. The peak-injected dose scaling method was also tried after
the conversion. High similarity in the AIF peak shapes were observed between the
PET-AIFs and MRI-AIFs. After the first pass, differences were seen in the AIF
tails. It was also seen that the some of the MRI-AIFs derived from the DSC-MRI
images had different lower peaks than the blood samples, which could be a cause of
the used temporal resolution. It was concluded that even though the blood sampled
contrast agent AIFs can be reliably converted to FDG PET-AIFs, the DSC-MRI
image derived AIFs had a worse performance in the conversion. Similar to the re-
sults presented by Poulin et al, a linear relationship between the AIF peak and the
injected activity was observed.
In 2015, Poulin et al. presented their method where they performed dual ki-
netic modelling of 18F-FDG PET and DCE-MRI data [Poulin et al., 2015]. Arterial
blood samples were withdrawn to measure the PET-AIF and MRI-AIF. Tumour and
reference region TACs were extracted by placing ROIs on the tumour and tongue,
which was chosen as a suitable reference region due to its large size and conve-
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nient location. A reference region AIF (RRAIF) was measured from the tongue,
where a linear relationship between its peak concentration and arterial samples AIF
peak concentration was observed. This relationship was used to scale the underes-
timated bolus of the RRAIF to arterial sample concentrations. The AIF conversion
method described above [Poulin et al., 2013] was used to convert the RRAIF to
PET-AIF. Results from 10 Fisher rats showed that tumour metabolic rate of glu-
cose consumption (tMRGlc) could be estimated using the AIF converted from the
corrected RRAIF with no significant difference to PET-AIF (p<0.05). This work
showed that a PET-AIF can be converted from a reference region measurement in
DCE-MRI when certain correction factors are applied.
6.3 Accounting for different injection rates
Similar peak shapes between the input function derived from PET and MRI studies
are expected if the differences which can be caused because of the different injection
durations are avoided. As described in the literature review of this chapter, some of
the previous research studies avoided this by injecting the MR contrast agent and the
PET tracer in a single combined injection, completely eliminating any discrepancies
which can be caused by the injection duration. However, this technique is not yet
validated in human studies. Instead, Ibaraki et al. [Ibaraki et al., 2005] used the
same injection protocol (i.e. injection rate) in separate injections of the Gd-DTPA
contrast agent and the PET tracer. However, this is not usually the case in clinical
practice as a fast injection of the contrast agent is usually favoured to increase the
signal in the MR images [Aerts et al., 2008] and the PET tracer is usually injected
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with a slower injection duration due to low temporal sampling capabilities of the
PET scanners.
In their method, Poulin et. al fitted the AIF curves using a convolution of
a rectangular function, representing the tracer/contrast agent injection with a bi-
exponential representing the elimination [Poulin et al., 2013]. The limitation of
this model is the convolution of a rectangular function with an exponential, result-
ing in a triangular peak which tends not to fit the bolus well. Instead of this, we
have used a 10 parameter ((τ1, τ2, P1, P2, β1, β2, β3, κ1, κ2 and κ3)) AIF model
which is shown in equation 6.1 and illustrated in figure 6.1. This model consists of
a double Butterworth function convolved with a tri-exponential function, where the
double Butterworth function represents the injection of the tracer or contrast agent
and the tri-exponential represents its wash out and clearance phase. The AIF bolus
shape can be modelled to represent a slower or faster injection by increasing or de-
creasing the width of the double Butterworth function, (τ2− τ1 or δτ) respectively.
A normalisation factor (ψ) is used to keep the injected volume constant when the
injection duration is changed.
Cp =
1
ψ
(
1− 1
1+( tτ1 )
P1
)(
1
1+( tτ2 )
P2
)
⊗ (β1e−κ1t +β2e−κ2t +β3e−κ3t) (6.1)
where,
ψ =
∫ ∞
0
(
1− 1
1+( tτ1 )
P1
)(
1
1+( tτ2 )
P2
)
dt
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AIF fitting was performed using MATLAB’s lsqcurvefit function, using the
trust-region algorithm. The average of each time frame was used in the optimisa-
tion. Curve fitting was performed in two stages: Firstly, the tail of the AIF, for
instance the last 10 time points, was fitted using equation 6.1 and the estimated
parameters were used as starting points in the second stage, where the whole AIF
curve was fitted.
Figure 6.1: Illustration of the two components of the double Butterworth function with 10
parameters. This function is a combination of a Butterworth function with two
different legs, representing the injection of the tracer/contrast agent, with a tri-
exponential function representing the washout.
Due to the high number of estimated parameters in this AIF model, it is likely
that the optimisation can get stuck in a local minimum during the curve fitting. In
order to avoid that, MATLAB’s multistart function was used with 500 iterations.
This function runs the optimisation in iterations with various combinations of start-
ing parameters and outputs the parameters which fits the data points with lowest
sum of squares error.
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6.4 Materials and Methods
6.4.1 Validity of the proposed AIF model
The validity of the proposed AIF model was assessed by fitting whole blood curves
derived from 18F-Cho and 18F-FMISO studies. Details about 18F-Cho data acqui-
sitions was reported in section 6.4.3 of this chapter. 18F-FMISO acquisitions were
performed on a GE Discovery VCT PET/CT scanner with an injection of 330 MBq
of 18F-FMISO. The time frame for the dynamic acquisition was 12x10 sec, 6x20
sec, 6x60 sec, 4x120 sec. Institutional Review Board permission, MHRA approval
and informed patient consent were obtained for all studies. The blood TACs used
in this validation were derived from dynamic PET frames utilising MR information
where the PV effects were corrected using iterative Yang method [Erlandsson et al.,
2012a].
The proposed AIF model shown in equation 6.1 was used to fit 8 whole blood
TACs derived from 18F-Cho studies and 10 whole blood TACs derived from 18F-
FMISO studies. The same whole blood TACs were also fitted using the commonly
used Feng’s input function model [Feng et al., 1993], which is the sum of a gamma
variate function with two exponentials. The goodness of fit of each model was
compared using an F-test, accounting for different number of estimated parameters
used in each of the AIF models. The F-test quantifies the relationship between the
relative change in the sum of squares error (SSE) and the relative change in the
degrees of freedom DF and is calculated using equation 6.2.
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F−TEST = (SSE1−SSE2)/(DF1−DF2)
SSE2−DF2 (6.2)
In order to better understand the behaviour of the proposed AIF model, the
relationship between the width of the fitted double butter worth function and the
injection duration used tracer/contrast agent administration is studied. Published
data from a study performed by Holt et. al [Holt et al., 2011] were used where
the impact of the injection duration on the AIF shapes and estimated Ktrans values
were evaluated. In this study, DCE-MRI scans with Gd-DOTA contrast agent were
performed on 24 patients with prostate cancer. The subjects were separated into 6
groups which represent the 6 different injection durations used in this study: 5 sec,
7.5 sec, 10 sec, 15 sec, 20 sec, and 30 sec. For each subject, AIFs were extracted
from a straight part of the femoral arteries (10 slices) using MR phase images. AIFs
of each of these six groups were averaged and group-averaged phase AIFs were
used in the further analysis.
6.4.2 Simulated Input Functions
18FDG AIFs were simulated using Feng’s parametric input function with their
published averaged values (equation 6.3) [Feng et al., 1993]: A1=851.1225,
A2=21.8798, A3=20.8113 in µCi/mL λ1=4.1339, λ2=0.1191 and λ3=0.0104 in
1/min. MRI-AIFs were simulated using Parker’s input function model (equation
6.4 [Parker et al., 2006] with the following published values: H1=0.809, H2=0.330
in mmol/min, y1=0.17046, y2=0.365, z1=0.0563, z2=0.132 in min, u=1.050 mmol,
rho=0.1685 1/min, s=38.078 1/min and v =0.483 min.
6.4. Materials and Methods 163
AIFFeng(t) = (A1t−A2−A3)e−λ1t +A2e−λ2t +A3e−λ3t (6.3)
AIFParker(t) =
2
∑
n=1
Hn
zn
√
2pi
e−(t−yn)
2/2z2n +
ue−ρt
1+ e−s(t−v)
(6.4)
No time delay was applied to the simulated PET-AIF and MRI-AIFs. MRI-
AIFs were simulated by sampling for every 4 second. The PET-AIF was simulated
using the following framing: 13 x 10 sec, 4 x 30 sec, 6 x 60 sec, 4 x 120 sec, 8 x
300 sec. The simulated PET-AIF and MRI-AIF can be seen in figure 6.3.
6.4.3 Clinical Data
Dynamic 18F-Fluoroethylcholine (18F-Cho) and DSC-MRI scans were performed
on four children with histologically proven astrocytic tumours. The 18F-Cho and
the MRI scans were performed as part of their diagnostic assessments. The subjects
were placed into the scanner and were injected with an average of 250 MBq (18F-
Cho). Dynamic PET acquisition was performed for 45 minutes. The PET tracer was
injected manually by a radiographer present in the scanning room with an unknown
injection duration. Two of the dynamic PET scans were acquired on a GE Discov-
ery VCT (GE Medical Systems, Milwaukee, Wis, USA) PET/CT system and the
other two were acquired on a Siemens Biograph mMR scanner (Siemens Health-
care, Erlangen, Germany). For the PET scans performed in the PET/CT scanner,
the map from the CT data was used for the attenuation correction whereas for the
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PET/MR scans, the UTE derived attenuation maps were used. The images were re-
constructed to a 128x128x51 image space with a voxel size of 1.953 x 1.953 x 3.27
mm. Iterative OSEM 3D reconstruction was used to reconstruct the dynamic PET
data to 23 frames with the following durations: 1 x 35 seconds, 8 x 12 seconds, 2 x
27 seconds, 2 x 60 seconds, 3 x 90 seconds, and 7 x 300 seconds.
18F-Cho is a PET tracer which is metabolised to form of radiometabolite side
products by the cell membranes. These metabolites can return back to the blood
plasma and contribute to the blood signal measured by the PET scanners. This
limits the non-invasive measurement of AIF using image-based methods and re-
quires collection of arterial blood samples to measure the parent tracer concentra-
tion. However, due to the lack of facilities available, no arterial blood samples were
obtained as part of this study.
All of the MRI data were acquired on the Siemens Biograph mMR system.
Anatomical T1 weighted MPRAGE images were acquired in saggital direction and
were reconstructed into a 192 x 227 x 512 image space with a voxel size of 1 x 1
x 0.508 mm. The MRI protocol also included a DSC-MRI scan with a Gd-DOTA
contrast agent (0.2 mL/kg). The contrast agent was administered using an automatic
injector with an injection rate set to 4 ml/sec. Images were acquired for 3.50 minutes
and reconstructed with a voxel size of 1.1 x 1.1 x 1.1 mm.
MRI-AIFs were extracted using Perfusion Mismatch Analyzer [Kudo et al.,
2007], and its automatic arterial pixel selection algorithm. For each subject, nine
best pixels were selected and their mean intensities over time were calculated. MR
images were used to improve quantification of the blood concentration measure-
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ment from PET images using a similar method to the methodology presented in
chapter 4. Post-contrast T1-weighted MPRAGE MR images were used to perform
3D segmentation of carotid arteries. PET frames were coregistered and resampled
to MPRAGE space using rigid body registration. PVC was performed on these co-
registered PET frames using the iterative Yang method [Erlandsson et al., 2012a],
where the reference MPRAGE image was used to create the brain mask for different
anatomical regions. Finally, the mean intensity over the defined arterial voxels was
computed to determine the whole blood concentration for each PET time frame.
The PET-AIF and MRI-AIF curves were fitted independently using our proposed
10 parameter AIF model.
6.5 Results
6.5.1 Validity of the proposed AIF model
The proposed AIF model was able to fit all of the 18F-Cho and 18F-FMISO whole
blood TACs with no visible artefacts. Results of F-test showed that the proposed
AIF model fit all of the 18F-Choline whole blood TACs and nine out of ten FMISO
whole blood TACs significantly better than Feng’s model (p < 0.05). These result
show that our proposed 10 parameter AIF model was able to fit the 18F-FMISO and
18F-Cho blood TACs with a good degree of accuracy and can be regarded as a valid
model to be used in AIF fittings.
The proposed 10 parameter AIF function was also able to fit the averaged MRI-
AIFs of each group used to assess the relationship between the injection duration
and the AIF shapes. The AIF curves and the fitted functions are illustrated in figure
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Figure 6.2: Illustration of arterial input functions with 6 different injection durations
Figure 6.3: Relationship between the injection duration and fitted ∆τ values.
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6.2. It can be seen that all of the AIF curves were fitted with a good accuracy,
regardless of the injection duration and the peak shape. The width of the AIF peak
increased as the injection duration was prolonged. As a result of this, the maximum
peak height decreased with the tracer arriving to the arteries with a smaller velocity.
Table 6.1: Comparison κ1, τ1, τ2 parameter values for AIFs with different injection dura-
tion when fitted with the 10 parameter AIF Model
AIF κ1 τ1 τ2 ∆τ
5 sec 27.2 26.4 35.2 8.8
7.5 seconds 26.4 26.0 32.7 6.7
10 seconds 26.7 25.9 36.2 10.3
15 seconds 27.4 24.4 41.9 17.5
20 seconds 29.3 22.5 45.1 22.6
30 seconds 28.7 24.9 57.2 32.3
The injection duration and the width of the fitted AIF peak (∆τ) is plotted in
figure 6.3 for each of the 6 input functions. This plot shows that the width of the
AIF peak or the double Butterworth function increases as the injection is further
prolonged. A linear relationship between the injection duration and the width of
the double Butterworth function is observed when a straight line is fitted through
the data points (R2=0.97). The estimated values of τ1, τ2, and κ1 parameters of the
AIF model are included in table 6.1. It can be seen from this table that the fitted
κ1 values, which is the exponential rate of the washout phase, do not vary much
between the fitted AIF groups and range between 26.4 and 29.3. This indicates that
the differences seen in the AIF peak shapes are mostly caused by the differences in
the fitted τ2 parameters, hence the difference in the injection duration.
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6.5.2 Simulated and Clinical AIF Fits
The proposed model was used to fit simulated PET and MRI AIFs, as well as clinical
18F-Cho and DSC-MRI derived whole blood TACs. The simulated AIFs and their
fits are shown in figure 6.4. It can be seen that the peak of the PET-AIF is wider
than the peak MRI-AIF, which shows the effects of the slower injection durations
used in PET tracer injection.
After the curves were fitted, τ2 parameter of the double Butterworth function
was modified to change the injection duration and the modified AIFs were visually
compared. For both PET and MRI AIFs, increasing the τ2, hence the ∆τ , caused
shorter and wider AIF peaks, which is what we would expect to observe with a
slower tracer injection. On the other hand, with smaller ∆τ values, taller but nar-
rower peaks were seen. Results for MRI-AIFs with modified τ2 parameter values
are shown in figure 6.5.
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Figure 6.4: ’Double Butterworth’ function fitted to (a) population based PET-AIF [Feng
et al., 1993] plotted together with a subplot illustrating the peak only (first two
minutes) and (b) population based MRI-AIF [Parker et al., 2006].
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Figure 6.5: Simulated MRI-AIFs using Parkers population-based input function refitted
with the developed function. AIF shapes with different injection durations,
∆τ are illustrated.
The four 18F-Cho image derived whole blood TACs and DSC-MRI derived
AIFs were also fitted with our 10 parameter AIF model. In order to account for dif-
ferent injection durations used during the PET tracer and MR contrast agent injec-
tions, the τ2 parameter of the MRI-AIF was increased to simulate a longer injection
duration. The remaining 9 parameters of the fitted AIF were not changed in this
process. This was performed within an optimisation procedure until the best match
between the modified MRI-AIF and PET-AIF was obtained.
PET-AIFs and adjusted MRI-AIFs of the four patients are shown in the figure
6.6. The peak of the MRI-AIF is scaled to match the peak of the PET-AIF. For
all of the four subjects, similar bolus shapes between PET-AIF and MRI-AIF were
seen after modifying the MRI-AIFs injection duration. These similarities were ob-
served for approximately the first 20 seconds from the time of administration of the
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Figure 6.6: Fitted PET-AIFs and MRI-AIFs, adjusted for injection duration, of 4 patients.
The MRI-AIFs were scaled to match the peak of the PET-AIF.
tracer/contrast agent. After that, the curves started to deviate as the 18F-Cho and
Gd-DOTA have different clearance characteristics.
Table 6.2: Comparison of fitted κ1 values when fitted with the 10 parameter AIF Model
PET MRI
Percentage
Error (%)
Patient 1 48.2 45.0 6.6%
Patient 2 62.5 66.1 -5.8%
Patient 3 47.8 45.1 5.6%
Patient 4 46.4 44.7 3.7%
In order to further validate this similarity in early AIF curve shapes, fitted
parameters of the PET-AIF and MRI-AIF were compared. We focus on the values
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of the κ1 parameter of the 10 parameter AIF model, the decay constant of the first
exponential, as it describes the early wash-out decay of the input function. κ1 values
for fitted PET and MRI curves are listed in table 6.2. These results show that similar
estimates were obtained in all of the AIF pairs. It can be stated from these 4 subjects
that the value of κ1 parameter of the PET-AIF can be determined from an MRI-AIF
with a maximum error of 6.6%.
Table 6.3: Comparison of fitted λ1 values when fitted with 6 parameter Feng AIF Model
PET MRI
Percentage
Error (%)
Patient 1 0.188 0.190 1.06%
Patient 2 0.209 0.204 -2.39%
Patient 3 0.227 0.235 3.52%
Patient 4 0.196 0.196 -0.26%
In addition, the PET AIFs and modified AIFs were fitted using the 6 parameter
Feng input function model [Feng et al., 1993], shown in equation 6.3. Similarly,
the fitted values of the gamma variate function’s decay constant,λ1, were compared.
Results are shown in table 6.3. Similar to the previous 10 parameter AIF fit results,
very minor differences were seen between between the λ1 parameters fitted in AIF
pairs, verifying that λ1 of the PET-AIF could be obtained from the MRI-AIF with
an average absolute error of 1.81% and maximum error of 3.52% for this group of
patients.
6.6 Discussions and Conclusions
We proposed an AIF model which could fit 18F-Cho and 18F-FMISO derived AIFs
with a good accuracy. This AIF model consist of convolution of a double But-
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terworth function, which represent the injection of the tracer/contrast agent, with
a tri-exponential function which represent its clearance. The width of the double
Butterworth function can be increased or decreased to represent longer or shorter
injection durations respectively. Fitting this AIF model to MRI-AIFs obtained using
different injection durations showed a linear relationship between the width of the
double Butterworth function and the injection duration. This linear relationship can
be utilised to obtain prior information regarding some of the parameters of the AIF
model when the injection duration is known.
Results of this work showed that 18F-Cho derived input functions and DSC-
MRI derived input functions have similar peak shapes in the early part of the input
function, during the first pass bolus, when accounted for different injection dura-
tions used in the administration of the 18F-Cho and Gd-based contrast agent. These
similarities are due to the fact that the early part of an AIF is mainly dominated
by the subject’s blood flow and vascular characteristics, which are expected not to
vary during PET and MRI acquisitions in a simultaneous PET/MRI scan. The PET
derived and MRI derived AIFs started to differ approximately 20 seconds after the
injection.
It was also seen that when fitted with our 10 parameter AIF model, κ1 parame-
ter of a PET-AIF can be obtained from a corresponding MRI-AIF with minor errors.
Similarly, both AIFs yielded similar λ1 values when corrected for different injection
durations and fitted with Feng’s input function model. These results can further be
used to reduce the number of estimated AIF parameters in the simultaneous esti-
mation method, described in chapter 5. If the injection duration of the PET tracer
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is known, then the linear relationship between the injection duration and the width
of the double Butterworth function can be used to estimate the width(τ1-τ2) of the
PET-AIF.
In conclusion, we have shown that similar peak shapes between PET-AIF and
MRI-AIF can be obtained even when different injection rates are used. This similar-
ity can be used to derive some of the PET-AIF parameters from an MRI-AIF, which
can be utilised to reduce the computational complexity of the PET simultaneous
estimation method.
Chapter 7
Application of Constrained SIME to
18F-FDG and 11C-SB207145 tracers
7.1 Introduction
As described in detail in Chapter 5, SIME is a non-invasive image-based method to
perform kinetic analysis of dynamic PET data without any need for a prior measure-
ment of the input function. It requires input of multiple TACs from different brain
regions and an involves estimation of the AIF together with the kinetic parame-
ters. This method is computationally complex due to the large number of parame-
ters estimated simultaneously and usually requires one or more arterial samples for
AIF normalisation. We have previously shown with simulated 18F-FDG data that
the performance of SIME can be improved by introducing experimentally obtained
prior information about the early part of the AIF [Sari et al., 2014].
In this chapter, the constrained SIME method with some prior AIF information
is evaluated with clinical 18F-FDG and 11C-SB207145 [Marner et al., 2009] datasets
7.2. Materials and Methods 175
and is validated against the gold standard arterial blood sample derived AIFs. 11C-
SB207145 is a radioligand used in quantification of 5-HT4 receptors in serotonin
studies involved in memory and learning. During its metabolism, 11C-SB207145
gets converted into metabolite products that recirculate in blood plasma. Therefore,
it traditionally requires arterial blood sampling and metabolite analysis in order to
measure the fraction of the parent compound for use in the kinetic analysis [Marner
et al., 2009]. Results from pig studies have shown that 11C-SB207145 distributes
consistently in the brain regions with known 5-HT4 densities, in the striatum, thala-
mus, cortical regions and cerebellum [Gee et al., 2008]. In this study, we used these
regions within the SIME with and without prior AIF information and reported the
results in this chapter. The aim of this work was to utilises prior AIF information to
reduce the complexity of the SIME method and develop a methodology to analyse
PET tracers non-invasively when radiometabolites are present in the blood plasma.
7.2 Materials and Methods
7.2.1 18F-FDG data
Data from the 18F-FDG data study presented in Chapter 4 is used in this experi-
ment. All of the studies were performed in Rigshospitalet, Copenhagen, Denmark
and they were conducted in accordance to the Declaration of Helsinki. To briefly
summarise the acquisition of the datasets, dynamic 18F-FDG data were acquired us-
ing a Siemens Biograph 64mCT PET/CT scanner (Siemens Healthcare, Erlangen,
Germany). Dynamic PET data were acquired for 1 hour and 19 PET frames were
reconstructed using the following frame durations: 6 x 10 seconds, 2 x 30 seconds,
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3 x 60 seconds, 2 x 150 seconds, 2 x 300 seconds and 3 x 600 seconds. 33 arterial
blood samples were collected during the scan and AIF was measured from these
samples as the gold standard AIF. For the early samples, 10 second intervals were
used in order to get a good definition of the input function peak. The MRI scans
were performed on a 3T Achieva MRI scanner (Philips Medical Systems, Best,
The Netherlands) using a 32-channel phased array head coil. Acquisitions included
MPRAGE and TOF-MRA sequences to obtain high resolution anatomical images.
Data from 10 subjects were included in the 18F-FDG analysis. As also de-
scribed in detail in chapter 4, carotid arteries were segmented from TOF-MRA im-
ages using ITK-SNAP v. 3.2 [Yushkevich et al., 2006]. The segmentation algorithm
included a tissue classification pre-processing step followed by a region growing al-
gorithm using evolving snakes. The segmented arteries covered the lower head and
upper neck regions to match the field of view of the PET datasets. Dynamic PET
frames were coregistered and resampled to MR angiography space using a two-step
rigid registration with an intermediate registration to MPRAGE space. Coregistered
PET frames were corrected for PV effects using the Single Target Correction (STC)
method [Sari et al., 2016]. The mean activity in carotid arteries for each PET frame
was computed to derive the CWB
The Simultaneous estimation model was implemented to perform kinetic anal-
ysis of multiple brain regions, simultaneously estimating the AIF. For each subject,
TACs from cerebellum, striatum, grey matter and white matter were extracted by
manually placing ROIs on the PET images. An example of used TACs derived from
one subject is illustrated in figure 7.1.
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Figure 7.1: TACs used in the constrained 18F-FDG SIME analysis. Cerebellum, striatum,
grey matter, and white matter regions were used to derive the TACs.
All of the regions were modelled using a 2 tissue compartment model with
4 kinetic parameters (K1, k2, k3, k4) and cerebral blood volume (Vb). SIME was
modelled using command line functions of COMKAT [Muzic and Cornelius, 2001]
in MATLAB and parameter optimization was performed using the Ordinary Least
Squares method with uniform weighting. The AIF was modelled using Feng’s AIF
model which consists of the sum of a gamma variate function with two exponentials
[Feng et al., 1994] as in equation 7.1.
Cp(t) = (A1t−A2−A3)e−λ1t +A2e−λ2t +A3e−λ3t (7.1)
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Prior information regarding the early part of the AIF was obtained by fitting
the PV corrected CWB using the model shown in equation 7.1 and from the fitted
A1 and λ1 values. The estimated values of these two parameters were used as an
input to SIME model to reduce the number of estimated parameters. This was done
by fixing the A1 and λ1 parameters of the SIME to the values obtained by fitting the
CWB curve. CWB was also used in the estimation of Vb, as this parameter represents
the fraction of the whole blood signal present in the volume of interest. We call
the SIME with prior information derived from PV corrected CWB the constrained
SIME.
The SIME was also run with no existing prior information for comparison.
In this model, Vb was linked to the AIF as the absence of whole blood concentra-
tion was assumed. AIF estimated using SIME and constrained SIME were used to
fit the 4 brain TACs individually as performing this second fitting was previously
shown to reduce the variation in the estimated parameters [Wong et al., 2002].
The 4 TACs were also fitted with the gold standard AIFSamples. The influx con-
stant (Ki) was computed for each region using the estimated microparameter values
(Ki=K1k3)/(K2+k3). Estimated Ki values were used in the comparison of SIME,
constrained SIME and AIFSamples.
7.2.2 [11C]-SB207145 PET data
All of the scans of this test-retest study were performed at Copenhagen University
Hospital, Rigshospitalet, Copenhagen, Denmark. This study was approved by the
Ethics Committee for Copenhagen and Frederiksberg ((KF)01-274821). These data
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have been collected for work previously published by Marner et al. [Marner et al.,
2009].
Six healthy volunteers (3 males and 3 females, age range 21-44 years) were
included in this test-retest study. The PET scans were performed on a 18-ring GE
Advance scanner (GE Healthcare, Milwaukee, Wisconsin, USA). Each subject re-
ceived an intravenous administration of the [11C]-SB207145 tracer with a mean ac-
tivity of 572 MBq (range of 512-601 MBq), with high specific activity (mean 48.4
GBq/µmol, range 34.2-71.0 GBq/µmol). A Dynamic PET scan was started before
the administration and 3D PET data were acquired for 2 hours. Frames were binned
using the following durations: 6x5s, 10x15s, 4x30s, 5x2min, 5x5min, 8x10min. 2D
filtered back projection (6 mm Hann filter and 8.5 mm axial ramp filter) was used in
the image reconstruction and the PET images were reconstructed on a 128 x 128 x
25 volumes with a voxel size of 2.0 mm x 2.0 mm x 4.25 mm. A CT scan was used
for the attenuation correction. PET data were also corrected for randoms, scatter
and deadtime.
Arterial blood samples were collected at 46 time points with 5 seconds interval
in the early part of the scan to get a good definition of the bolus shape. Whole blood
and plasma radioactivity concentration were measured in a well counter (COBRA
5003, Packard Instruments, Meriden, CT, USA). In addition, 7 arterial samples were
withdrawn at times 3.5, 10. 17.5, 32.5, 55, 85, and 115 mins to measure the concen-
tration of metabolites. The parent fraction was measured using a column-switching
HPLC method [Gillings et al., 2007]. Subjects also had structural MRI scans on
a 3T Siemens Trio Scanner (Siemens Healthcare, Erlangen, Germany). 3D T1-
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weighted MPRAGE images of the whole head were acquired in saggital planes for
each subject.
As high resolution TOF-MR Angiograms of carotid arteries were not collected
as part of this study, T1 weighted MPRAGE images were used to segment the
carotid arteries. One of the subjects had no blood signal on the MPRAGE im-
age and it was excluded from the analysis as a reliable carotid artery segmentation
was not possible. For the rest of the subjects, carotids were segmented using ITK-
SNAP [Yushkevich et al., 2006]. As part of the segmentation preprocess, MPRAGE
images were thresholded to keep the intensities above one third of the maximum
image intensity. This step was performed to separate the carotid arteries from back-
ground regions with relatively high MR signal and replaced the automatic tissue
classification method used in Chapter 4. Using tissue classification as preprocess-
ing step did not yield acceptable results, possibly due to the proximity of carotid
arteries to tissues with relatively high T1 signal. Once the MPRAGE images were
thresholded, a region growing algorithm was applied to delineate the arterial voxels.
The dynamic PET frames were registered to the MPRAGE MR images using
6-parameter rigid registration. The first 10 frames (90 seconds) of the dynamic
PET data was added together to have a summed image with high activity in carotid
arteries. This summed image was used in the image registration. Image registration
was performed using FSL Linear Image Registration Tool (FLIRT) [Jenkinson and
Smith, 2001]. The resulting transformation matrix was used to coalign all of the
PET frames to the MPRAGE image. PET frames were resampled to MR space using
tri-linear interpolation. The coregistered PET images were corrected for PV effects
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using the STC method with the segmented carotid artery mask as the region of
interest. An empirically derived PSF FWHM of 6.8 was used in the PV correction.
This PSF was derived using the image-based PSF derivation method [Sari et al.,
2016] also presented in Chapter 4 of this thesis. The mean intensity in carotids for
each PV corrected PET frame was computed to derive the CWB.
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Figure 7.2: TACs used in the constrained [11C]-SB207145 SIME analysis. Cerebellum,
parietal cortex, superior frontal cortex, hippocampus and striatum were used to
derive the TACs.
All of the brain TAC extraction work was performed at Rigshospitalet, Copen-
hagen, Denmark [Marner et al., 2009]. The T1 weighted MPRAGE image of each
subject was coregistered to the 5th frame of the PET data and was parcellated into 19
different regions in left and right hemispheres automatically using Pvelab software
package (www.nru.dk/downloads/software) [Quarantelli et al., 2004]. The derived
7.2. Materials and Methods 182
ROIs were applied to the PET data to extract the TACs. In our implementation,
TACs from 5 different brain regions: cerebellum, parietal and frontal cortici, hip-
pocampus and striatum were used in the SIME as they reflect low, moderate and
high binding regions. These 5 TACs are illustrated in figure 7.2.
7.2.3 [11C]-SB207145 Constrained SIME model
The [11C]-SB207145 tracer can convert into metabolite side products once it is
metabolised, making an AIF derived from PET images erroneous if it is used in
the kinetic analysis without any separate metabolite correction. The original SIME
model can be modified to perform this correction without any need for arterial sam-
ples. In traditional metabolite correction methods, a few arterial samples are col-
lected during the PET scan and these are analysed to measure the concentration of
metabolite products at different time points and hence derive the parent fraction.
The obtained parent fraction can be modelled using a parametric function, such as a
Hill function or constrained bi-exponential function and used to convert the plasma
concentration to metabolite free parent concentration [Tonietto et al., 2016]. The
Hill function can be written as equation 7.2.
fHill(t) = 1− (1−a)t
b
c+ tb
(7.2)
In the presence of multiple brain TACs with varying kinetic behaviours, the
SIME method can give an accurate estimation of metabolite free AIF by simultane-
ously fitting the TACs. However, due to its computational complexity and possible
bias in the estimated parameters, SIME has to be complemented with a few plasma
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samples obtained towards the end of the study. Arterial and venous samples ob-
tained towards the end of a scan include a high fraction of radiometabolites and
still require manual work to derive metabolite free concentrations. The constrained
SIME method with prior image derived information regarding the A1 and λ1 of the
AIF function can be used to reduce the complexity of the model and make a more
reliable AIF estimation. The cost function of the constrained SIME can be written
as following:
φ(p) =
m
∑
i=1
n
∑
j=1
w
[
Ei(t j)−Mi(t j)
]2
and
Ei = (1−Vb)CP(t)⊗hi[K1,k2,k3,k4]+VbCWB
where Ei is the estimated output, Mi the measured PET activity and hi is the
impulse response of the 2-TC compartmental model. Parameter m represent the
number of TACs to be fitted, n represents the number of samples for each TAC and
w is the weight, which was set to 1 to apply uniform weighting.
This model was implemented to analyse the [11C]-SB207145 datasets and fit
the 5 TACs derived from multiple brain regions. Image derived CWB curve is fitted
using Feng’s AIF model [Feng et al., 1994] and fitted A1 and λ1 values were used
to fix these parameters in the constrained SIME method. The remaining 4 AIF pa-
rameters and kinetic parameters of each region was simultaneously estimated using
OLS optimisation. This method was further extended by introducing a second step
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with an additional constraint by fitting the estimated parent fraction using the Hill
function. The ratio of the SIME estimated CP and the image derived CWB was com-
puted to determine the SIME derived parent fraction which was fitted using the Hill
function. Then, the final AIF was estimated using equation 7.3.
CP(t) =CWB(t) fHill(t)Cratio(t) (7.3)
Where fHill is the fitted Hill function and Cratio is the ratio of plasma to whole
blood concentration as a function of time. In this study, a population based Cratio
was used to convert the whole blood concentration to plasma concentration. In order
to derive this population based ratio, Cratio of each dataset was computed by fitting a
straight line through the plasma to whole blood concentrations derived from arterial
samples. The mean of fitted ratios was computed to be used as the population based
Cratio. This ratio and the variance between subjects is illustrated in figure 7.7.
The constrained SIME method which was described above can be further sim-
plified by combining the two steps into a single optimisation step. If the CWB can
accurately be measured from PET images, the relationship expressed in equation
7.3 can directly be incorporated into the SIME where the 3 parameters of the Hill
function is estimated by simultaneously fitting the TACs. In other words, instead
of modelling the AIF by estimating 6 parameters, 3 parameters of the Hill function
can be estimated to derive the AIF utilising additional prior information. In our
implementation, as illustrated in figure 7.4, the 5 TACs were simultaneously fitted
by estimating the Hill function parameters (a,b,c) which is multiplied with image
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derived whole blood concentration and a population based plasma to whole blood
tracer concentration ratio to derive the actual AIF.
Figure 7.3: Parent fractions of 10 subjects fitted with the Hill function. The red curve
represents the average of all fitted curves and green curves represent the bounds
in 4 standard deviations.
Parent fraction curves derived from blood samples of each subject were fit-
ted using the Hill function. The mean value of the 10 parent fractions was calcu-
lated and used as the starting point of the Hill function in the SIME optimizaton
(a=0.0591, b=1.1816, c=7.7934). Upper and lower bounds of Hill function parame-
ters were set to be within 4 standard deviations of the mean Hill function. The mean
Hill function and the bounds used in this analysis is illustrated in figure 7.3.
VT =
K1
k2
(
1+
k3
k4
)
(7.4)
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Figure 7.4: Constrained SIME model used to analyse [11C]-SB207145 tracer. The AIF
was modelled as product of CP, plasma to whole blood ratio and Hill function.
3 parameters of the Hill function (a, b, c) were optimised simultaneously by
fitting 5 TACs measured from different brain regions. CWB is derived from PV
corrected PET images and population based plasma to whole blood ratio, Cratio
is derived by measuring the average plasma to whole blood concentration ratio
across test and retest studies of 10 subjects
This AIFs derived using the original SIME, the constrained SIME and the sim-
plified constrained SIME were used to fit each TAC individually to obtain the kinetic
parameters, K1, k2, k3, and k4. Volume of distribution (VT ) in each region was com-
puted using equation 7.4. The gold standard AIF derived from metabolite corrected
arterial samples was also used to perform kinetic analysis of each region. Kinetic
parameter and VT estimates obtained using each AIF were used in comparing meth-
ods and validation against arterial samples.
Since results were present from test and retest studies, reliability of the pro-
posed methods could be quantified by computing the intraclass correlation coeffi-
cient (ICC) between these studies, which was done using:
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ICC =
BMS−WMS
BMS+WMS
(7.5)
where BMS is the mean sum of squares between subjects and WMS is the
mean sum of squares between the test and retest studies for each subject. Equation
7.5 produces a score between -1 and +1 which represent minimum reliability and
maximum reliability respectively.
Finally the identifiability of the proposed method was tested in terms of the
number of different ROIs and the kinetic variation between the extracted brain
TACs. This was done by running the experiment in an ideal scenario where the
errors in image derived whole blood extraction and plasma to whole blood ratio
were minimized. Different combinations of TACs were generated by utilizing TACs
from cerebellum, hippocampus and superior frontal cortex and SIME with fitted Hill
function was performed with these TACs. Whole blood concentration and plasma
to whole blood ratio were derived from arterial samples to minimize potential er-
rors which could be caused by PV correction and use of population based plasma
to whole blood ratio. Accuracy of estimated VT values were compared against VT
estimates using the gold standard arterial sample derived AIFs.
7.3 Results
7.3.1 18F-FDG Results
The results of the 18F-FDG analysis are summarised in this section. Figure 7.5 il-
lustrated the results for Ki macroparameter averaged across 10 patients. Results are
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plotted for each brain region and each method: The original SIME method with no
prior AIF information, the constrained SIME method with prior information from
an image derived AIF, and arterial blood samples. The results show that introduc-
ing the prior AIF information improved the accuracy of the results for all of the
four regions and brought the Ki estimates closer to the values estimated using the
gold standard arterial samples. The SIME method yielded Ki estimates with 29.7%
error for cerebellum, 38.8% for Striatum, 48.6% for grey matter and 47.9% for
white matter. Introducing the prior AIF information reduced these errors to 4.4%,
5.1%, 6.6%, and 5.1% for each region respectively. These averaged results show
that the constrained SIME slightly overestimated Ki for striatum, grey matter and
white matter but slightly underestimated for cerebellum. The original SIME method
overestimated the Kifor all of the regions.
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Parent AIF SIME Original SIME Constrained
Cerebellum 0.03525153592745
78
0.04570987014105
04
0.03368397688064
46
Striatum 0.05270532210916
48
0.07315556670269
44
0.05538737751137
93
Grey Matter 0.04448135747265
58
0.06609132533768
82
0.04740936337608
11
White Matter 0.01613947669467
01
0.02386650292357
41
0.01696673276713
81
Standard Dev
Cerebellum 0.00453849055176
042
0.01795739198481
56
0.01256482972161
81
Striatum 0.00498876359889
746
0.02849420598805
72
0.02145512756235
14
Grey Matter 0.00375776005943
780
0.02360844367249
27
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22
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812
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 1
Figure 7.5: Ki parameter values estimated using SIME, Constrained SIME and arterial
blood samples. Averaged results are illustrated for cerebellum, striatum, grey
matter and white matter.
Results for individual kinetic parameters, K1, k2, k3 and k4 are shown in figure
7.6. A similar trend to Ki results was observed for K1 parameters and the errors
in parameter estimates were reduced for all of the regions with the introduction of
prior AIF information. Using the SIME with no prior information estimated the K1
parameter with the following percentage errors: 26.5% for cerebellum, 21.0% for
striatum, 27.2% for grey matter and 34.9% for white matter. Using the constrained
SIME reduced these errors to 12.5% for cerebellum, 5.8% for striatum, 19.1% for
grey matter and 16.9% for white matter. Similarly, an improvement in the k2 param-
eter estimates was observed with the introduction of the prior information where the
absolute percentage error in estimates was reduced from 28.6% to 11.3% for cere-
bellum, 40.8% to 23.5% in striatum, 27.2% to 5.3% for grey matter and 14.3% to
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1.6% for white matter.
SIME and Constrained SIME methods yielded similar k3 estimates with almost
identical errors against arterial samples for cerebellum, striatum and grey matter.
For white matter, the original SIME estimated k3 with a very small error (0.4%)
where constrained SIME produced underestimated k3 with an average percentage
error of 10.1%. Finally, constrained SIME reduced the percentage error in k4 esti-
mates compared to the SIME in 3 of the 4 regions (111.4% to 54.5% for striatum,
287.8% to 80.7% for grey matter and 117.8% to 35.6% for white matter). For cere-
bellum, the SIME method underestimated k4 with 12.6% error where constrained
SIME underestimated this parameter with 44.8% error averaged across 10 subjects.
7.3.2 [11C]-SB207145 Results
In this section, results of the [11C]-SB207145 are reported and performances of
different methods used to derive the AIF and fit the brain TACs are compared.
Throughout this section, the AIF derived from metabolite-corrected arterial sam-
ples is referred as AIFSamples, the original SIME method with no prior information
as SIME, the constrained SIME with image derived prior information regarding the
two AIF parameters is referred as SIMEConstrained, the constrained SIME method
with the second constrain using the Hill function is referred as SIMEConstrained2 and
finally, the SIME method where the Hill function parameters are estimated instead
of AIF parameters is referred as SIMEHill.
The plasma to whole blood ratio of arterial samples of each dataset is plotted
in figure 7.7 together with fitted straight lines for each dataset. The average of
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all fitted lines was computed and is also plotted on the same figure. A reasonable
variance was observed among the datasets which can be reliably represented using
the averaged line. The fitted plasma to whole blood concentrations varied between
0.9 and 1.1 during the two-hour scan for 8 of the datasets whereas two datasets had
steeper slopes, representing faster changes happening between plasma and whole
blood concentrations.
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Figure 7.7: The population based plasma to whole blood ratio used in [11C]-SB207145
analysis derived by averaging the plasma to whole blood ratio of each dataset
fitted using a straight line. The red lines represent the fitted plasma to whole
blood curve of each dataset and the blue line represents the mean ratio which
is used in the data analysis.
The accuracy of the image derived whole blood TAC measurement was as-
sessed by comparing the AUCs between image derived whole blood curves (WBID)
and blood sample derived whole blood curves (WBSamples). Examples of these two
curves are illustrated in figure 7.8. Figure 7.9 shows the comparison of AUCs be-
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tween whole blood curves derived using both methods. A good agreement between
the WBID and WBSamples was observed in 9 of 10 subjects. In one subject, the WBID
had half AUC compared to the WBSamples. The reason for this is unknown but may
be due to errors propagated from segmentation and coregistration steps.
Figure 7.8: Comparison of image derived and blood sample whole blood curves for one
subject plotted together with the metabolite free parent AIF derived from blood
samples. The first two minutes were also separately plotted to zoom on the
curve peaks
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Figure 7.9: Comparison of area under curves between image derived and blood sampled
derived whole blood curves.
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Figure 7.10: Average of the parent fractions estimated using SIMEHill plotted together with
averaged parent fraction derived from plasma samples. The curves are mean
of parent fractions measured for each of the 10 datasets
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The SIMEHill was applied to optimise the parameters of the Hill function which
was used together with image derived whole blood TAC to derive the metabolite free
AIF. Figure 7.10 illustrates the mean of the fitted Hill functions plotted together
with the blood sample derived parent fractions averaged across 10 datasets. A good
agreement was observed in the early part of the this pair of averaged parent fraction
curves. The curves started to deviate approximately 60 minutes after the injection.
The fitted Hill functions overestimated the tail of the parent fraction curve which
might cause higher AUC under derived AIFs.
SIMEConstrained2 was used to estimate the metabolite free AIF, utilising infor-
mation from the WBID curve, a separate Hill function constrain and a population
based plasma to whole blood ratio. The AUC of these estimated AIFs were calcu-
lated and compared to the AUC of metabolite corrected AIFs derived from arterial
blood samples. This comparison is illustrated in figure 7.11 and it can be seen
that AUC of AIF pairs in all of the 10 datasets correlated linearly, including the
one dataset where a difference was previously observed between image derived and
blood sample derived whole blood curves.
After the metabolite free AIF was computed using the listed methods, TACs
derived from cerebellum, parietal cortex, superior frontal cortex, hippocampus and
striatum were individually fitted using a 2-tissue compartmental model and the de-
rived AIFs. The mean VT results are illustrated in figure 7.12 and averaged kinetic
parameter results obtained using the three different methods are shown in figure
7.13.
Figure 7.12 illustrates volume of distribution values for each region, averaged
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Figure 7.11: Comparison of area under curves between constrained SIME derived and
blood sampled derived parent AIF curves.
across 10 datasets, estimated using each of the different AIF estimation techniques.
It is shown that SIME with no prior information produced VT estimates with largest
difference to arterial samples for all of the 5 regions. The SIME yielded estimates
with 60% error for cerebellum, 49% for parietal cortex, 41% for superior frontal
cortex, 52% for hippocampus and 65% for striatum. Introducing the prior infor-
mation for the A1 and λ1 parameters reduced this percentage error to to 42% for
cerebellum, 31% for parietal cortex, 31% for superior frontal cortex, 20% for hip-
pocampus and 51% for striatum. SIMEConstrained2 with two fixed parameters and an
additional constrain applied by fitting a Hill function yielded more accurate VT es-
timates, further reducing the percentage error to 13%, 11%, 17%, 12% and 25% for
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Figure 7.12: VT estimated for each of the 5 regions using the AIFs derived from arterial
samples, SIME, SIMEConstrained, SIMEConstrained2, and SIMEHill. The bars rep-
resent the averaged VT estimates across 10 datasets and error bars represent
the standard deviation between the datasets.
these regions respectively. SIMEHill estimated VT with a comparable performance
to SIMEConstrained2, with absolute percentage errors of 10% error for cerebellum,
16% for parietal cortex, 15% for superior frontal cortex, 10% for hippocampus and
13% for striatum. It was observed that SIMEHill underestimated the VT parameter
in all of the 5 regions where the other methods produced overestimated VT values.
As can be seen in figure 7.13, a similar improvement in K1 estimates was ob-
served between SIME, SIMEConstrained, and SIMEConstrained2 as more prior informa-
tion was introduced. Even though SIMEConstrained2 showed the best performance
among these three methods, it still yielded K1 estimates with a percentage error
of 14% for cerebellum, 22% for parietal cortex, 14% for superior frontal cortex,
19% for hippocampus and 12% for striatum. However, the less complex SIMEHill
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method yielded the most accurate K1 estimates among all these methods where
the percentage error improved notably and dropped to 4% for cerebellum, pari-
etal cortex, superior frontal cortex, and striatum and 3% for hippocampus. Simi-
lar to VT results, SIMEHill produced underestimated K1 values whereas the SIME,
SIMEConstrained and SIMEConstrained2 overestimated this parameter in all regions.
Figure 7.13b shows that SIMEHill produced most similar k2 estimates to arterial
samples followed by SIMEConstrained2 and SIMEConstrained whereas SIME with no
prior information had the parameter k2 with largest error. It was seen that SIMEHill
underestimated this parameter with absolute percentage errors of 8% for cerebellum
and parietal cortex, 3% for superior frontal cortex, 7% for hippocampus and 20%
for striatum whereas SIMEConstrained2 was able to recover this parameter with 5%,
12%, 17%, 9%, and 30% percentage errors respectively. Similar to Vt and K1 re-
sults, SIMEHill was the only method to underestimate k2 parameter in average. Fig-
ure 7.13c illustrates that SIME and SIMEConstrained estimated the k3 parameter ac-
curately in overall, whereas SIMEConstrained2 and SIMEHill produced estimates with
greater errors. SIMEConstrained2 particularly estimated this parameter with a large er-
ror where the k3 values estimated using this technique had a large percentage error
(greater than 100%) for all of the regions with a large standard deviation. SIMEHill
was also not able to recover the k3 parameter accurately and yielded estimates with
a percentage error of 23% for cerebellum, 70% for parietal cortex, 95% for supe-
rior frontal cortex, 31% for hippocampus and 42% for striatum. Finally, SIME and
SIMEConstrained showed the best performance in estimating the k4 parameter where
a comparable performance were observed in all of the regions apart from striatum.
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Table 7.1: Estimated VT s using different number and variations of TACs. Results obtained
using AIF samples are present to stand as the true ground. The percentage errors
against the gold standard VT for each method and each region are included. The
following TACs are removed to generate the different TAC sets: 4 TACs: sup.
fr. cortex, 4 TACs 2: cerebellum, 3 TACs: cerebellum and sup. fr. cortex, 3
TACs 2: cerebellum and hippocampus, 2 TACs: cerebellum, sup. fr. cortex, and
hippocampus.
Striatum Par. Ctx. Sup. Fr. Ctx. Hippocampus
VT % Error VT % Error VT % Error VT % Error
AIF Samples 42.14 - 13.77 - 12.62 - 17.07 -
5 TACs 37.19 11.7 12.23 11.2 10.66 15.5 15.89 6.9
4 TACs 39.35 4.2 11.89 13.6 - - 15.33 10.2
4 TACs 2 35.74 15.2 11.36 17.5 10.22 19.0 - -
3 TACs 29.07 31.0 10.05 27.0 8.89 29.6 - -
3 TACs 2 25.39 39.7 8.25 40.1 - - 10.91 36.1
2 TACs 28.33 32.8 9.24 32.9 - - - -
Introducing further prior information regarding the parent fraction caused the k4 to
differ more compared to arterial samples. SIMEConstrained2 produced estimates with
51% overestimation averaged across 5 regions whereas SIMEHill overestimated this
parameter by 103% averaged across 5 regions.
Table 7.1 shows the effects of using different number of TACs and TACs with
different kinetic variation on the performance of the SIMEHill method. It can be seen
from ’4 TACs’ that removing the superior frontal cortex TAC, which has similar ki-
netics to parietal cortex, has improved the VT estimates in Striatum and reduced
the percentage error from 11.7% to 4.2%. This percentage error increased to 15.2%
when TAC derived from hippocampus was removed instead (shown as 4 TACs 2).
Similar results were observed for parietal cortex, where the percentage error was
13.6% when TAC from cerebellum was included compared to 17.5% where TAC
from superior frontal cortex was included instead. Using 3 TACs in the analysis
increased this percentage error to the range of 27% to 40.1%, significantly worse
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Figure 7.14: Intraclass Correlation Coefficient (ICC) of VT estimates showing the reliabil-
ity of the VT according to test-retest results. Maximum reliability is repre-
sented as +1 where minimum reliability is represented by -1.
than results obtained using 4 TACs. Similar to the previous results, using 3 TACs
with a larger kinetic variation yielded more accurate estimates than 3 TACs with
poorer kinetic variation (’shown as 3 TACs 2’). Using 2 TACs with different ki-
netics produced estimates significantly better than 3 TACs with similar kinetics and
with comparable accuracy to 3 TACs with different kinetics. Overall, these results
indicate that using 4 or more regions in the analysis improved the performance of
the SIMEHill method whereas increasing the kinetic variation between the TACs
further improved the accuracy of the estimates.
The intraclass correlation coefficient (ICC) results shown in figure 7.14 in-
dicates the reliability of the SIMEConstrained2 and SIMEHill by comparing the VT
estimates obtained in test and retest studies. The SIME and SIMEConstrained2 were
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not included in this analysis as previous results had shown that these two methods
produced less accurate VT estimates. In this figure, positive 1 represents the max-
imum reliability whereas the negative 1 represents the minimum reliability. The
ICC results of these two methods were compared against the ICC score of VT es-
timates calculated using AIFSamples. It can be seen that both SIMEConstrained2 and
SIMEHill had positive ICC values in all of the 5 regions, showing that these methods
had reliable performances, yielding similar results between test and retest studies.
However, both of these SIME methods produced estimates with lower reliability
compared to gold standard arterial samples. It can be said that SIMEConstrained2 and
SIMEHill had comparable performances in overall as they had similar ICC scores
in 4 of the 5 regions. SIMEHill had noticeably higher ICC score in superior frontal
cortex compared to SIMEConstrained2
7.4 Discussions and Conclusions
In this chapter, our work to incorporate prior image-derived AIF information in
the SIME analysis of dynamic PET is presented. Different methods with various
amount of prior information were evaluated and results were presented. Anatom-
ical MR images were used with the Single Target Correction PVC method to get
a good measurement of whole blood TAC. Results in Chapter 4 had showed that
this method could reliably be used to obtain the image derived input function in
18F-FDG studies. In this chapter, a similar method was used to derive the whole
blood concentration in [11C]-SB207145 tracer studies and results indicated that the
proposed method could return an accurate measurement of the whole blood concen-
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tration with similar results to gold standard arterial samples.
The Constrained SIME approach with prior information derived from IDIF
or whole blood concentrations was implemented to analyse 18F-FDG and [11C]-
SB207145 studies. For the 18F-FDG analysis, the method was used to derive the
AIF by fitting TACs from cerebellum, striatum, grey matter, and white matter. The
derived AIF was used to perform kinetic analysis of these ROIs individually to
derive kinetic parameters (K1-k4) and calculate the influx constant, Ki. Results indi-
cated that the original SIME approach with no prior information overestimated the
Ki in all of the ROIs compared to the Ki values estimated using arterial samples.
Introducing the prior information derived from the IDIF reduced this error and im-
proved the accuracy of Ki estimates. The greatest improvement was seen in the K1
andk2 parameter estimates whereas less improvement was observed in the k3 and k4
estimates.
An adapted version of the constrained SIME was used to analyse [11C]-
SB207145 serotonin receptor studies. Kinetic analysis of this tracer requires infor-
mation about concentration of metabolite products which is traditionally done using
arterial sampling. SIME method could be a non-invasive alternative to analyse such
tracers but it was observed that it produced large amount of errors in the estimated
parameters when no blood sampling was performed to normalise the AIF. Using
prior AIF information derived from PV corrected whole blood curves improved the
K1, k2 and more importantly VT estimates which is one of the main sought param-
eters in the analyses of this tracer. It was also observed that modelling the parent
fraction during the optimisation also helped to further improve the performance of
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the SIME, bringing results closer to gold standard arterial samples.
We also presented a simplified version of the constrained SIME, called
SIMEHill which can be used to analyse tracers with radiometabolites. Instead of
fitting the estimated parent fraction separate to SIME, the parent function model
was incorporated into the SIME cost function and its parameters were estimated
simultaneously with kinetic parameters of multiple ROIs. This method has the ad-
vantage of having less parameters than constrained SIME method as it fits three
parameters of the Hill function, which is a parametric function of the parent frac-
tion, rather than six parameters of the AIF. The fitted Hill function was multiplied
with the image derived whole blood TAC and a population based plasma to whole
blood concentration to derive the metabolite free AIF. Results showed that SIMEHill
was able to recover the AIF correctly and was able to estimate VT , K1, and k2 with
good accuracy. The two latter are the parameters which are directly linked to AIF
which be the reason behind these findings. The intraclass coefficient results showed
that both SIMEConstrained2 and SIMEHill had reliable performance in estimating VT
in test and retest studies. In overall it can be said that SIMEHill had a slightly better
performance compared to SIMEConstrained2 and can be favoured in practice as it has
reduced number of parameters to estimate within the SIME cost function.
The proposed SIMEHill requires an accurate measurement of the whole blood
curve from PET images and knowledge of a model which can be used to define
the parent fraction which can be specific to the used tracer [Tonietto et al., 2016].
Results of this work showed that the percentage error on VT estimates was halved
when a 4th TAC was added. This percentage error was further reduced when the
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4th TAC had a different kinetic behaviour from the rest of the TACs. Therefore,
it can be conluded that at least 4 TACs are required for accurate VT estimates and
reliability of the method can be improved as the differentiability between the TACs
is increased.
In this work, we presented results using the Hill function which had been previ-
ously shown as a suitable function to fit blood sample derived parent fraction curves
in [11C]-SB207145 studies. Constrained bi-exponential curves with 3 parameters is
also an alternative function which can be used to analyse [11C]-SB207145 [Marner
et al., 2009]. An accurate definition of the plasma to whole blood ratio can be es-
sential for the analysis of some tracers, where large amount of binding occurs in red
blood cells. The errors present in the population based plasma to whole blood ratio
used in this work could be one of the reasons for the observed differences between
SIME derived and blood sample derived AIFs.
The constrained SIME method can be an alternative method to estimate the
kinetic parameters in 18F-FDG PET studies without any need for blood sampling.
It requires presence of a suitable carotid artery in the field of view and a high res-
olution anatomical MR image of head and neck region to perform a reliable artery
segmentation. However, as we are able to derive an IDIF in 18F-FDG PET studies,
the constrained SIME can be a more complex and less practical way of estimating
kinetic parameters. The constrained SIME can be particularly useful if the tail of
an IDIF is affected by motion artefacts or high amount of noise in the reconstructed
PET images. In such cases, an accurate definition of the AIF peak can be adequate
to derive an accurate definition of kinetic parameters using the constrained SIME.
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In addition, the AIF derived from a SIME method will be free of delay and disper-
sion whereas an IDIF derived from a common carotid artery might slightly suffer
from these effects.
The constrained SIME, or more practical SIMEHill can be used to eliminate
the need for arterial sampling for the analysis of PET tracers with radiometabolite
products present in the blood plasma. In order to use these methods, the dynamic
PET acquisition had to be complemented with anatomical MR images such as T1
weighted MPRAGE, or preferably TOF-MR angiograms to be used in artery seg-
mentation. This method can potentially be used to analyse other PET tracers where
the binding to red blood cells is slow and tracer concentration in plasma and whole
blood are similar in the early part (first 60 seconds) of the scan upon tracer injection.
A slow formation of the metabolite products is also essential to use this method in
derivation of the parent AIF. For instance, if a PET tracer uptake is present in the
lungs, radiometabolite products can rapidly form and return to blood plasma during
the first pass of the tracer, causing differences in the early parts of parent AIF and
whole blood TACs. An AIF derived from a dynamic MRI study can be also be used
to derive information regarding the early part of the AIF, which will not be affected
by these changes in parent plasma and whole blood PET tracer concentrations. Dy-
namic MR techniques also benefit from their high temporal resolution abilities to
produce a more accurate definition of the AIF peaks. Similarities between PET
derived and MR derived AIFs were presented in chapter 6 and but use of an MRI
derived AIF in PET SIME is still needs to be validated in clinical studies.
In conclusion, this chapter present a method which can be used to non-
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invasively analyse dynamic PET data, even in the presence of radiometabolites.
Anatomical MR images were used with STC PVC method to get a good mea-
surement of whole blood TAC. The parent fraction of the tracer in the plasma was
modelled using a parametric equation with parameters estimated using constrained
SIME. The product of whole blood TAC, constrained SIME derived parent frac-
tion and population derived plasma to whole blood relationship was computed to
obtain the AIF. The proposed method was able to derive VT , K1 and k2 parameters
accurately. Parameters k3 and k4 could be derived with larger errors.
Chapter 8
Conclusions and future work
8.1 Conclusions
As a result of growing interest in the PET community to use novel tracers in neuro-
receptor studies as well as to quantify the tumour diagnosis in oncology studies,
increasing attention is being given to using dynamic studies which can provide a
more detailed quantification of the system of interest compared to traditional Stan-
dard Uptake Value measurements. Dynamic PET data can be analysed using kinetic
modelling techniques where an accurate measurement of the arterial input func-
tion, the concentration of parent tracer in plasma over time, is required. The gold
standard method to obtain the AIF requires withdrawal of multiple arterial sam-
ples during the course of the PET scan which are further analysed to measure the
concentration of tracer in plasma for each sample. Due to its invasiveness and the
labouring work it requires to obtain the AIF, arterial sampling is often avoided in
clinical practice.
There has been an increasing amount of work to develop less invasive and
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more automatic methods which can measure image derived input functions from
PET images. In the presence of a suitable artery or vascular structure in the PET
field of view, the changing concentration of tracer in the blood can be measured by
placing a volume of interest and measuring the activity for each PET frame. How-
ever, accuracy of a such measurement directly from PET images is restricted by
the low spatial resolution and high statistical variance of the PET data. Further-
more, radiometabolites, which are radioactive side products which can form in the
body organs and return to blood plasma contributing to the blood signal, can make
measurement of an IDIF more challenging.
With the commercial availability of the hybrid PET/MR scanners, excellent
soft tissue contrast and high spatial resolution of MR images can be easily acquired
and used to complement the quantitative information obtained from PET data. In
this work, we used time of flight MR Angiography images with high blood signal
contrast to perform an accurate segmentation of the common carotid arteries from
lower head and upper neck region. Dynamic 18F-FDG PET frames were registered
to MRA space and partial volume correction of PET images was performed us-
ing Single Target Correction method. The STC method can be a practical way of
performing PVC for IDIF measurement applications as it only requires the segmen-
tation of carotid arteries and does not require additional parcellation of background
regions. The performance of the implemented IDIF measurement method was com-
pared to gold standard arterial samples in 18F-FDG studies and results have shown
that the proposed method was able to recover the AIF accurately and obtain cM-
RGlc estimates with no statistically significant difference to arterial samples. The
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proposed method was also applied to measure the wholeblood TAC from [11C]-
SB207145 PET images and an accurate TAC could be measured in the vast majority
of the datasets.
Kinetic analysis of dynamic MRI data also requires a reliable measurement
of the AIF, which represents the concentration of Gadolinium based contrast agent
in the blood plasma. We studied the presence of any mutual information between
PET derived and MR derived AIFs and tested if a reliable AIF conversion between
modalities can be performed. The different injection durations used in the admin-
istration of PET tracer and MRI contrast agent had to be accounted for before an
AIF conversion can be made. We proposed an AIF model which can model the
effects of the used injection duration on the AIF bolus shapes and allows the ad-
justment of PET and MRI AIFs to same injection durations. We have analysed 4
pairs of AIFs derived from [18F]fluorocholine PET and DSC-MRI datasets using
this model and observed similar bolus shapes in the early part of the AIFs once the
differences caused by different injection durations were elimiated. The early part of
the input function is dominated by blood flow and vascular characteristics, which
are expected to be similar if the PET and MRI acqusitions are performed simultane-
ously or on the same day. The two AIFs started to deviate after the recirculation as
the PET tracer and Gadolinium contrast agent have different clearance and washout
characteristics. Results showed that parameters representing the early part of the
AIF could be converted reliably from PET to MRI or vice versa. It can be argued
that using an MRI technique with a high temporal resolution over PET with limited
temporal sampling abilities can be advantageous since the rapid changes happening
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in the early part of the AIF can be defined more accurately.
Simultaneous estimation method is another image-based method which can be
used to derive the AIF simultaneously by fitting multiple TACs from different tissue
regions. This method has the ability to recover a metabolite-free AIF in the presence
of metabolites in the blood but often suffer from computational complexity due to
large number of parameters estimated at once. SIME is usually accompanied by
one or more blood samples to normalize the estimated AIF. It can be hypothesised
that information derived from a reliable image-based blood measurements with PV
correction or from an MRI derived AIF can be used as prior information to decrease
the number of parameters simultaneously estimated in the SIME method, reducing
the computational complexity. We showed that the early part of a parameterised
PET-AIF can be accurately measured from an MRI-AIF and this information can
be used to fix some of the AIF parameters to priorly measured values. Results from
analysis of simulated 18F-FDG data showed that incorporating the prior information
highly improved the parameter estimation and reduced the bias on the estimated Ki
values.
The wholeblood curves which can be measured with a good accuracy using
the proposed IDIF extraction method was also used to reduce the difficulties faced
in the SIME method. For the PET tracers with negligible uptake in the lungs and
red blood cells, the radiometabolites start to build in the blood plasma after the first
recirculation. Hence, it can be said that early peak of a wholeblood curve will be
minimally affected for these tracers and similar shapes between wholeblood TAC
and parent AIF boluses are expected to be seen. We have utilised this phenomenon
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to developed a constrained SIME, called SIMEconstrained and where fitted image de-
rived wholeblood TACs were used to fix two of the AIF parameters in the SIME. As
a proof of concept, this method was firstly tested on 18F-FDG data obtained from
healthy volunteers. Similar to results of the simulations study, introducing prior
AIF information improved the AIF recovery and the accuracy of the parameter es-
timation. The constrained SIME method was also used to noninvasively analyse
dynamic [11C]-SB207145 PET datasets which traditionally requires arterial blood
samples for metabolite correction. Similar to 18F-FDG analysis results, using con-
strained SIME with less parameters improved the accuracy of estimated parameters.
It was also observed that introducing additional constrains by modelling the parent
fraction, the ratio of metabolite free parent tracer concentration to plasma concen-
tration, using a parametric model further improved the SIME performance.
As results indicated that modelling the parent fraction yielded more accurate
kinetic parameter and volume of distribution estimations, we developed a simplified
version of the SIMEconstrained called SIMEHill. In this model, the parent fraction was
modelled using a parametric model called the Hill function with three parameters.
Instead of directly estimating the AIF parameters in the SIME, parameters of the
Hill function were estimated by fitting multiple TACs from different brain regions.
The product of the image derived wholeblood curve, SIME fitted Hill function and a
population based wholeblood to plasma curve was computed to derive the metabo-
lite free AIF. It was observed that using this AIF was able to estimate VT, and 2 of
the 4 microparameters, K1, and k2, accurately with similar results to arterial sam-
ples. The results showed that the proposed method with prior information derived
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from image derived wholeblood curve and modelled parent fraction can be used
as an alternative noninvasive method to perform kinetic analysis of tracers with
metabolite products.
8.2 Future work
In this section, several recommendations to extend the work reported in this thesis
are listed.
• Due to the lack of availability of arterial blood samples together with dynamic
PET and dynamic MRI data, the constrained SIME method with MR derived
prior AIF information was never fully validated. Since an MR-compatible se-
rial blood sampling equipment, such as Swisstracer [Alf et al., 2013] was not
available, we were not able to design an in-house experiment to perform dy-
namic PET acquisition, dynamic MR acquisition and arterial blood sampling
to measure the PET tracer concentration for gold standard AIF measurements.
[18F]fluorocholine PET and DSC-MRI datasets were used to study the simi-
larities between PET and MRI derived AIFs but this work was not extended
to be analysed using SIME since [18F]fluorocholine has limited uptake in the
brain which prevents extraction of multiple TACs and hence use of SIME for
the analysis of this tracer. Future work can include design of a more compre-
hensive experiment with simultaneous dynamic PET and MRI acquisitions
complemented with an arterial blood sampling protocol to evaluate the in-
corporation of MRI-AIF derived information into analysis of dynamic PET
data using constrained SIME approach and validate the results against gold
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standard arterial sample derived AIFs.
• The SIME method requires input of at least 3 TACs with varying kinetic be-
haviours for a reliable performance. In this work, we used both manual and
automatic method to extract TACs from different brain regions. However,
the TACs were examined manually to choose regions with different kinetics.
This can be extended by implementing a clustering algorithm to automatically
choose TACs with different uptake and binding patterns. A similar technique
was presented by Guo et. al [Guo et al., 2003], where a distance measure-
ment was applied to cluster voxel derived TACs. A similar technique was
also applied to automatically extract a suitable reference region in brain PET
studies [Yaqub et al., 2012]. Automatic extraction of TACs can improve the
accuracy of SIME method as it can determine TACs with the highest kinetic
variations more easily than manual observations.
• In this work, ITK-SNAP was used for the segmentation of carotid arteries
from TOF-MR Angiography images with a clustering and region growing al-
gorithm. The region growing stage requires the user to input initial starting
points on each carotid artery which later expands in 3D and delineate the ar-
terial voxels. Even though this step only requires a minimal user input, an
automatic carotid artery segmentation method can be used instead to speed
up the IDIF extraction method. Adaptive segmentation methods for fully au-
tomatic segmentation of carotid arteries from TOF-MRA images are available
in the literature [Wilson and Noble, 1999] [Bogunovic et al., 2011] and have
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been accurately used in similar IDIF extraction methods [Su et al., 2013a] [Su
et al., 2015].
• Currently, the Single Target Correction method assumes a single background
region and corrects for spill-over effects by performing a voxelwise correction
to the carotid arteries and the neighbouring background regions. The STC
can be improved by implementing a voxel clustering algorithm to determine
voxels with similar intensities and group them to automatically form multiple
regions in the background. This can improve the performance of the PVC by
reducing the noise present in the background region.
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